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Abstract 
 
Introduction: The mammalian neocortical areas arise from graded/regionalized gene 
expression from the earliest stages of corticogenesis. However, little is known about the 
establishment of the human motor cortex, despite being a common site of perinatal 
damage causing cerebral palsy. Affymetrix gene chip analysis of human neocortical 
tissue from 8-12.5 post-conceptional weeks (PCW) previously discovered genes 
expressed in gradients along the anterior-posterior human neocortex. 
Aims: i) Identify putative anterior/posterior molecular determinants of the developing 
human neocortex. ii) Test the hypothesis that the anterior pole of the human neocortex 
as an early site of the developing motor cortex generating corticofugal neurones and 
understand their development. iii) Establish a human in-vitro regionalisation model and 
study potential regulatory mechanisms of some corticofugal neurone-related genes. 
Results and Conclusion: Graded expression of some putative anterior/posterior 
markers was confirmed in the human neocortex by real-time PCR (8-12 PCW). Among 
them, the corticofugal neurone-related genes (transcription factor CTIP2, axon guidance 
molecule ROBO1 and its downstream signalling molecule SRGAP1) were up-regulated 
anteriorly. Their spatiotemporal expression patterns were examined further by tissue in-
situ hybridization and immunohistochemistry, and compared with other corticofugal 
neurone-related transcription factors that showed no/opposite expression gradients 
(FEZF2 and SOX5) and various laminar-enriched markers previously established in 
humans (ER81, TBR1, TBR2, GAP43 and Synaptophysin) or validated in the current 
project (SATB2 and NURR1). Layer V was shown to arise as early as 12 PCW in 
humans. Prominent medullary pyramids containing corticospinal fibres strongly 
expressed both ROBO1/SRGAP1 by 14-17 PCW, when a distinct ROBO1/SRGAP1-
positive Layer V emerges. Co-expression of the three genes in anterior neocortex might 
mark the site of the emerging human motor cortex, which is the predominant origin of 
corticofugal neurones such as corticospinal/corticopontine projection neurones. 
Dissociated neocortical cell cultures were established from anteriorly-/posteriorly-
derived foetal neocortex that maintained regional intrinsic molecular identities. This in-
vitro model of regionalization allowed gene regulation study to be performed in which a 
preliminary investigation of fibroblast growth factor signalling in controlling the 
expression of corticofugal neurone-related genes was initiated.  
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GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GC-RMA Gene Chip-Robust Multi-array Average 
gDNA Genomic deoxyribonucleic acid 
GE Ganglionic eminence 
GFAP Glial fibrillary acidic protein 
GLAST Astrocyte-specific glutamate transporter  
GO Gene Ontology 
GRIA3 Glutamate receptor, ionotropic, AMPA 3 
Grg1/4 Groucho-related gene 1/4 
Gsh2 Glutathione synthetase homeobox 2 
H & E Haematoxylin and eosin 
HASH1 Achaete-scute complex homolog 1 (Human) 
HBSS Hank‟s balanced salt solution 
HDBR Human Developmental Biology Resource 
HRP Horseradish peroxidase 
HSPGs Heparin sulphate proteoglycans 
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ICC Immunocytochemistry 
IFL Inner fibrous layer 
Ig Immunoglobulin 
IGH Immunoglobulin heavy chain variable region 
IHC Immunohistochemistry 
INPs Intermediate neuronal precursors 
IPCs Intermediate progenitor cells 
ISH In-situ hybridization 
ISVZ Inner subventricular zone 
IZ Intermediate zone 
KCC2 K
+
 Cl
–
 co-transporter 2 
kDa Kilodalton 
KO Knock-out 
LDS Lithium dodecyl sulfate 
LGE Lateral ganglionic eminence 
Lhx6 LIM homeobox 6 
LSD Least significant difference 
M Molar 
M1 Primary motor cortex 
MAP2 Microtubule-associated protein 2 
MAPK Mitogen-activated protein kinase 
MARs Matrix attachment regions 
Mash1 Achaete-scute complex homolog 1 (Murine) 
MEM Minimum essential medium  
MGE Medial ganglionic eminence 
MTT Methylthiazol tetrazolium 
MZ Marginal zone 
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n= (number) Number of embryos/foetuses used 
NAALADL2 N-acetylated alpha-linked acidic dipeptidase-like 2 
NCBI National Center for Biotechnology Information 
NCOR2 Nuclear receptor co-repressor 2 
NEK9 Never in mitosis gene A (NIMA)-related kinase 9 
NeuroD Neurogenic differentiation factor 
Ngn1/2 Neurogenin 1/2 
NIH National Institute of Health 
Nkx2.1 Nk2 homeobox 1 
NPY Neuropeptide Y 
nr Non-redundant protein sequences 
NREC Newcastle and North Tyneside Research Ethics Committee 
Nrg1/3 Neuregulin 1/3 
Nrp2 Neuropilin 2 
NRQ Normalized relative quantities 
Nurr1 Nuclear receptor-related protein 1  
Oct6/7 Octamer-binding transcription factor 6/7 
OSVZ Outer subventricular zone 
Otx1 Orthodenticle homeobox 1 
p≤ Probability 
P(number) Postnatal day 
Pax6 Paired-box 6 
PBS-T Triton X-100 / phosphate buffered saline 
PCDH17 Protocadherin 17 
PCW Post-conceptional weeks 
Pea3 Polyomavirus enhancer activator 3 
PFA Paraformaldehyde 
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PI3 Phosphatidylinositol-3 
PKC Protein kinase C 
PLCγ Phospholipase Cγ 
PlxnB2 Plexin receptor B2 
POA Preoptic area 
PP Preplate 
PSB Pallial-subpallial boundary 
PV Parvalbumin 
RC2 Radial glial cell marker 2 
RGCs Radial glial cells 
RNF13 Ring finger protein 13 
Robo1/2/3 Roundabout 1/2/3 
RORβ Retinoic acid-related orphan receptor beta 
RP Reverse primer 
RREB1 Ras responsive element binding protein 1 
rtPCR Real-time polymerase chain reaction 
S1 Primary somatosensory cortex 
S100A10 S100 calcium binding protein A10 
Satb2 Special AT-rich sequence-binding protein 2 
SDHA Succinate dehydrogenase complex subunit A 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
S.E.M. Standard error of mean 
Sema3F Semaphorin 3F 
Sfrp2 Secreted frizzled-related protein 2 
SG Subpial granular layer 
Shh Sonic hedgehog 
siRNA RNA interference 
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SNPs Short neural precursors 
Sox2/5 Sex determining region Y (SRY)-box 2/5 
SP Subplate 
Sp8 Specificity protein 8 
SPARC Secreted protein acidic and rich in cysteine (Osteonectin) 
Spry1/2 Sprouty 1/2 
SRGAP1/2 SLIT-ROBO Rho GTPase activating protein 1/2 
SSC Sodium citrate 
SST Somatostatin 
Svet1 Subventricular expressed transcript 1 
SVZ Subventricular zone 
Tbr1/2 T-box brain 1/2 
TBS Tris-based buffer 
Tgfα Transforming Growth Factor alpha 
Tle1/4 Transducin-like enhancer of split 1/4 
Tlx T-cell leukemia homeobox 
TMS Transcranial magnetic stimulation 
U Units 
UTR Untranslated region 
V Volt 
vGlut1/2 Vesicular glutamate transporter 1-2 
V1 Primary visual cortex 
VB Ventrobasal complex 
VIP Vasointestinal peptide 
VL Ventrolateral nucleus 
VZ Ventricular zone 
WDR81 WD repeat domain 81 
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Wnt2b/3a/5b/7a/8b Wingless 2b/3a/5b/7a/8b 
ZFYVE1 Zinc finger FYVE domain-containing protein 1 
µg Microgram 
μl Microlitre 
µm Micrometer 
µM Micromolar 
mA Milliamps 
ml Millilitre 
mM Millimolar 
mm Millimetre 
ng Nanogram 
nm Nanometre 
ρmol Picomole 
Chapter 0 Gene Nomenclature 
Gene Nomenclature 
 
Species Gene Symbol Protein Symbol 
Homo sapiens SATB2 SATB2 
Mus musculus 
Rattus norvegicus 
Satb2 Satb2 
Drosophila melanogaster 
Xenopus laevis 
satb2 satb2 
Table 0.1. Gene and protein symbol conventions. 
Special AT-rich sequence-binding protein 2 (SATB2) is used as an example. Gene symbols are 
in italics and protein symbols are in normal fonts. Human (Homo sapiens) gene/protein symbols 
are capitalized. The first letter of rodent (Mus musculus, Rattus norvegicus) gene/protein 
symbols are capitalized followed by small letters. The gene/protein symbols for invertebrates 
described in this thesis (Drosophila melanogaster, Xenopus laevis) are all in small letters. 
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Chapter 1  Introduction 
 
1.1 Corticogenesis in the Neocortex  
 
The mammalian neocortex is a highly differentiated structure which arises from the 
dorsal telencephalon, and thus is also known as the dorsal pallium. Neocortical 
neurogenesis is initiated in anterolateral domains and it progresses posteromedially 
(McSherry and Smart, 1986), accounting for the uneven thickness of the neocortex 
along these tangential axes. During development, the neocortex differentiates radially 
from a morphologically uniform structure into a six-layered cortex, with neurones and 
glia arising at different developmental stages. Two main types of neurones are found in 
the mature neocortex: 20-30% are interneurones (non-pyramidal) and 70-80% are 
projection (pyramidal) neurones.  
 
1.1.1 GABAergic Interneurones of the Neocortex 
 
Classification of Neocortical Interneurones 
 
The majority of the neocortical interneurones are inhibitory and utilize gamma-
aminobutyric acid (GABA) as a neurotransmitter (Marin and Rubenstein, 2001). 
Neocortical interneurones can be subdivided on the basis of different properties, such as 
morphology, electrophysiology, ion channels composition and molecular profile 
(Markram et al., 2004). They are located in different layers and form multiple synaptic 
connections primarily with pyramidal projection neurones to strategically control their 
neuronal activities (Markram et al., 2004). A recent review has outlined the 
conservative grouping of mice neocortical interneurones into four major classes: i) fast-
spiking, Parvalbumin (PV)-expressing basket and chandelier cells, ii) intrinsically burst-
spiking or adapting non-fast-spiking, Somatostatin (SST)-expressing Martinotti cells 
with the majority of them extend their long axons into the neocortical Layer I (marginal 
zone, MZ), iii) rapidly adapting, Calretinin (CR)- and/or Vasointestinal peptide (VIP)-
expressing bipolar or double-bouquet cells, and iv) rapidly adapting, Neuropeptide Y 
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(NPY)- and/or Reelin-expressing (but not SST) multipolar interneurones (Figure 1.1; 
(Gelman and Marin, 2010)). These neocortical interneurone subtypes are found to be 
largely in common between different mammalian species, however some subtypes in 
humans and non-human primates, such as the double bouquet cells (DeFelipe et al., 
2006; Yanez et al., 2005) or interneurones of the preplate (PP)/MZ exhibit more 
elaborate morphology and distribution (Bystron et al., 2008; Meyer, 2007; Rakic and 
Zecevic, 2003). 
 
 
Figure 1.1. Cortical interneurone subtypes in mice neocortex. 
There are four major groups of neocortical interneurones identified in the mouse neocortex: i) 
fast-spiking, Parvalbumin (PV)-expressing basket and chandelier cells; ii) intrinsically burst-
spiking or adapting non-fast-spiking, Somatostatin (SST)-expressing Martinotti cells, which can 
be further subdivided by Reelin, Calretinin (CR) and/or Neuropeptide Y (NPY) expression; iii) 
rapidly adapting, CR- and/or Vasointestinal peptide (VIP)-expressing bipolar or double-bouquet 
cells; and iv) rapidly adapting, Reelin- and/or NPY-expressing (but not SST) multipolar 
interneurones. Adapted from (Gelman and Marin, 2010). 
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Origin and Migration of Neocortical Interneurones 
 
In rodents, nearly all the neocortical interneurones are generated in the proliferative 
regions of the subpallial telencephalon, including the medial ganglionic eminence 
(MGE; 50-60%), caudal ganglionic eminence (CGE; 30-40%) and preoptic area (POA; 
8-10%) predominantly, and to a lesser extent, the lateral ganglionic eminence (LGE), 
and septum (at E11 in mice), and migrate tangentially into different regions of the 
developing brain including the neocortex and olfactory bulb later in the development (at 
E13 and E15 in mice) (Gelman and Marin, 2010; Marin and Rubenstein, 2001). The 
interneurones migrate tangentially into the neocortex along different routes as 
neocortical layers are sequentially formed (described in Section 1.1.2): briefly, during 
early neurogenesis the interneurones enter the neocortex via the PP; while during mid 
stages of neurogenesis, they travel through the intermediate zone (IZ) and MZ; and 
during late stages they migrate mainly through the lower IZ/subventricular zone (SVZ), 
subplate (SP) and MZ (Metin et al., 2006).  
 
In general, fate-mapping analyses in mice (Gelman and Marin, 2010; Miyoshi et al., 
2010; Gelman et al., 2009; Wonders and Anderson, 2006) have shown that: 
1)  PV-containing neocortical interneurones are produced predominantly from the 
ventral MGE.  
 2) SST-containing neocortical interneurones are derived from the dorsal MGE with 
some of them also co-expressing Reelin, NPY and/or CR. 
 3)  CGE on the other hand is the source of interneurones that express primarily CR 
(but not SST or PV) and/or VIP. 
 4)  An additional population of interneurones derived from CGE express Reelin with 
some of them co-expressing NPY.  
5)  POA is recently identified as a source of neocortical interneurones, and is 
believed to generate interneurones with molecular profiles similar to MGE- (PV-, 
SST-expressing) and CGE- (NYP- and/or Reelin-expressing) derived 
interneurones.  
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6) The dorsal LGE generates interneurones that migrate towards the olfactory bulb 
expressing CR, while the ventral LGE and septum produce some unknown 
populations of neocortical interneurones. 
 
However evolutionary changes have been observed in humans (Letinic et al., 2002) and 
in non-human primates (Petanjek et al., 2009b; Petanjek et al., 2009a). The major 
sources of neocortical interneurones are the germinal layers of the neocortex: 
ventricular zone (VZ) and SVZ, and the proportion of the subpallium-derived 
neocortical interneurones decreases (Figure 1.2; (Petanjek et al., 2008)). Ganglionic 
eminence (GE)-derived interneurones also migrate through the IZ and SVZ within the 
neocortex as observed in rodents, nevertheless both GE- and neocortical-derived 
interneurones eventually populate the neocortical layers II-VI arise from the cortical 
plate (CP) (Petanjek et al., 2009b; Petanjek et al., 2009a). A recent study has identified 
the origins of different interneurones subtypes in brain tissues obtained from human 
foetuses or infants suffered from holoprosencephaly with severe striatal hypoplasia and 
revealed changes of expression of neocortical GABAergic interneurone markers 
(Fertuzinhos et al., 2009). As a subset of NPY- and SST-expressing neocortical 
interneurones are shown to be significantly reduced or absent due to striatal hypoplasia, 
the authors suggest these neurones are of subpallial origin; whereas the unaffected 
interneurones containing CR are generated locally (Fertuzinhos et al., 2009). 
 
 
13 
 
 
Figure 1.2. Origins of neocortical interneurones. 
Schematic diagrams showing developmental changes of origins of rat, monkey and human 
neocortical interneurones presented on schematized coronal sections of human brains of 14 
gestational weeks at an anterior level in the presence of ganglionic eminence (GE), thalamus 
(Th), hypothalamus (Hyp), caudate nucleus (S), putamen (P) and corpus callosum (CC). During 
early neurogenesis, nearly all neocortical interneurones are generated in the GE which have 
migrated tangentially into the developing rat neocortex (red arrows, A). In humans and 
monkeys, some radially migrating neocortical interneurones begin to be derived in the 
proliferative zones of the most dorsal part of the neocortex (blue arrows, C), and gradually 
increases throughout the developing neocortex as development progresses (blue arrows, D, E). 
Meanwhile, the proportion of GE-derived neocortical interneurones is decreasing (red arrows, 
D, E). During late stages of neurogenesis in rats, a small population of neocortical interneurones 
is also found to be produced locally in the proliferative zones of the neocortex (blue arrows, B). 
Adapted and modified from (Petanjek et al., 2008). 
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Molecular Specification and Differentiation of Neocortical Interneurones 
 
GABAergic interneurone fate and localization (pallium vs. subpallium; LGE vs. MGE 
vs. CGE) are regulated by various transcription factor genes expressed by their 
progenitors locating in these different domains. Briefly, studies in rodents have 
identified Paired-box 6 (Pax6) and Glutathione synthetase homeobox 2 (Gsh2) having 
opposing effects in order to specify progenitors in the pallium and subpallium into 
becoming projection neurones or interneurones respectively (Yun et al., 2001; Toresson 
et al., 2000). Together they are expressed in an over-lapping pattern by progenitors in 
the dorsal LGE during early neurogenesis, marking out the boundary between dorsal 
LGE and MGE (Yun et al., 2001; Stoykova et al., 2000; Toresson et al., 2000).  
 
Within the MGE, Nk2 homeobox 1 (Nkx2.1) specifies progenitors into adopting the 
MGE fate whereby their progenies migrate towards the globus pallidus (mantle zone of 
MGE), instead of adopting the LGE fate towards the striatum (mantle zone of LGE) 
(Sussel et al., 1999). A study which transplanted GFP-positive MGE cells into host 
embryos to map the fate of these cells postnatally from distinct domains of the MGE 
elegantly demonstrated that the two major neocortical (PV- and SST-expressing) 
interneurones are generated by progenitors residing in different MGE domains, thus 
providing evidence for the existence of distinct progenitor pools within the MGE 
(Flames et al., 2007).   
 
The CGE is considered as the caudal extension of LGE and MGE that fuse together and 
is distinguishable on coronal sections in the presence of mid- to caudal-diencephalic 
structures. Thus the dorsal domain of CGE strongly expresses Gsh2, similar to the 
dorsal LGE, whereas the ventral domain of CGE expresses Nkx2.1, as observed in the 
MGE (Wonders and Anderson, 2006). Interestingly, recent transcriptomic analyses of 
the CGE have revealed progenitor domains with unique molecular profiles distinct from 
those found in the LGE and MGE (Willi-Monnerat et al., 2008). Chicken ovalbumin 
upstream promoter transcription factor II (CouptfII) is found to be highly expressed by 
progenitor cells within the CGE and involved in mediating the migration of 
interneurones into the neocortex via the caudal migratory stream (Kanatani et al., 2008).  
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In all the domains of the ganglionic eminence, GABAergic phenotypic specification of 
progenitors is controlled by Achaete-scute complex homolog 1 (Ascl1/Mash1) and  
Distal-less homeobox 1/2 gene (Dlx1/2) as they regulate the expression of the GABA 
synthesizing enzyme, Glutamic acid decarboxylase (Gad) (Stuhmer et al., 2002; Fode et 
al., 2000; Casarosa et al., 1999). As these progenitors exit the cell cycle, the post-
mitotic interneurones either migrate towards the mantle zone of the subpallium or the 
neocortex. Semaphorin 3F (Sema3F)/Neuropilin 2 (Nrp2) (Marin et al., 2001) and Slit1 
and -2/Roundabout 1 and -2 (Robo1 and -2) (Andrews et al., 2008; Andrews et al., 
2007; Wichterle et al., 2003) are two repulsive mechanisms mediating the migration of 
MGE-derived neocortical interneurones to prevent them from entering the mantle zone 
of the subpallium; while Neuregulin 1 (Nrg1)/Erythroblastic leukemia viral oncogene 
homolog 4 (ErbB4) mediates the attraction of neocortical interneurones migrating 
towards the developing neocortex (Flames et al., 2004). During the migration towards 
the mantle zone of the subpallium or the neocortex, changes of gene expression are 
detected. One example is the expression of LIM homeobox 6 (Lhx6), a downstream gene 
of Nkx2.1, by the MGE-derived post-mitotic interneurones in the mantle zone of MGE 
and the neocortex (Lavdas et al., 1999; Grigoriou et al., 1998). Lhx6 is important for the 
differentiation and migration of MGE-derived interneurones, as these neurones do not 
express PV or SST and fail to migrate to their appropriate target layers in the neocortex 
in the absence of Lhx6 (Zhao et al., 2008; Liodis et al., 2007). In contrast, Nkx2.1 
expression is down-regulated in post-mitotic interneurones before entering the 
neocortex (Marin et al., 2001). This down-regulation of Nkx2.1 is paralleled by the up-
regulation of Nrp2 expression in neocortical, migrating interneurones in order to avoid 
the developing striatum (Nobrega-Pereira et al., 2008). On the contrary, Nkx2.1 
expression is maintained in post-mitotic interneurones entering the striatum, thus 
repressing Nrp2 expression and rendering the interneurones insensitive to Sema3F 
(Nobrega-Pereira et al., 2008).  
 
Changes in the molecular profiles of neocortical interneurones during development are 
also observed in humans as well as non-human primates. This may be useful to identify 
pallial vs. subpallial origins of neocortical interneurones. In humans, MASH1 is 
expressed by progenitors in the GE, but in both humans and rodents, MASH1/Mash1 is 
absent in DLX1/2/Dlx1/2-positive post-mitotic interneurones migrating away from the 
proliferative zone of GE (Figure 1.3; (Letinic et al., 2002)). On the other hand, MASH1 
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expression is maintained in post-mitotic interneurones derived from VZ/SVZ of the 
neocortex, and is probably involved in up-regulating the expression of DLX genes to 
induce the GABAergic phenotype (Figure 1.3; (Letinic et al., 2002)). Similar changes of 
gene expression were also observed in non-human primates in which Mash1 expression 
is detected in Gad65-positive neurones originating from the pallial proliferative zones 
but not in those generated from the subpallium (Petanjek et al., 2009a). Another human-
specific feature observed is the expression of NKX2.1/NKX2.1 mRNA and protein in 
the proliferative zones as well as the post-mitotic layers of the neocortex from 6-22 
post-conceptional weeks (PCW), whereas in rodents Nkx2.1 is not expressed in the 
neocortex (Rakic and Zecevic, 2003). 
 
 
Figure 1.3. Neocortical GABAergic interneurones originating in the ganglionic eminence 
and neocortex. 
The schematic diagram illustrates the molecular profiles of GABAergic interneurones that are 
generated from progenitors residing in either the ganglionic eminence (GE; blue), or the 
neocortical ventricular zone/subventricular zone (VZ/SVZ; red). The progenitors in the 
proliferative zones of the GE express MASH1 that induces the expression of DLX1/2 and then 
GABA in progenitors as well as post-mitotic interneurones as they migrate tangentially to reach 
the neocortex. MASH1 expression is down-regulated during differentiation and migration. The 
progenitors in the proliferative zones of the neocortex express MASH1, which continues to be 
expressed by migrating post-mitotic interneurones to induce the expression DLX1/2 and GABA. 
Adapted and modified from (Letinic et al., 2002). 
17 
 
1.1.2 Glutamatergic Projection Neurones of the Neocortex 
 
Origin of Neocortical Projection Neurones 
 
In contrast to neocortical interneurones, neocortical projection neurones are excitatory, 
utilizing glutamate as their neurotransmitter. Neocortical projection neurones are 
generated locally from progenitors in the neocortical proliferative zones (VZ/SVZ). As 
suggested by the radial unit hypothesis, “after progenitors have completed their 
proliferative cell divisions, post-mitotic projection neurones migrate along a common 
pathway radially to the developing CP to form ontogenetic columns” (Rakic et al., 
2009). Each of the ontogenetic columns in the developing CP contains polyclonal post-
mitotic neurones (i.e. they arise from different progenitors) and an inside-out generation 
sequence is observed (Rakic et al., 2009). Note that ontogenetic columns are different 
from functional columns which refer to groups of neurones subserving particular 
functions later e.g. neurones in barrel fields that respond to the same receptive field 
(Rakic et al., 2009). Nevertheless, each functional column comprises of several 
ontogenetic columns that originate from adjacent proliferative units in the VZ (Rakic et 
al., 2009).  
 
The rodent and human VZ maintains its thickness and homogeneous appearance 
throughout corticogenesis, however it contains a heterogeneous population of 
progenitors. Two morphologically and molecularly distinctive neocortical progenitors 
have been identified in rodents, the radial glial cells (RGCs) (Pinto et al., 2008; 
Anthony et al., 2004; Noctor et al., 2002; Hartfuss et al., 2001; Miyata et al., 2001; 
Noctor et al., 2001) and short neural precursors (SNPs) (Mizutani et al., 2007; Gal et al., 
2006), that divide at the apical surface and undertake interkinetic nuclear migration (the 
apical-basal movement of nuclei) during G1 and G2 phases of their cell cycles (Dehay 
and Kennedy, 2007). Recent study has discovered the importance of gap 
junctions/hemichannels in modulating the interkinetic nuclear migration, as gap 
junction/hemichannel-dependent calcium waves are detected in these progenitors in the 
VZ, and blockade of gap junctions/hemichannels affects the dynamics of the migration 
(Liu et al., 2010). Radial glial cell marker 2 (RC2)- and Astrocyte-specific glutamate 
transporter (GLAST)-expressing RGCs extend their basal fibres towards the pial 
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surface, spanning the entire thickness of the neocortex throughout mitotic division 
which is essential for proper radial migration of post-mitotic neurones (Gal et al., 2006). 
α-Tubulin 1-expressing SNPs on the other hand are anchored by ventricular end feet and 
have a short basal process that is retracted during mitotic division (Gal et al., 2006). 
Both RGCs and SNPs are confirmed as VZ progenitors as they express Pax6, which is 
important for neuronal fate specification, and confined to the VZ in rodents (Stancik et 
al., 2010; Heins et al., 2002). In contrast, they also reside in the human SVZ as revealed 
by presence of PAX6 expression in this layer during early corticogenesis, thus SVZ 
may be a source of additional PAX6-expressing progenitors (Fietz et al., 2010; Hansen 
et al., 2010; Bayatti et al., 2008a). 
 
As corticogenesis progresses, mitotic activities take place at the basal surface of the VZ 
resulting in the gradual formation of the SVZ, where interkinetic nuclear migration is 
not detected (Dehay and Kennedy, 2007). Here in the SVZ, a third type of neocortical 
progenitor is found, known as basal progenitors or intermediate progenitor cells (IPCs) 
or intermediate neuronal precursors (INPs, to be used throughout the thesis), these cells 
are generated from RGCs (Englund et al., 2005; Noctor et al., 2004). INPs reside within 
the SVZ expressing T-box brain 2 (Tbr2) (Englund et al., 2005; Noctor et al., 2004) 
with a small proportion shown to divide at the ventricular surface (Kowalczyk et al., 
2009; Noctor et al., 2008). Although these small number of Tbr2-positive cells dividing 
at the ventricular surface show similar morphologies to SNPs, they do not co-express α–
Tubulin 1, indicating INPs are distinct from SNPs (Stancik et al., 2010). Unlike the thin 
rodent SVZ which constitutes only a few layers of cells (Martinez-Cerdeno et al., 2006), 
the human and non-human primate SVZ expands significantly and separate into an 
inner (ISVZ) and outer (OSVZ) layer by a cell-poor/fibre-rich inner fibrous layer (IFL) 
during the mid stage of gestation (Bayatti et al., 2008a; Smart et al., 2002). As observed 
in rodents, TBR2-expressing INPs are found in the ferret and human SVZ, mostly in the 
ISVZ and also diffusely in the OSVZ and VZ (Fietz et al., 2010; Hansen et al., 2010; 
Bayatti et al., 2008a). Recently, a fourth type of progenitor was identified via 1, 1-
dioctadecyl-3, 3, 3‟, 3‟-tetramethylindocarbocyanine perchlorate (DiI) tracing from the 
pial surface along their long basal processes into the elaborate human OSVZ as well as 
the ferret SVZ, namely the radial glia-like cells that express RGCs markers, Sex 
determining region Y (SRY)-box 2 (SOX2), PAX6 and Glial fibrillary acidic protein 
(GFAP) but lack apical contact with the ventricular surface (Fietz et al., 2010; Hansen et 
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al., 2010). In contrast to the interkinetic nuclear migration of VZ RGCs, the OSVZ 
radial glial-like cells exhibit mitotic somal translocation in which the nucleus moves 
rapidly up the basal fibre before cell division (Fietz et al., 2010; Hansen et al., 2010). 
 
Different modes of division have been observed among the four types of progenitors: 
RGCs are able to divide symmetrically for self-renewal and asymmetrically for 
neurogenic differentiation to produce immature neurones as well as other neuronal 
precursor cells SNPs and INPs, thus contributing more extensively to laminar expansion 
by generating neurones for multiple layers over a longer period of time; SNPs are 
neuronal-committed precursor cells that undergo differentiative division to produce 
immature neurones, hence producing distinct neuronal populations over a shorter period 
of time as compared to RGCs; most INPs divide symmetrically to generate two 
immature neurones with a small population undergo asymmetrical division to produce 
one INP and one immature neurone (Stancik et al., 2010; Dehay and Kennedy, 2007); 
OSVZ radial glia-like cells often divide asymmetrically to produce two morphologically 
different daughter cells that both are able to proliferate before differentiation (Fietz et 
al., 2010; Hansen et al., 2010). The upper daughter cells that inherited the basal 
processes and some of the bipolar lower daughter cells continue to express SOX2 and 
are able to further proliferate, expanding the progenitor pool; other bipolar lower 
daughter cells are able to differentiate and become glutamatergic and GABAergic 
neuronal precursors expressing TBR2 or ASCL1 (also known as MASH1) (Hansen et 
al., 2010). Figure 1.4 summarizes the differential division of these neocortical 
progenitor cells during development (Fietz et al., 2010; Hansen et al., 2010; Stancik et 
al., 2010; Dehay and Kennedy, 2007). 
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Figure 1.4. Differential division of neocortical progenitor cells during development. 
Within the VZ, the RC- and GLAST-expressing radial glial cells (RGCs) extend long basal 
fibres towards the pial surface, undergo interkinetic nuclear migration and divide 
asymmetrically to produce immature neurones (red), TBR2-positive intermediate neuronal 
progenitors (INPs) and α–Tubulin 1-positive short neural precursors (SNPs), thus generating 
neurones for multiple laminae over an extended period of time. The SNPs possessing a short 
basal process and ventricular end foot also undergo interkinetic nuclear migration and give rise 
to immature neurones (red) primarily, thus supplying discrete neuronal population over a shorter 
period of time as compared to RGCs. Within the SVZ, INPs do not undergo interkinetic nuclear 
migration but divide symmetrically to produce two immature neurones (blue) primarily or 
asymmetrically to generate one INP and one immature neurone (red or blue). As development 
progresses, the human SVZ is segregated into inner and an elaborate outer compartment, 
namely the ISVZ and OSVZ respectively. The SOX2-, PAX6- and GFAP-expressing radial 
glia-like cells, which project their basal fibres towards the pial surface but lack the apical fibres, 
populate the OSVZ. They undergo mitotic somal translocation and produce upper and lower 
daughter cells. After each round of cell division, the upper daughter cells always adopt the basal 
fibres and maintain a proliferative potential by continually expressing SOX2. The lower 
daughter cells however become bipolar in morphology which are able to either divide 
asymmetrically to generate an upper proliferating SOX2-positive cell and an lower neuronal-
committed TBR2-/ASCL1-positive cell (purple), or symmetrically to generate two neuronal-
committed TBR2-/ASCL1-positive cells (purple). Adapted and modified from (Fietz et al., 
2010; Hansen et al., 2010; Stancik et al., 2010; Dehay and Kennedy, 2007). 
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The determination of proliferative vs. differentiative divisions of RGCs and INPs is 
believed to be controlled through the length of G1 phase of cell cycles, in which a 
longer G1 phase would promote differentiative divisions, while a shorter G1 phase 
would result in self-renewing proliferative divisions (Pilaz et al., 2009; Dehay and 
Kennedy, 2007). RGCs and SNPs have remarkably different cell cycle kinetics in which 
SNPs have a longer G1 phase compared to RGCs (Stancik et al., 2010). RGCs and 
SNPs also differ in terms of the effects of Notch signal transduction pathways. While 
Notch signalling inhibits differentiation of both RGCs and SNPs, RGCs but not SNPs 
signal through the canonical Notch effector C-promoter binding factor 1 (CBF1) to 
maintain their proliferative state (Mizutani et al., 2007). OSVZ radial glia-like cells also 
rely on Notch signalling to retain their proliferative potential in order to expand their 
population (Hansen et al., 2010). β3-Integrin receptors are found to be expressed along 
the basal process of ferret OSVZ radial glia-like cells, and their blockade has led to a 
reduction of these OSVZ radial glia-like cells in ferret slice cultures, proving the 
importance of retention of the basal process for self-renewal via this type of receptors 
(Fietz et al., 2010). Furthermore, transgenic mice with a fibroblast growth factor 
receptor 3 (Fgfr3) kinase domain mutation displayed increased proliferation in 
progenitors via activation of the mitogen-activated protein kinase (MAPK) pathway 
(Thomson et al., 2007; Inglis-Broadgate et al., 2005) and Fgfr1, -2 and -3 signalling is 
shown to inhibit the differentiation of RGCs to INPs (Kang et al., 2009), whereas cyclin 
D2 induces the transition from RGCs to INPs (Glickstein et al., 2009). Another gene 
deemed to be a key cell cycle regulator with differential effects temporally and 
regionally is T-cell leukemia homeobox (Tlx) (Li et al., 2008; Roy et al., 2004). In the 
absence of Tlx, expression of some cell cycle regulators such as p21 and cyclin D1 is 
affected (Li et al., 2008; Roy et al., 2004). Furthermore, the loss of Tlx has shortened 
the cell cycle length of early progenitor cells but prolonged the cell cycle length of late 
progenitor cells (temporal), eventually decreased the numbers of progenitor cells in the 
VZ posteriorly but throughout the entire anterior-posterior pole in the SVZ (regional) 
(Li et al., 2008; Roy et al., 2004). Tlx has also been shown recently to activate the 
canonical Wingless (Wnts)/β-catenin signalling pathway to stimulate adult mouse 
neural stem cell proliferation and self-renewal (Qu et al., 2010). 
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Formation of Transient Layers of the Developing neocortex 
 
Before the onset of local neurogenesis, the first post-mitotic neurones that are believed 
to be unique to humans observed in the primordium of neocortex are known as the 
predecessor cells (Bystron et al., 2006). They have multiple origins including the basal 
telencephalon and migrate tangentially into the primordium of neocortex at around 
human Carnegie Stage (CS) 12, expressing β–Tubulin and TBR1 but not Reelin or DLX 
(Bystron et al., 2006). These cells have no axons but contain processes that project 
horizontally and attach to the pial surface of the neocortex, which potentially guide and 
trigger the commencement of local neurogenesis (Bystron et al., 2006). As neurogenesis 
begins, progenitor cells from VZ and SVZ migrate radially along radial glial fibres and 
differentiate into earlier born and later born projection neurones respectively in an 
inside-out fashion. The first neurones generated in the VZ start to aggregate 
superficially to form the PP (mouse E10.5-E12.5; human CS16-CS20), which 
subsequently segregates into the most superficial aspect of the neocortex, the MZ 
(Layer I) and SP, by the later-generated CP neurones (mouse E12.5-E13.5; human 
CS20-CS22) (O'Leary and Nakagawa, 2002; Meyer, 2001; Meyer et al., 2000). The PP 
neurones are also referred to as the pioneer neurones since they are the earliest neurones 
to be produced locally, and to differentiate into a heterogeneous population of 
neocortical cells including Cajal-Retzius cells, marginal zone cells and subplate cells, 
forming the earliest functional network via synaptic connections within the primitive 
neocortex (Super et al., 1998). However, other studies have argued that synaptic 
formation can only be detected after the formation of CP and cells in the PP 
communicate and show spontaneous oscillations (Kostovic and Judas, 2007). Tbr1 is 
expressed by PP neurones, regulating the partition of the PP, and is subsequently 
expressed in the SP and Layer VI of the developing CP (Hevner et al., 2001). The MZ 
(Layer I) contains several cell types, principally the Cajal-Retzius cells which secrete 
Reelin to guide the radial migration of post-mitotic neurones through the SP, displacing 
this layer away from the MZ and ensuring that neurones deposit gradually in an inside-
out fashion in the CP (Rice and Curran, 2001). A smaller size of cell in the MZ is the 
marginal zone cell which is considered to be a local inhibitory interneurone expressing 
GABA (Super et al., 1998). Above the MZ, a transient layer of undifferentiated granular 
cells known as the subpial granular layer (SG) is a feature unique to human or non-
human primate neocortex (Meyer, 2001). This layer is most prominent when maximal 
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neuronal migration into the CP occurs, during the mid-gestation period (Meyer, 2001). 
The migration of these cortical neurones requires guidance signals and defective 
migration and differentiation of Cajal-Retzius cells, GABAergic interneurones and 
projection neurones is observed in the absence the Plexin receptor B2 (PlxnB2) in mice 
(Hirschberg et al., 2010). In humans, a thin layer, termed pre-SP, is visible at 7-8 PCW 
(CS21-23) during the formation of the CP (Kostovic and Rakic, 1990). This layer 
begins to expand extensively after 13 PCW via detachment of the deep CP which 
merges with the pre-SP to form the proper SP, and contains branched neurites extended 
by immature pyramidal neurones at this age (Bayatti et al., 2008a; Kostovic and Rakic, 
1990). During mid- to late-gestation, the elaborate SP contains GABAergic, 
glutamatergic and peptidergic neurones, synapses and thalamocortical afferents that are 
waiting and gathering in the superficial SP between 21 and 23 PCW before entering the 
CP after 22-24 PCW (Kostovic and Judas, 2007). A cell-sparse/fibre-rich layer termed 
the IZ is formed underneath the SP where axons of post-mitotic neurones are found 
during their migration to take up their laminar positions within the CP (O'Leary and 
Nakagawa, 2002). The formation of these transient layers of the developing neocortex 
in human is summarized in Figure 1.5 (Bystron et al., 2008). 
 
 
Figure 1.5. The formation of transient layers of the developing neocortex. 
The Boulder Committee‟s summary diagram of neocortical development, revised in 2008 and 
depicting the sequential events during the formation of transient layers including the ventricular 
(VZ) and subventricular (SVZ), the preplate (PP), the intermediate zone (IZ), the subplate (SP) 
and the marginal zone (MZ). The human- or primate-specific subpial granular layer (SG) which 
forms part of the MZ is also illustrated in the diagram. Adapted and modified from (Bystron et 
al., 2008). 
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In summary, during different stages of neocortical development, progenitor cells 
originating from the neocortical proliferative zones have different cell cycle kinetics and 
unique molecule profiles contributing to the production of various populations of 
cortical neurones. Nevertheless, as they differentiate and migrate towards the post-
mitotic layers radially, a sequential order of transcription factors expression across these 
transient layers of the developing neocortex is observed in rodents and in humans: 
Pax6/PAX6 is expressed in the VZ by RGCs. Upon asymmetric division, a RGC 
directly produces an immature neurone at earlier stages. Alternatively, a RGC 
asymmetrically divides and indirectly produces immature neurones via generation and 
symmetric division of INPs at later stages that migrate away from the VZ into the SVZ. 
As the differentiation progresses Pax6/PAX6 expression is lost and Tbr2/TBR2 
expression is detected in the SVZ. These cells continue to migrate through the IZ to the 
CP and differentiate into post-mitotic neurones, in which they sequentially express 
neurogenic differentiation factor (NeuroD/NEUROD) and Tbr1/TBR1 in the IZ and CP. 
(Figure 1.6; (Bayatti et al., 2008b; Hevner et al., 2006)). 
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Figure 1.6. Production of cortical projection neurones and molecular profile of transient 
layers of the developing neocortex. 
(A) During early stage of development, direct neurogenesis occurs in which a radial glia cell 
(RGC) divides asymmetrically to self-renew and produce one immature neurone directly that 
migrates towards the SVZ, IZ and eventually the developing CP. (B) During a later phase of 
development, indirect neurogenesis takes place whereby a RGC divides asymmetrically to self-
replenish and produce one intermediate neuronal progenitor (INP) that migrate towards the 
SVZ. The INP undergoes symmetric division to differentiate into two immature neurones which 
migrate through the IZ until reaching the developing CP. (A, B) Nevertheless, a sequential order 
of gene expression was observed in these transient layers of the developing neocortex: Pax6  
Tbr2  NeuroD  Tbr1, making them a useful molecular tool to mark out the different layers 
of the developing neocortex. Adapted and modified from (Hevner et al., 2006). 
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Classification of Neocortical Projection Neurones 
 
Neocortical projection neurones are morphologically different and reside in different 
laminae of the six-layered neocortex that arise from the CP during development. 
Cellular staining of human mature neocortex has revealed some layer specific 
characteristics: Layer I, the outermost layer, contains the fewest cells; Layer II, the 
external granular layer, is highly populated by small granule cells; Layer III, the 
external pyramidal layer, harbours mostly medium-sized pyramidal cells; Layer IV, the 
internal granular layer, is compactly formed by small granule cells; Layer V, the 
internal pyramidal layer, houses pyramidal cells; and Layer VI, the multiform layer, is 
made up of various populations of cells (Kahle and Frotscher, 2002). As Layer IV is 
often referred as the granular layer, Layer II and III become collectively known as the 
supragranular layers, whereas Layer V and VI together are considered as the 
infragranular layers. These neurones in different laminae project their axons to different 
targets and in general: neurones in Layer II and III send axons to other neocortical areas 
ipsilaterally or contralaterally (callosally), forming corticocortical connections; whereas 
neurones in Layer V and VI extend axons to subcortical structures, forming ipsilateral 
corticostriatal, corticotectal, corticopontine and contralateral corticospinal projections 
from Layer V and corticothalamic projection from Layer VI (Molyneaux et al., 2007). 
Notice that within Layer V and VI, contralateral/callosal projection neurones are also 
found which are morphologically and electrophysiologically different from the 
subcerebral projection neurones residing in the Layer V and corticothalamic projection 
neurones in the Layer VI (Molyneaux et al., 2007; Molnar and Cheung, 2006). 
Neurones in Layer I and IV project axons intracortically, and in Layer IV neurones 
receive thalamocortical input (Molyneaux et al., 2007; Kahle and Frotscher, 2002). 
These major projection neurones subtypes are summarized in Figure 1.7 (Molyneaux et 
al., 2007). Their laminar identities and phenotypic projections are regulated by 
combinational expression of various transcription factors which will be described in the 
subsequent section. 
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Figure 1.7. Major subtypes of projection neurones within the neocortex. 
On the basis of their hodological properties, several principal subtypes of cortical projection 
neurones were classified: (a) The callosal projection neurones that send intracortical-
interhemispheric axons are locating in Layer II/III, V and VI (grey). Within Layer V, there are 
two other callosal projection neurones: the contralateral corticocortical projections with 
ipsilateral/contralateral corticostriatal branches (blue); and contralateral corticocortical 
projections with ipsilateral frontal cortex branches (green). The corticothalamic neurones (b), a 
subtype of corticofugal projection neurones, are found in Layer VI (blue). Other Layer V 
corticofugal projection neurones (c) include corticotectal (orange), corticopontine (pink) and 
corticospinal motor (purple) neurones. Adapted from (Molyneaux et al., 2007).  
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Molecular Specification and Differentiation of Neocortical Projection Neurones 
 
The CP, which emerges at around CS22-CS23 in humans, has provided the neocortex 
with the six-layer characteristics, constituting different populations of projection 
neurones. The sequential production, distinct laminar and projection phenotypes of 
neocortical neurones are pre-determined by the intrinsic molecular profiles of their 
neocortical progenitors when they are born and can also be reflected in the post-mitotic 
projection neurones themselves. During the early stage of corticogenesis (mouse E12.5-
E13.5) the glutamatergic code of early progenitors is programmed by two proneural 
genes, Neurogenin 1 and -2 (Ngn1 and -2) that are expressed highly in the germinal 
zone of dorsal telencephalon and repressing the Mash1-regulating GABAergic 
programme (Fode et al., 2000). Furthermore, Ngn2
-/-
 and Ngn1
-/-
2
-/-
 knock-out (KO) 
mice show abnormal glutamatergic phenotypes and molecular profiles of early born, 
deeper layer neurones in the CP (reduced expression of Vesicular glutamate transporter 
1, -2 (vGlut1, -2) and Tbr1 in Layer VI and E-twenty six (Ets) variant 1 (Er81) in Layer 
V) while late born, upper layer neurones (Retinoic acid-related orphan receptor beta 
(RORβ)-expressing Layer IV and Octamer-binding transcription factor 6 (Oct6)- and 
Cut-like homeobox 1 (Cux1)-expressing Layer II-IV) remain normal, thus suggesting 
Ngn1 and -2 are important in specifying glutamatergic fate of early born neocortical 
neurones (Schuurmans et al., 2004). On the other hand, the Ngn-independent mid and 
late phases of corticogenesis (E15.5 and E18.5) require Pax6 and Tlx genes to function 
both independently and synergistically in the proliferative zone to specify the 
glutamatergic fate of late born, upper layer neurones (RORβ-expressing Layer IV and 
Oct6- and Cux1-expressing Layers II-IV) (Schuurmans et al., 2004).  
 
The gene expression profiles of these upper and lower neocortical layers of the 
developing CP provide useful tools for marking out the boundaries between each layer. 
INPs within the SVZ generate post-mitotic neurones in superficial layers of the CP, and 
Subventricular expressed transcript 1 (Svet1), Cux1 and -2 expression is initially 
observed in the SVZ and later in the upper layers II-IV from embryonic stages to 
adulthood (Cubelos et al., 2007; Nieto et al., 2004; Tarabykin et al., 2001). 
Transcriptional repressor gene transducin-like enhancer of split 4 (Tle4) or Groucho-
related gene 4 (Grg4), a mammalian homologue of Drosophila groucho 4 (grg4), is 
expressed in deeper layers while Tle1 or Grg1 shows a complementary expression 
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pattern restricted to the superficial layers of the CP (Yao et al., 1998; Koop et al., 1996). 
Later on, Forkhead box P2 (Foxp2) gene expression is observed restricted to Layer VI 
while the other family member, Foxp1, is expressing exclusively in the Layer III to V, 
although its expression seems to be increased in Layer VI postnatally (Ferland et al., 
2003). In order to distinguish between Layer II, III and IV, expression of two POU 
domain transcription factor genes, Oct6 and Oct7 come into play since post-mitotic 
neurones of Layer III show co-expression of the two genes whereas post-mitotic 
neurones in Layer II and IV express either Oct7 and Oct6 genes respectively (Hevner et 
al., 2003). Two other transcription factors, Er81 and Orthodenticle homeobox 1 (Otx1), 
exhibit expression that is confined to Layer V. Er81 expression is specific to deeper half 
of Layer V and Otx1 is expressed superficially in Layer V (Hevner et al., 2003). More 
thorough and detailed lists of layer specific markers have been provided in reviews by 
Guillemot et al. (2006) and Molyneaux et al. (2007) (Molyneaux et al., 2007; Guillemot 
et al., 2006). Although molecular markers appear to be promising in mapping out 
different layers of the CP, one should be cautious when applying them and taking into 
account other factors that cause variation in gene expression such as species- and 
regional-specific differences within the neocortex. 
 
As described previously, multiple types of projection neurones co-exist within each 
neocortical layer, particularly Layer V. On the other hand, certain types of projection 
neurone can be found in multiple layers, such as the callosal projection neurones. 
Nevertheless, with the use of retrograde labelling and fluorescence-activated cell sorting 
(FACS), these distinct projection neurone subtypes can be isolated for gene expression 
comparison at various stages of late embryonic and early postnatal murine development. 
This allows the identification of the combinatorial genetic codes potentially involved in 
the specification and/or differentiation of the corticospinal motor 
(CSMN)/callosal/corticotectal projection neurones by microarray analyses in various 
layers of the developing CP (Molyneaux et al., 2009; Arlotta et al., 2005). 
 
Of the CSMN markers identified at various developmental stages, Forebrain embryonic 
zinc finger-like protein 2 (Fezf2) and Chicken ovalbumin upstream promoter 
transcription factor-interacting protein 2 (Ctip2) are found to be highly up-regulated in 
CSMN throughout their development and during early stages respectively (Arlotta et al., 
2005) and have been studied the most. They are shown to be important in different 
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developmental aspects of subcerebral projection neurones including CSMN. Fezf2 
expression is initially detected in the developing neocortex as early as E8.5 in mice and 
gradually displays a low anterior to high posterior neocortical gradient by E10.5 (Hirata 
et al., 2004). By E15.5 in mice, Fezf2 is expressed throughout the developing CP and its 
expression is enriched in Layer V and detected at lower level in Layer VI postnatally in 
mice and at 22 PCW in humans (Kwan et al., 2008; Arlotta et al., 2005; Molyneaux et 
al., 2005; Hirata et al., 2004). In the Fezf2
-/-
 null mutant mice, subcerebral projection 
neurones including CSMN are not specified and are therefore lost in Layer V, as 
manifested by the absence of various CSMN markers despite normal migration and 
survival of Layer V neurones, while Layer VI appears to be expanded and disorganized 
with an abnormal molecular profile (Molyneaux et al., 2005). In addition, the 
differentiation of all subcerebral projection neurones including CSMN is defective as 
they have altered dendritic morphologies and fail to project their axons to appropriate 
subcortical targets beyond the thalamus, despite normal expression of major axon 
guidance molecules (Chen et al., 2008; Chen et al., 2005b; Chen et al., 2005a). Fezf2 is 
shown to act as a cell fate switch between callosal and subcerebral projection neurones, 
evidently revealed by i) the transformation of most of the Layer V and VI neurones that 
normally express the CSMN marker Ctip2 into neurones expressing the callosal 
projection neurone marker special AT-rich sequence-binding protein 2 (Satb2) 
(genotype), and displaying electrophysiological profiles, morphologies and connections 
of callosal projection neurones (phenotype) in the absence of Fezf2; and ii) the 
induction of subcerebral projection neurone markers expression and phenotype in upper 
layer or heterotopic layer neurones where Fezf2 is ectopically expressed (Chen et al., 
2008; Chen et al., 2005b; Molyneaux et al., 2005).  
 
Ctip2 is expressed predominantly by post-mitotic, subcortical projection neurones 
including CSMN in Layer V, at a lower level by corticothalamic projection neurones in 
Layer VI of the CP postnatally in mice (Lai et al., 2008; Arlotta et al., 2005) and in 
humans at 19 PCW (Johnson et al., 2009), regulating the post-mitotic differentiation of 
CSMN including axons outgrowth, pathfinding and/or survival (Arlotta et al., 2005). 
Additionally, ectopic expression of Ctip2 in upper layer neurones induces subcerebral 
axonal targeting (Chen et al., 2008). Although both Ctip2 and Fezf2 are vital for 
subcerebral projection neurone development including CSMN as their null mutants are 
phenotypically similar, they are different in their mechanisms of function: Fezf2 is 
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expressed at earlier stages during development in both cortical progenitors and post-
mitotic subcerebral projection neurones to control their specification and differentiation, 
whereas Ctip2 is expressed later than Fezf2 and only in post-mitotic subcerebral 
projection neurones to control their differentiation primarily (Chen et al., 2008; Chen et 
al., 2005b; Chen et al., 2005a; Molyneaux et al., 2005). Hierarchically, Ctip2 is a major 
downstream effector of Fezf2 in regulating axonal targeting. This is because not only is 
Ctip2 expression abolished in Fezf2
-/-
 mutants, electroporation of Ctip2-encoding 
transcript into Fezf2
-/-
 null cortex is able to rescue the subcerebral projection phenotype 
of the electroporated neurones, restoring the projection of CSMN axons towards the 
spinal cord (Chen et al., 2008; Chen et al., 2005b; Chen et al., 2005a; Molyneaux et al., 
2005). However, Ctip2 is not the solitary downstream effector of Fezf2, as i) the 
subcerebral projection phenotypic defect of Fezf2
-/-
 is more severe as compared to 
Ctip2
-/-
 mutants (failure in projecting beyond thalamus vs. pons) (Arlotta et al., 2005; 
Molyneaux et al., 2005); and ii) the electroporation of a Fezf2-encoding transcript into 
Fezf2
-/-
 cortex during the period of subcerebral projection neurone production (E13.5 in 
mice) salvages development of the electroporated neurones and ectopic expression of 
Fezf2 in upper layer neurones during their production period (E15.5 in mice) induces 
subcerebral axonal targeting, but does not always restore or induce their expression of 
Ctip2 (Chen et al., 2008). 
 
Like Ctip2, another gene Sox5 was also identified, by microarray analysis, to be highly 
up-regulated by CSMN during their early development (Arlotta et al., 2005). It is 
initially expressed by post-mitotic neurones in the PP but absent in the proliferative 
zones at E12.5 in mice. Gradually from E14.5-E16.5 in mice, its expression is detected 
in the Layer V, VI and SP neurones and by postnatal stages its expression is highly 
enriched in Layer VI and SP (Kwan et al., 2008; Lai et al., 2008). Two mechanisms of 
function for Sox5 have been proposed: i) It is involved in controlling the sequential 
production and proper migration of SP neurones, Layer VI corticothalamic projection 
neurones and Layer V subcerebral projection neurones (Lai et al., 2008).  Loss of Sox5 
function results in premature generation of Layer V subcerebral projection neurones in 
place of SP and Layer VI corticothalamic projection neurones due to premature 
induction of CSMN markers Ctip2 and Fezf2 (Lai et al., 2008). This proposal suggests 
the varying levels of Sox5 act in concert with distinct levels of genes expressed in the 
SP and Layer VI such as Tbr1 and Ctip2 in Layer V in order to control the specification 
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of SP and deep layer neurones. SP neurones therefore can be characterized by 
combination of a high level of Tbr1, intermediate level of Sox5 and low level of Ctip2; 
Layer VI corticothalamic projection neurones express high levels of Sox5 and Tbr1 and 
a low level of Ctip2; and Layer V subcerebral projection neurones strongly express 
Ctip2, with intermediate and low levels of Sox5 and Tbr1 respectively (Lai et al., 2008; 
Leone et al., 2008). ii) In contrast to the prevention of premature induction mechanism, 
Sox5 also controls the proper migration and post-migratory differentiation of SP, Layer 
V and VI neurones by down-regulation of the transient expression of CSMN-related 
genes Ctip2 and Fezf2 in SP and Layer VI corticothalamic neurones and thus restricting 
their expression predominantly to Layer V (Kwan et al., 2008). According to this 
proposal, the expression of Ctip2 and Fezf2 is maintained in Layer VI and SP in the 
absence of Sox5, however this does not induce subcerebral projection phenotypes in 
Layer VI and SP neurones (axons are only misrouted towards hypothalamus; (Kwan et 
al., 2008)), contrary to the observation of the former proposal (Lai et al., 2008). 
Differences in Sox5 function between these two proposals are further revealed by gain 
of Sox5 function analyses in which the former study has shown an acquisition of earlier-
born, subcerebral projection phenotype in later-born, callosal projection neurones when 
Sox5 over-expression is occurring at the time when subcerebral projection neurone 
production has ceased (at E14.5) (Lai et al., 2008), whereas callosal projections are 
maintained when Sox5 is over-expressed during the production of upper layer, callosal 
projection neurones (at E15.5) in the latter study (Kwan et al., 2008). Nevertheless, both 
studies have demonstrated the role of Sox5 in repressing the expression of Fezf2 and 
Ctip2, and a more direct relationship between Sox5 and Fezf2 has been identified by 
Kwan and co-authors, 2008 in which Sox5 is able to bind to a conserved enhancer 
element near Fezf2 and suppress its transcription (Kwan et al., 2008; Lai et al., 2008).  
 
As described previously, Tbr1 is also highly expressed by deep layers, corticothalamic 
projection neurones. In the absence of Tbr1 in-vivo, the number of cells expressing 
Layer VI markers decreases while Layer V markers are ectopically expressed in earlier-
born neurones, causing them to send axons into subcerebral targets instead of the 
thalamus (McKenna et al., 2011; Bedogni et al., 2010). Furthermore, Layer V neurones 
do not project their axons subcerebrally towards the brainstem and spinal cord when 
Tbr1 is ectopically expressed in this layer (McKenna et al., 2011). Thus Tbr1 promotes 
the fate specification of Layer VI corticothalamic projection neurones in the expenses of 
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Layer V subcerebral projection neurones and is found to achieve this by repressing the 
expression of Fezf2 directly and activate/maintain the expression of Sox5 (McKenna et 
al., 2011; Bedogni et al., 2010). 
 
Satb2 is important in controlling the differentiation of some interhemispheric projection 
neurones, such as the callosal projection neurones, in Layer II-V of the neocortex by 
binding to and suppressing the expression of subcerebral projecting neuronal markers 
such as Ctip2 as well as regulating expression of axonal guidance molecules such as 
Ephrin type-A receptor 4 (EphA4) (Alcamo et al., 2008; Britanova et al., 2008), 
probably via interacting with chromatin-remodeling molecules histone deacetylases and 
binding directly to AT-rich matrix attachment regions (MARs) of target genes (Gyorgy 
et al., 2008; Szemes et al., 2006; Britanova et al., 2005). Bromodeoxyuridine (5-bromo-
2-deoxyuridine; BrdU)-birthdating experiments indicate that early born SATB2-positive 
cells in the neocortex were generated before E11.5 in mice (Britanova et al., 2005). 
From E15.5-18.5 in mice, Satb2 mRNA is detected in the CP and IZ of the neocortex, 
whereas its protein is predominantly expressed throughout Layer II-V above the TBR1-
expressing lower CP (Alcamo et al., 2008; Britanova et al., 2008; Britanova et al., 
2005). As Satb2-deficient neurones have altered genetic makeup, these conflicting 
molecular profiles cause defects in migration that lead to premature termination within 
the lower layers of the CP (Alcamo et al., 2008; Britanova et al., 2008). Moreover, these 
molecular profile changes also cause defects in post-mitotic differentiation such as 
axonal targeting. In the absence of Satb2 functions, the callosal projecting axons are 
mis-routed towards subcortical targets such as cerebral peduncles despite an apparently 
intact adjoining callosal structure (Alcamo et al., 2008; Britanova et al., 2008). 
Alternatively, ectopic expression of Satb2 in lower layers of the CP down-regulates 
Ctip2 expression and affects the development of corticospinal projection (Alcamo et al., 
2008; Britanova et al., 2008). Various types of SATB2 mutation in human patients as 
well as mouse models have been shown to be associated with defects in cleft palate 
formation, craniofacial patterning, osteoblast differentiation, jaw development and also 
cognition (Leoyklang et al., 2007; Britanova et al., 2006a; Britanova et al., 2006b; 
Dobreva et al., 2006). 
 
Nuclear receptor-related protein 1 (Nurr1) is an orphan nuclear receptor transcription 
factor that is important for early differentiation and maintenance of dopamine neuronal 
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phenotypes in the midbrain through regulating genes involved in dopamine synthesis, 
transport, release and reuptake and continues to be expressed into adulthood 
(Kadkhodaei et al., 2009; Simon et al., 2003). Within the developing rodent neocortex, 
Nurr1 is found to be expressed predominantly by neurones in the SP of the dorsal 
neocortex and by both SP and lower layer CP neurones towards the lateral regions of 
the neocortex which are glutamatergic but not GABAergic (Hoerder-Suabedissen et al., 
2009; Arimatsu et al., 2003). Retrograde tracing and immunostaining studies show that 
Nurr1-expressing neurones including those in the SP contribute predominantly to long-
range intrahemispheric corticocortical projections, sparsely to interhemispheric 
corticocortical projections, and even more sparsely to the corticothalamic projections in 
developing rat neocortex (Arimatsu et al., 2003). This projection specificity is also 
shown to be conserved in monkeys (Watakabe et al., 2007). NURR1 may have a role to 
play in Parkinson disease and psychiatric disorders such as schizophrenia in which 
dopamine neurones are found to be degenerating. Many studies to-date have found 
correlations between NURR1 mutations and Parkinson‟s disease (Sleiman et al., 2009; 
Jacobsen et al., 2008; Grimes et al., 2006; Huang et al., 2004), however there is not 
always a linkage between NURR1 mutations and the etiologies of psychiatric diseases 
such as schizophrenia (Feng et al., 2005; Ruano et al., 2004; Ishiguro et al., 2002; Chen 
et al., 2001; Buervenich et al., 2000). During development in rodents, there seems to be 
more neurones expressing Nurr1 in the lateral compared to the medial region of the 
neocortex persistently from embryonic to postnatal stages (Arimatsu et al., 2003) and 
predominant expression in the occipital cortex is observed from E14.5-18 ((Muhlfriedel 
et al., 2007); http://www.Genepaint.org).  
 
A proposed model for the specification/differentiation of the major neocortical 
projection neurones during the development is illustrated in Figure 1.8 (adopted and 
modified from (Leone et al., 2008); with Sox5 and Tbr1 information incorporated based 
on (McKenna et al., 2011; Bedogni et al., 2010; Kwan et al., 2008; Lai et al., 2008)). 
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Figure 1.8. A proposed working model for the specification/differentiation of major 
neocortical projection neurones during development. 
This model is based on the molecular profiles and genetic manipulation analyses of the above 
neocortical projection neurones. Fezf2 acts upstream of Satb2 and Ctip2 to suppress callosal 
projection neurones fate via inhibition of Satb2 expression and specify subcortical projection 
neurones fate via activation of Ctip2 expression. Satb2 is required for the development of 
callosal projection neurones and represses Ctip2 expression in this neuronal subtype. Thus lack 
of Satb2 would cause callosal projection neurones to extend their axons subcortically; while in 
the absence of Fezf2, Ctip2 expression is repressed by Satb2 expression and neurones would 
adopt callosal projection neurones fate. Sox5 represses the expression of Fezf2, and together 
with Tbr1 is known to be important in the development of SP and corticothalamic neurones. 
Adapted and modified from (Leone et al., 2008); with Sox5 and Tbr1 information incorporated 
based on (McKenna et al., 2011; Bedogni et al., 2010; Kwan et al., 2008; Lai et al., 2008). 
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1.2 Regionalisation across the Neocortex 
 
Across the tangential dimension, the neocortex of the adult brain is subdivided into 
areas with clear sharp boundaries that are functionally unique and different from one 
another on the basis of cyto- and chemo-architecture, afferent/efferent connections and 
patterns of gene expression (O'Leary et al., 2007). In humans, functional division of 
neocortical areas indicates the primary motor area (Brodmann area 4 and 6) are located 
anterior to the central sulcus, the primary somatosensory (Brodmann area 1, 2 and 3) 
and visual areas (Brodmann area 17) are found posteriorly, and primary auditory area 
(Brodmann area 41 and 42) are bilaterally positioned in temporal lobe (Kahle and 
Frotscher, 2002). These areas display special features correlating to the functions they 
are serving. The primary somatosensory and auditory areas that receive inputs from 
ascending projection neurones contain thicker granular layers (Layer II and IV) that are 
densely packed with more cells as compared to the thinner pyramidal layers (Kahle and 
Frotscher, 2002). This feature is most prominent in the primary visual area, where Layer 
IV even appears to be duplicated (IVa and IVc) and separated by a cell-sparse layer 
(IVb) (Kahle and Frotscher, 2002). However, the pyramidal layers of the primary motor 
area which contain efferent projection neurones appears to be more elaborate in 
comparison to the granular layers (Kahle and Frotscher, 2002). (Figure 1.9; modified 
and adapted from (Kahle and Frotscher, 2002)) 
 
The process of areal differentiation of the neocortical primordium is frequently known 
as neocortical regionalisation and is believed to be regulated based on two mechanisms: 
the protomap (Rakic, 1988) and protocortex (O'Leary, 1989; Van der Loos and 
Woolsey, 1973) model (Mallamaci and Stoykova, 2006). The former model proposed 
an intrinsic mechanism for regulating early patterning of the neocortex by differential 
gene expression in progenitor cells, which is under the control of diffusible signalling 
molecules secreted from patterning centres and counter-gradient expression patterns of 
transcription factors. This model suggested heterogeneity of the cortical primordium in 
which the intrinsic molecular cues are carried forward to their progenies to impose their 
mature regional identities and is activity-independent. The later model, however, put 
forward a different theory by suggesting the neocortical primordium as a homogeneous 
structure with regionalisation directed by information conveying into the developing 
neocortex via external influences such as the thalamocortical afferents. This mechanism 
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is activity-dependent and established to refine the genetically pre-programmed regional 
specification processes, representing the later patterning of the neocortex (i.e. after the 
innervation of thalamocortical afferents). 
 
 
Figure 1.9. Cortical areas of the human adult neocortex. 
(A) Primary areas of the human adult neocortex show cyto-architectural differences: area 
4/motor cortex is characterized by a more elaborate Layer V; whereas Layer II and IV appears 
to be much thicker in area 3/sensory cortex and area 41/auditory cortex, and in the area 
17/visual cortex Layer IV is even duplicated to become IVa and IVc which is separated by a 
cell-sparse layer (IVb). (B) Lateral view of the human adult neocortex illustrating various 
Brodmann areas, highlighting the location of area 4/motor cortex in the frontal lobe anterior to 
the central sulcus, area 3/sensory cortex in the parietal lobe posterior to the central sulcus, area 
17/visual cortex in the occipital lobe lining the calcarine sulcus and area 41/auditory cortex in 
the temporal lobe on the transverse temporal gyri. Adapted and modified from (Kahle and 
Frotscher, 2002). 
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1.2.1 Protomap Theory 
 
Two main classes of molecules presumed to be crucial for early regionalisation of the 
neocortical primordium are: i) signalling molecules, morphogens or secreted ligands (to 
be used throughout this section) and ii) transcription factors. The former molecules are 
discharged by surrounding borders of the cortical morphogenetic field that are often 
referred as the “patterning centres” or “signalling centres”; whereas the later ones are 
expressed by progenitor cells within the cortical morphogenetic fields. The secreted 
ligands are often capable of controlling the expression of transcription factors in a dose-
dependent manner, thereby generating a gradient or transient expression of transcription 
factors by neocortical progenitors in the proliferative zones. 
 
Secreted ligands and Patterning centres 
 
Several patterning centres that are relevant for regionalisation have been discovered to 
secrete a set of ligands, locating at different regions of the brain and cooperate with each 
other in order to establish regional identities of the neocortex along the anterior-
posterior and medial-lateral axes (Figure 1.11). Interfering with the expression of these 
ligands or their downstream signalling pathways has led to shifting of neocortical areas 
across the tangential dimension, thus allowing the deduction of their functional 
implications in regionalisation of the neocortex.  
 
In general, during early stages of cortical neurogenesis (E10-E12.5), anterior cortical 
regionalisation is predominantly controlled by the anterior neural ridge (ANR), a region 
formed via the neural tube folding process and later become the commissural plate 
(CoP)/septum. Four members of the Fibroblast Growth Factor (Fgf) genes are 
expressed in discrete and partially overlapping domains of this anterior patterning 
centre: from E8-E12 in mice, Fgf8 and Fgf18 are expressed in the central domain of this 
anterior midline structure, whereas Fgf17 expression extends more dorsally and Fgf15 
expression is much broader and extends ventrally but is absent in Fgf8-positive domain 
(Iwata and Hevner, 2009; Borello et al., 2008; Cholfin and Rubenstein, 2007; Gimeno 
and Martinez, 2007; Gimeno et al., 2003; Bachler and Neubuser, 2001; Crossley et al., 
39 
 
2001; Xu et al., 1999; Hoshikawa et al., 1998; Maruoka et al., 1998; Crossley and 
Martin, 1995). Fgf8 and Fgf17 are known to specify the frontal-motor cortical area 
fates, as shown by anterior or posterior displacement of these area boundaries upon 
reduction of Fgf-signalling or over-expression of Fgfs (Cholfin and Rubenstein, 2007; 
Fukuchi-Shimogori and Grove, 2001). A more specific task of Fgf17 in patterning the 
dorsal-frontal cortex has been revealed while the ventral-orbital frontal cortex 
specification appears to be Fgf17-independent (Cholfin and Rubenstein, 2007). 
Interestingly, Fgf8 is shown to act positively upstream of Fgf17 and Fgf18, but repress 
the expression Fgf15 to cause their complementary expression pattern in the anterior 
patterning centre (Borello et al., 2008).  
 
Additionally, the cortical hem, which is of medial pallial origin locating at the medial 
margin of the dorsal telencephalon, expresses multiple Wnts (-2b, -3a, -5b, -7a, -8b) and 
Bone morphogenetic proteins (Bmp2, -4, -5, -7) is important in the development of the 
adjacent hippocampus along the mediolateral axis of cortical neuroepithelium. 
Shimogori and co-authors (2004) have deduced interactions between the two signalling 
centres, suggesting that Bmps are able to suppress the anterior-pole patterning activities 
of Fgf8 or -17 to disinhibit Wnts signalling in order to promote the hippocampal fate 
(Shimogori et al., 2004). This conclusion is drawn based on the observation that 
inhibiting Bmps signalling dramatically increases expression of Fgf8, and with the 
expansion of Fgf8 domain, expression of Wnts in the cortical hem is suppressed, as 
phenotypically manifested by a shrunken hippocampus (Shimogori et al., 2004).  
 
An additional patterning centre in the ventral telencephalon and the hypothalamus of 
ventral diencephalon expresses Sonic hedgehog (Shh), which is involved in regional 
patterning of the forebrain to induce ventral fate via influencing factors from other 
patterning centres such as Bmps and Fgf8 (O'Leary et al., 2007; Ohkubo et al., 2002; 
Crossley et al., 2001). Recently, Forkhead box G1 (Foxg1) has been identified to 
integrate signals from the two patterning centres, the Shh-expressing ventral 
telencephalon/hypothalamus and the cortical hem, by acting downstream of Shh 
signalling pathway and directly repressing the transcription of Wnts during 
telencephalic dorsal-ventral patterning (Danesin et al., 2009).  
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During later stages of cortical neurogenesis (E12 onwards), a structure locating at the 
lateral edge of the cortex near the pallial-subpallial boundary (PSB), termed the cortical 
anti-hem, specifically expresses five genes for secreted ligands: Transforming growth 
factor alpha (Tgfα), Nrg1 and -3, Fgf7 and Secreted frizzled-related protein 2 (Sfrp2), 
which is a Wnt antagonist. However their function in regionalisation is less known 
(Subramanian et al., 2009). Fgf15 is found to be also weakly expressed in the 
neuroepithelium of PSB, in addition to its expression in the ANR/CoP/septum (Borello 
et al., 2008). 
 
Graded expression of transcription factors 
 
A range of transcription factor genes are found to be expressed by neuronal progenitors 
in gradients along the anterior-posterior and medial-lateral pole of the neocortex and are 
important for imposing progenies with region-specific identities (Figure 1.10). In 
rodents, Pax6 and Empty spiracles homeobox 2 (Emx2) are shown to be expressed by 
progenitor cells in a reciprocal gradient throughout neurogenesis, i.e. Pax6 is expressed 
higher in the anterolateral domains of the proliferative zone of the neocortex and lower 
in the posteromedial domains, on the other hand, Emx2 expression appears to be higher 
posteromedially and lower anterolaterally in the neocortex (Bishop et al., 2002). Indeed, 
Pax6 and Emx2 preferentially impart anterolateral (e.g. motor and somatosensory) and 
posteromedial (e.g. visual) regional identities respectively by mutually suppressing 
expression of one another since Pax6 loss-of-function experiments have shown an 
anterior shift of visual areal markers; while Emx2 KO animals have displayed a 
posterior shift of motor and somatosensory areal markers (Bishop et al., 2003; Bishop et 
al., 2002; Lopez-Bendito et al., 2002; Muzio et al., 2002; Bishop et al., 2000). The 
contraction or expansion of cortical areas is in proportion to the alteration of cortical 
size and paralleled by misrouted (ventrally-displaced) thalamocortical and 
corticothalamic projections at the diencephalic-telencephalic boundary, indicating 
possible defects in early guidance (Bishop et al., 2003; Bishop et al., 2002; Jones et al., 
2002; Lopez-Bendito et al., 2002; Muzio et al., 2002; Bishop et al., 2000). However, 
KO of Pax6 and Emx2 has detrimental effects which result in prominent reduction of 
cortical total surface areas thus compromising the comparison between mutants and 
wild type littermates. Furthermore, it causes animals to die at birth, limiting further 
analyses on area patterning postnatally. Therefore, later studies seek to investigate the 
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role of Emx2 in controlling regionalisation of the neocortex have performed gain-of-
function analyses and found disproportionate changes in size of primary somatosensory 
and motor areas shifting anterolaterally, whilst the cortical size, lamination, thalamic 
nuclei and thalamocortical projection development remain normal (Hamasaki et al., 
2004). On the other hand, gain-of-function studies on Pax6 seem to have resulted in 
minimal effects on regionalisation of the neocortex with a small though significant 
decrease in the size of primary somatosensory area, but more prominent alterations in 
the proliferation of late neocortical progenitors (Manuel et al., 2007). Additional 
evidence supporting the idea that Pax6 has little direct importance in area patterning of 
the neocortex comes from a neocortical conditional KO of Pax6 mutant, in which 
normal thalamocortical and corticofugal projections are developed normally despite 
anterior shift of positional specific molecular markers (Pinon et al., 2008).  
 
The orphan nuclear receptor CouptfI, downstream of Emx2, is expressed highly by 
neocortical progenitors and post-mitotic neurones in the parietal and occipital lobe of 
the neocortex where sensory areas are located (Armentano et al., 2007). Its expression 
level is the lowest towards the frontal lobe of the neocortex constituting the motor areas 
(Armentano et al., 2007). Conditional KO of CouptfI (Emx1-Cre: CouptfI
loxP/loxP
; 
CouptfI-cKO) in the neocortex causes enormous expansion of frontal/motor areas and 
significant compression of sensory areas towards the posterior occipital cortex, with 
altered axonal projections to maintain the area specific afferent and efferent 
connections, evidently supporting its role in repressing frontal-motor areal identities and 
specifying sensory-visual areal identities (Armentano et al., 2007). More specific 
functions of CouptfI in controlling the area-specific differentiation of distinct neuronal 
subtypes have been revealed by a recent study using conditional KO mice (Tomassy et 
al., 2010). CouptfI represses the differentiation of Layer VI corticothalamic neurones in 
sensory areas into Layer V corticofugal neurones by inhibiting expression of Ctip2 and 
Fezf2, such that, in the absence of CouptfI function, presumptive corticothalamic 
neurones abnormally display the molecular features and projection patterns of 
corticospinal neurones (Tomassy et al., 2010). Additionally, Layer V neurones in the 
sensorimotor cortex fail to develop into corticospinal neurones (Tomassy et al., 2010). 
CouptfI is also shown to be able to repress Fgf signalling by promoting the expression 
of the Fgf signalling inhibitors Sprouty 1 and -2 (Spry1 and -2), and thereby advancing 
posterior fate (Faedo et al., 2010). 
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A member of the zinc-finger transcription factors family, Specificity protein 8 (Sp8) is 
expressed strongly but transiently in the Fgf8-postive ANR/CoP at E8.0-8.5, and 
throughout the entire forebrain by neocortical progenitors with a high anteromedial to 
low posterolateral gradient across the VZ by E9.0 in mice (Sahara et al., 2007; 
Zembrzycki et al., 2007). Thereafter from E10.5 onwards, Sp8 mRNA transcript level 
gradually decreases in neocortical VZ, but maintain strong expression levels throughout 
adulthood in other regions (Sahara et al., 2007; Zembrzycki et al., 2007). Like Pax6 and 
Emx2, Sp8 also plays a role in regionalisation. A study utilizing Cre-loxP conditional 
neocortical specific Sp8 KO mutants (Foxg1-Cre: Sp8
loxP/loxP
; Sp8-cKO) has revealed an 
anterior shift of neocortical areas at E12.5 paralleled by changes in thalamocortical 
innervation at E18.5 (Zembrzycki et al., 2007). Another study conducted by a separate 
group has electroporated in-utero a dominant negative expression construct of Sp8 into 
the ANR/CoP at E11.5 in mice that also results in a considerable shift of cortical areas 
towards the anterior region of the neocortex accompanied by a decrease in sizes of 
primary sensory areas at P7, a phenotype observed when the endogenous Fgf8 secreted 
from the ANR/CoP is suppressed (Sahara et al., 2007). Additionally, expression of Fgf8 
and its downstream genes (e.g. Polyomavirus enhancer activator 3 (Pea3), Ets-related 
molecule (Erm) and Er81) are strikingly reduced within ANR/CoP (Sahara et al., 2007). 
This provides evidence for the importance of Sp8 in the maintenance of Fgf8 and its 
targets‟ expression within the ANR/CoP by direct activation of Fgf8 transcription 
(Sahara et al., 2007). This transcriptional activity is under the repression of Emx2 in the 
neocortex thereby limiting Fgf8 expression in the ANR/CoP but not in the neocortical 
proliferative zones (Sahara et al., 2007). However, Sp8 seems to act upstream of Emx2 
by direct regulation as the loss of Emx2 function does not alter the expression of Sp8 
(Zembrzycki et al., 2007). These studies have revealed some interactions between 
secreted ligands and transcription factors that are expressed in graded fashion. 
Furthermore, the shifting of neocortical areas and changes in thalamocortical inputs 
observed in these loss-of-function analyses suggest a role for Sp8 in controlling the 
balance of regional patterning along the anterior-posterior axis of the neocortex. 
 
The homeodomain transcription factor Otx1 is expressed by subcerebral but not 
corticocortical projection neurones within Layer V and the progenitors that generate 
these neurones throughout the entire neocortex (Weimann et al., 1999). Yet when 
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knocking-out Otx1, aberrant subcerebral axonal projections are observed only from the 
visual cortex where exuberant connections from visual cortex to the spinal cord are not 
removed, thus associating Otx1 with visual cortical fate specification and establishment 
of the visual area-specific Layer V subcerebral projections (Weimann et al., 1999). 
Recent evidence shows that Otx1 is important in establishing the visual area identity, 
potentially via competing with sensorimotor area molecular determinants, as tract 
tracing of corticospinal projection neurones demonstrate a posterior shift of 
sensorimotor area in the slightly smaller Otx1
-/-
 mice neocortices (Ando et al., 2008).  
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Figure 1.10. Role of graded expression of transcription factors in controlling 
regionalisation of the neocortex. 
(a) Transcription factors Emx2, Pax6, CouptfI, and Sp8 are expressed in a graded fashion along 
the anterior (A) - posterior (P) and lateral (L) - medial (M) axes of the neocortex. Emx2 is 
expressed in high posteromedial to low anterolateral gradient, whereas Pax6 showed opposite, 
counter-acting gradient as compared to Emx2. CouptfI is expressed in high posterolateral to low 
anteromedial gradient, whereas Sp8 is expressed in an opposite manner to CouptfI. 
(b) Results obtained via loss- or gain-of-function mutant mice of the above transcription factors 
as compared to wild-type littermates have revealed their importance in regionalisation of the 
neocortex. Analyses of homozygous Emx2 KO (Emx2 KO null) mice during late embryonic 
stage reveals a significant reduction in the size of posterior areas paralleled by an enlargement 
and posterior shift of anterior areas (F/M, frontal-motor; S1, somatosensory). A similar but less 
severe areal shifting is observed in heterozygous mutant mice (Emx2 KO het) with reduced 
Emx2 expression. Conversely, Nestin promoter-driven over-expression of Emx2 (Nestin-Emx2 
transgenic) causes anterior shift of areas due to visual area (V1) expansion. Pax6 KO mice 
(Sey/Sey [Pax6]) lack the functional Pax6 protein, display an anterior shift of areas as the 
posterior areas enlarge. However, over-expression of Pax6 (YAC-Pax6 transgenic) only causes 
a small, but significant, reduction in the size of S1 without obvious areal shift (asterisk). 
Neocortical deletion of CouptfI in mutant mice (conditional CouptfI KO) causes a substantial 
posterior shift of areas due to an enormous expansion of the F/M, paralleled by a significant 
reduction of the S1. Neocortical and commissural plate deletion of Sp8 (conditional Sp8 KO) 
causes a similar anterior areal shift during late developmental stages as observed in the Fgf8 
hypomorphic mutants. A1, auditory area. Adapted from (O'Leary and Sahara, 2008). 
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1.2.2 Protocortex Theory: role of thalamocortical axon projections 
 
Most sensory inputs are transmitted to the according primary areas of neocortex through 
intermediate targets, the dorsal-thalamic nuclei (dTh), forming topographic projections 
from these functional modules in the thalamus to the neocortical primary areas: the 
dorsolateral geniculate nucleus (dLGN) projects to the visual cortex (V1); the 
ventrobasal complex (VB) to the somatosensory cortex (S1); and the ventrolateral 
nucleus (VL) to the motor cortex (M1) (Garel and Rubenstein, 2004). As described 
previously, secreted ligands and graded expression of transcription factors determine the 
relative size and location of these neocortical areas during early development. Since 
thalamocortical axon projections are the only supply of modality-specific information to 
the neocortex, further functional specifications of the primary areas are defined by and 
relied on the extrinsic influences via thalamocortical input at later stages of 
development. During development, the thalamocortical axons follow a long and 
complex trajectory: in general, they exit the dorsal thalamus (CS16-18) by turning 
abruptly at the diencephalic-telencephalic boundary and course anteriorly through the 
subpallial structures (CS20), then turn subsequently at the pallial-subpallial boundary 
through the internal capsule (Bystron et al., 2005; Garel and Rubenstein, 2004) to enter 
the neocortex via the SP from 13 PCW (Kostovic and Rakic, 1990), and stay in this 
zone for a period of time before further invading the CP (Layer IV) after 22-24 PCW 
(Kostovic and Judas, 2007). This prolonged period of axonal pathfinding and target 
selection requires proper guidance to lay down the route towards their final destination, 
potentially through cell adhesion molecules, while interference of the pathway has been 
shown to affect cortical map specification.  
 
The guidance of thalamocortical projections is shown to be dependent on guidance cues 
expressed by other neuronal subtypes or in the environment where these neurones 
reside, which is detected by the transmembrane receptors/cell adhesion molecules 
expressed by thalamocortical axons. One example is via the subcortical “corridor cells” 
that are GABAergic neurones derived from LGE expressing Nrg1 (Lopez-Bendito et al., 
2006). These “corridor cells” lay out a permissive route, which is superficial to the 
proliferative zones of the MGE and deep to the developing mantle zone where the 
globus pallidus is forming, for the tangential extension of thalamocortical axons 
expressing ErbB4 receptors (Lopez-Bendito et al., 2006). On the other hand, handshake 
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hypothesis suggests that local molecular cues are derived from SP neurones that send 
out early pioneer fibres to lay down a pathway and in the basal telencephalon 
intermingle with and guide the growing thalamocortical axons towards their neocortical 
target areas (Molnar and Blakemore, 1995). The radial unit hypothesis proposed to 
describe the generation of CP neurones (Rakic et al., 2009) can also be applied to the 
generation of SP neurones in which the spatial relationships and radial patterning of SP 
progenies are also maintained when they are generated from the VZ progenitors 
(O'Leary and Borngasser, 2006). Thus as proposed by the protomap hypothesis (Rakic, 
1988), SP neurones in different regions of the neocortex may contain region specific 
molecular cues that guide the differential innervation of thalamocortical afferents to the 
appropriate neocortical areas. 
 
The role of thalamocortical projection guidance cues in the patterning of developing 
neocortical areas has been illustrated by Dufour and co-authors (Dufour et al., 2003). 
The Eph family of receptor tyrosine kinases and their ligands, Ephrins, are implicated in 
the guidance of thalamocortical projections (Dufour et al., 2003). EphA4 receptor and 
its ligand EphrinA5 are expressed in similar medio
HIGH
-lateral
LOW
 gradients in the 
rodent primary thalamic VB nuclei and in the primary cortical S1 (Layer IV), while 
double mutant EphA4
-/-
EphrinA5
-/-
 mice manifest aberrant thalamic VL motor nuclei 
projections to the cortical S1 area (Dufour et al., 2003). The design of a triple KO 
mutant EphrinA2
-/-
A3
-/-
A5
-/-
, which severely disrupted the orderly patterns of 
thalamocortical projections from the dLGN to V1, have directly demonstrated a crucial 
role of thalamocortical patterning of neocortical areas along the tangential dimension, 
since V1 in these mutant mice is rotated and shifted medially and the internal 
organization of the visuotopic map also appears to be distorted (Cang et al., 2005). 
Furthermore, ectopic expression of EphrinA5 in regions lateral to V1 shifts this cortical 
area medially, while ectopically expressing EphrinA5 and -A2 within V1 disrupts its 
topographic functional organization (Cang et al., 2005). A recent study has revealed the 
requirement for neural cell adhesion molecule L1 and Close homolog of L1 (CHL1) in 
eliciting the repellent responses to EphrinA5 to guide thalamocortical axons to the M1 
(Demyanenko et al., 2010). Double KO of CHL1
-/-
/L1
-/-
 in mice has caused a significant 
posterior shift of thalamocortical projections from motor thalamic nuclei (VL) to the V1 
(Demyanenko et al., 2010). 
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1.2.3 Summary 
 
The protomap and protocortex mechanisms are important in specifying neocortical areas 
into distinctive functional modules and would certainly impose effects on one another 
(Figure 1.11; adapted from (O'Leary and Sahara, 2008)). Intrinsic molecular 
combinatorial codes within a cortical region act as notations for progenitor cells to play 
the tune of neuronal differentiation and migration accordingly in earlier stages of 
corticogenesis, forming a basic scaffold to guide any incoming axons. On the other 
hand, the later arrival of thalamocortical axon projections would conduct activity-based 
signals to their designated areas in order to orchestrate and shape the further 
differentiation of neurones within the cortical field at the later stage. Indeed, the 
thalamocortical influences on protomap have been demonstrated by Eph/Ephrin studies, 
whereas experiments performed by Shimogori and Grove (2005) have shed light onto 
the protomap influence on thalamocortical axon projections (Shimogori and Grove, 
2005). In mice, ectopically expressing Fgf8 in the posterior neocortex has rearranged 
the area map by duplicating the S1 field for which the thalamocortical axons are shown 
to be loyally tracking the changes in area position and innervate both S1 fields 
(Shimogori and Grove, 2005). Moreover, they have also shown Fgf8 can control the 
distribution of axon guidance molecules such as EphrinA5 in both the SP and CP along 
the anterior–posterior axis thereby offering laminar- as well as area-specific information 
for thalamocortical axon termination (Shimogori and Grove, 2005). 
 
During development, corticogenesis and regionalisation are two closely associated 
processes as they shared similar molecular determinants. In addition to their importance 
in setting up the early neocortical map, secreted molecules such as Wnts and Fgf8 have 
been shown to regulate neocortical proliferation whereas Fgf15 plays a role in 
differentiation (Borello et al., 2008; Machon et al., 2007; Storm et al., 2006). 
Furthermore, the four transcription factors (Pax6, Emx2, CouptfI and Sp8) described 
previously are known to also control the proliferation of neocortical progenitors and/or 
their laminar destiny (Faedo et al., 2008; Mo and Zecevic, 2008; Zembrzycki et al., 
2007; Heins et al., 2001; Warren et al., 1999). 
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Figure 1.11. Mechanisms of regionalisation of the developing neocortex. 
Four patterning centres are identified that secrete different ligands, termed morphogens (to be 
used in this figure legend) during early stages of development. The anterior midline domain, 
anterior neural ridge (ANR)/commissural plate (CoP) (red), produces Fgfs (such as -8 and -17); 
the cortical hem (purple) locating along the dorsal/posterior midline expresses Wnts and BMPs; 
the ventral telencephalon/hypothalamus in the ventral diencephalon (green) is a known source 
of Shh; whereas the anti-hem at pallial-subpallial boundary bilaterally, is a later patterning 
centre producing morphogens including Tgfα, Fgf7 and Sfrp2. These morphogens in turn 
control the expression of transcription factors (Pax6, Emx2, CouptfI, and Sp8) in the ventricular 
zone (VZ) of the dorsal telencephalon (dTel), establishing their graded expression patterns 
across the anterior-posterior (A-P) and medial-lateral (M-L) axes. These transcription factors are 
expressed by neocortical progenitors, thereby conveying regional or areal identities to the cells 
expressing them. Thus these genes can be referred to as the regionalisation genes. These genes 
are also able to regulate expression of other genes encoding transcription factors or cell 
adhesion molecules in the cortical plate (CP) that under the influence of extrinsic factors such as 
thalamocortical inputs, and are gradually transformed into distinct patterns with sharp 
boundaries. These downstream genes though with graded or restricted patterns of expression 
across the neocortex, they should be referred to as areal genes. As corticogenesis proceeds 
alongside with regionalisation, neocortical areas are eventually formed with unique 
anatomically distinctive neocortical layers (2-6), serving different functions. A1, primary 
auditory area; F/M, frontal/motor cortex; S1, primary somatosensory area; V1, primary visual 
area. Adapted from (O'Leary and Sahara, 2008). 
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1.3 Summary of Human-Rodent Differences in Neocortical Development 
 
1.3.1 Cytoarchitectural Differences 
 
During neocortical development of both humans and rodents, the neuroepithelial cells 
of the neocortical primordium proliferate and differentiate to become a complex multi-
layered structure with regionally diverse cytoarchitecture. The sequential formation of 
neocortical transient layers is largely conserved between humans and rodents, however 
certain transient layers in humans become more complex and elaborate as neocortical 
development progresses, potentially accounting for the larger surface area with the 
formation of gyri and sulci and thicker neocortex in adult humans. During early 
embryonic development, prior to the segregation of the PP into MZ and SP, the human 
PP develops transiently into multiple layers namely the superficial Cajal-Retizus cell 
layer, the intermediate monolayer and the deep pioneer plate, in which such complexity 
is unique to humans (O'Leary and Nakagawa, 2002; Meyer, 2001; Meyer et al., 2000). 
During foetal development, the human SVZ is visibly divided into ISVZ and OSVZ by 
a cell-poor/fibre-rich IFL at around 12 PCW (Bayatti et al., 2008a), containing 
heterogeneous populations of progenitor cells giving rise to more diverse subtypes of 
glutamatergic projection neurones and also GABAergic interneurones (Fietz et al., 2010; 
Hansen et al., 2010); whereas the rodent SVZ only contains a few layers of cells and 
maintains its thickness throughout development (Martinez-Cerdeno et al., 2006). The 
human SP also starts to expand drastically during mid-gestation due to gradual 
accumulation of vast amount of fibre tracts and is about four times thicker than the CP 
at its maximal size (Kostovic and Rakic, 1990). The amount of fibre tracts accumulating 
in the SP correlates with the appearance of gyri as area with the largest number of fibre 
tracts in the SP causes bulging of the CP and is preferentially observed in regions where 
gyri become pronounced (Kostovic and Rakic, 1990). Thus the elaborate and complex 
SVZ and SP potentially underlie the neocortical thickness and surface area expansion in 
gyrencephalic humans. Furthermore, the MZ is another layer prominently different 
between the two species, in which a transient layer of undifferentiated granular cells are 
found above the human MZ, termed SG layer (Meyer, 2001). Figure 1.12 illustrates the 
histological comparison of sequential formation of neocortical transient layers between 
humans and rodents during development (Molnar et al., 2006). 
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Figure 1.12. Comparison of neocortical layer formation in the developing human and 
rodent neocortices. 
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The top and bottom panels depict the sequential formation of various neocortical layers in 
humans and rodents respectively at comparable developmental stages. The internal detail of 
each layer reflects the orientation and shape of cells residing in each layer as well as its relative 
cell density. Notice a “clear-layer” indicated by an asterisk (*), is transiently present at E72 in 
non-human primates locating in the deep subplate (SP), which disappears during later stages of 
development (top panel). CP, cortical plate; IFL, inner fibrous layer; ISVZ, inner subventricular 
zone; IZ; intermediate zone; MZ, marginal zone; OSVZ, outer subventricular zone; PP, 
preplate; VZ, ventricular zone. Scale bars indicate 0.1 mm. Adapted and modified from (Molnar 
et al., 2006). 
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1.3.2 Molecular Differences 
 
As described in previous section, Pax6 and Emx2 are the two best characterized 
transcription factors known to be involved in neocortex regionalisation with supporting 
evidence from mutant mice experiments to show they are expressed in counteracting 
gradients and control anterior and posterior neocortical area specification respectively 
(Muzio et al., 2002; Bishop et al., 2000). Spatial and temporal analysis of graded 
expression patterns of PAX6 and EMX2 by our group has previously revealed 
similarities and differences with previously published rodent data (Table 1.1; (Ip et al., 
2010a; Bayatti et al., 2008b; O'Leary et al., 2007)). At 8 PCW they exhibited reciprocal 
gradients as described in rodents. However from 9 PCW, PAX6 failed to exhibit the 
high anterolateral, low posteromedial gradient (seen at 8 PCW), while the EMX2 
gradient (high posteromedial, low anterolateral) persisted. Furthermore, PAX6/PAX6 
expression is not limited to the VZ in humans but also detected in the SVZ (Bayatti et 
al., 2008b). On the other hand, expression of EMX2/EMX2 in humans is limited to the 
proliferative zones at 8 PCW, however, unlike rodents, the majority of its expression is 
shifted to the CP by 10 PCW while its expression in the proliferative zones maintained 
throughout all investigated stages (Bayatti et al., 2008b).  
 
Thus although many mechanisms involved in corticogenesis and regionalisation are 
shared in common between rodents and humans, the human neocortex is composed of 
diverse and more complex local area identities reflecting differences in structure and 
function (Molnar and Cheung, 2006; Hill and Walsh, 2005; Monuki and Walsh, 2001). 
The differences observed between humans and rodents have highlighted the importance 
of utilizing human materials to investigate regionalisation further in order to identify 
some human-specific mechanisms. 
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Genes Gradient (Humans) Gradient (Rodents) 
Laminar 
localization 
(Humans) 
Laminar 
localization 
(Rodents) 
PAX6 
↑Anterior/Lateral 
↓Posterior/Medial 
at 8 GW, no gradient 
afterwards 
↑Anterior/Lateral 
↓ Posterior/Medial 
SVZ, VZ VZ 
EMX2 
↑Posterior/Medial 
↓Anterior/Lateral 
↑Posterior/Medial 
↓Anterior/Lateral 
CP, SVZ, VZ VZ 
Table 1.1. Summary of the observed neocortical expression patterns of EMX2 and PAX6 
(gradients and laminar localization) in the human brain as compared to previous studies 
in rodent. 
Compiled by comparing studies reported in (Bayatti et al., 2008b; O'Leary et al., 2007). CP, 
cortical plate; SVZ; subventricular zone, VZ. Adapted from (Ip et al., 2010a). 
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1.4 Affymetrix Gene Chip Analysis 
 
The observation of reciprocal gradients at early stages of human neocortical 
development implies that regionalisation events may be occurring relatively early in the 
developing human brains and that cells in the developing neocortex at this stage may 
exhibit a degree of intrinsic identity information (Rakic et al., 2009; Rakic, 1991). 
However, the loss of the PAX6 (high anterolateral, low posteromedial) gradient at 9 
PCW in humans is still early in neocortical development as CP starts to form at 7.5 
PCW (Meyer et al., 2000) and even Layer VI has not formed completely (Bayatti et al., 
2008a). Although in rodents Pax6 has been found to be expressed in a gradient 
throughout neurogenesis (Manuel and Price, 2005), our observation supports recent 
evidence in rodents suggesting that Pax6 is not directly involved in regional identity. 
 
In order to identify other potential anterior markers during human neocortical 
development and assess whether any putative markers may be intrinsically regulated, 
our group has previously analyzed gene expression levels in developing neocortical 
tissue dissected anteriorly and posteriorly between 8-12.5 PCW using an Affymetrix 
whole genome chip array (U133 Plus 2.0, Affymetrix UK Ltd., High Wycombe, UK) 
(Ip et al., 2010a). In brief, GeneSpring GX 7.3 software (Agilent Technologies) was 
used for expression level analysis. Expression data for each probe set was background-
corrected, normalized and summarized by Gene Chip-Robust Multi-array Average (GC-
RMA), and gene expression levels between the two regions of the neocortex were 
calculated as fold changes. Using 1.75 as a threshold fold change (this threshold was 
arbitrary and chosen as EMX2 was measured at 1.77-fold which had previously been 
confirmed to exhibit a gradient along the anterior-posterior axis by in-situ hybridization 
(ISH) in tissue sections; (Bayatti et al., 2008b)), the scatter plot in Figure 1.13A showed 
383 Affymetrix probe sets that are more highly expressed anteriorly than posteriorly 
(marked by white) and 154 probe sets that exhibit higher expression posteriorly than 
anteriorly (marked by white) (Ip et al., 2010a). It is noteworthy that Affymetrix gene 
chip analysis is only one of the many applications to examine graded gene expression 
and the use of 1.75-fold as the threshold fold change does not preclude genes exhibiting 
<1.75-fold to be also expressed in gradients which could be significantly detected by 
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other methods such as quantitative real time-polymerase chain reaction (rtPCR) (Ip et 
al., 2010a). 
 
Clustering study of all genes between different samples analyzed by condition tree 
analysis (Figure 1.13B) and principal component analysis (Figure 1.13C) by 
GeneSpring GX software indicated that gestational age was a variable affecting total 
gene expression between samples, as close clustering was observed at ages 9-11 PCW, 
while samples aged 8 and 12.5 PCW exhibited more variability (Ip et al., 2010a). 
 
Gene ontologies were analyzed using the GO Ontology Browser within the GeneSpring 
GX analysis platform. This functional ontological analysis revealed expression profiles 
consistent with an enrichment of neural developmental processes occurring in both 
anterior- and posterior-derived neocortical tissue (Ip et al., 2010a). However genes 
classified within cell-signalling, adhesion, proliferation and cell death categories were 
up-regulated in anterior- compared to posterior-derived cells suggesting greater 
interactions between cells are taking place anteriorly than posteriorly (Ip et al., 2010a). 
Conversely posteriorly-derived samples tended to exhibit high expression levels of 
genes involved in ion transport, including ionotropic neurotransmitters and transporters 
(Ip et al., 2010a). 
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Figure 1.13. Affymetrix Chip Analysis of genes differentially expressed across the 
anterior-posterior axis of the developing human neocortex. 
Scatter plot (A) showed expression levels of genes from posteriorly (X-axis) and anteriorly (Y-
axis) plotted against each other. Genes marked in white correspond to those found to be 
differentially regulated along the anterior-posterior axis by at least 1.75-fold. Colours 
correspond to an arbitrary „heatmap‟ indicating expression levels.  
Condition tree (B), showing levels of all genes indicates that clustering of samples occurs in an 
age-dependent manner. At each indicated age 2 chips corresponding to levels of genes from 
anteriorly- and posteriorly-derived tissue are indicated.  
Principal component analysis (C) revealed that age is one principal component variable in gene 
expression levels (principal component 2, Y-axis). The variance exhibited on the X-axis also 
highlights the differences between the closely clustering chips 9-11.5 PCW, and the two ages 
which cluster the least; 8 and 12.5 PCW. Chips are colour-labelled according to age (Blue 8 
PCW, Grey 9 PCW, Yellow 10-10.5 PCW, Orange 11 PCW, and Red 12.5 PCW as indicated by 
the heatmap).   
Performed by Dr. Nadhim Bayatti. Adapted from (Ip et al., 2010a).  
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1.5 Aims and Objectives 
 
The development of anterior neocortical areas such as the motor cortex and the CSMN 
originating from this region in humans is of particular interest to our group since the 
potential anterior molecular determinants are yet to be identified in humans. 
Furthermore, the motor cortex and corticospinal tract is a common site of 
developmental brain damage leading to cerebral palsy (Eyre, 2007). In order to promote 
mechanisms that facilitate substitution or repair of these corticofugal neurones in the 
lesioned region, it is important to first localize their developmental origin. In addition, it 
is essential to identify genes that are related to these corticofugal neurones and 
investigate how these genes are regulated. Ultimately, the identification of regulatory 
mechanisms of corticofugal neurone- (especially CSMN-) related genes will facilitate 
potential future approaches aiming to promote population of endogenous stem cells or 
those from other source towards a corticospinal neurone phenotype. 
 
The aim of the current project was to investigate graded gene expression in humans 
from the time when CP starts to emerge (8 PCW) to the innervation of thalamocortical 
afferents (around 12 PCW and above) in order to identify regulated genes that are 
related to the development of motor cortex and the associated corticofugal neurones. 
Additionally, in order to test the hypothesis that the anterior pole of the human 
neocortex may be an early site of the developing motor cortex harbouring corticofugal 
neurones including CSMN and to understand the development of this type of projection 
neurones, regulated candidate genes were then examined further to deduce the type and 
location of cells expressing them within the neocortex and/or along the axonal pathways 
of these subcerebral projection neurones. Furthermore, we sought to establish a human 
in-vitro regionalisation model in order to investigate the regulatory mechanisms of these 
candidate genes.  
 
The objectives of this project were  
1) to perform quantitative rtPCR to confirm the graded expression of a subset of 
genes identified previously by Affymetrix gene chip analysis between 8-12 PCW 
in humans, including a number of transcription factors, cell adhesion and axonal 
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guidance molecules and growth factors receptors, in which some are associated 
with corticospinal and other subcerebral projection neurones. (Chapter 3) 
 
2) to verify laminar-enriched expression patterns of SATB2 and NURR1, which 
were to be used for demarcating various laminae in developing human neocortex, 
alongside with other laminar-enriched markers such as ER81 and Growth-
associated protein 43 (GAP43) by performing ISH and immunohistochemistry 
(IHC). (Chapter 4) 
 
3) to investigate of the spatiotemporal expression patterns of the anteriorly-
upregulated candidate genes that are associated with subcerebral projection 
neurones in the developing human brains by performing ISH and IHC. These 
anteriorly-upregulated candidate genes were the transcription factor CTIP2; 
axonal guidance molecule, ROBO1 and its downstream signalling molecule, Slit-
Robo Rho GTPase activating protein 1 (SRGAP1). Other neuronal markers were 
also included for comparison as a) they are also known to be crucial for the 
development of subcerebral projection neurones in rodents but without obvious 
graded expression in developing human neocortex (FEZF2 and SOX5); or b) they 
have laminar-enriched expression patterns in the rodent and/or human neocortex 
that aid the demarcation of various laminae (ER81, SATB2, NURR1, TBR1, 
GAP43 and Synaptophysin). (Chapter 5) 
 
4) to establish a human in-vitro model of regionalisation by isolating cells from the 
anterior and posterior region of the neocortex and allowing them to grow 
separately in culture, and characterize this model by carrying out a) 
immunocytochemistry (ICC) with progenitor (Nestin), glial (GFAP), neuronal 
(CTIP2, MAP2, ROBO1 and SRGAP1) and some putative regionalisation 
markers (EMX2 and PAX6); and b) rtPCR with regulated genes as characterized 
in-vivo. Preliminary gene expression regulation study was initiated by stimulating 
cells with various treatments of FGFs and determined the changes in expression 
level of the anteriorly-upregulated candidate genes (CTIP2, ROBO1 and SRGAP1) 
and the genes encoding receptors for FGFs (FGFR1, -2 and -3) by rtPCR. 
(Chapter 6)  
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Chapter 2 Materials and Methods 
 
2.1 Human Foetal Brains and Ethical Approval 
 
Brains were dissected from human foetal and embryonic terminations of pregnancies 
obtained from the MRC-Wellcome Trust Human Developmental Biology Resource at 
Newcastle University (HDBR, http://www.hdbr.org). The HDBR has a license to act as 
a tissue bank from the Human Tissue Authority (license number 12534; Designated 
individual: Professor Andrew Hall) under Section 16 (2) (e) (ii) of the Human Tissue 
Act, 2004. The license authorizes “the storage of relevant material which has come from 
a human body for the use of a scheduled purpose”.  Ethical approval was obtained from 
the Newcastle and North Tyneside Research Ethics Committee (NREC, reference 
08/H0906/21). The ethical approval covers the collection of the material for the HDBR 
tissue bank and all registered UK research projects including those of our group using 
material from the bank. 
 
Tissue from ages between 8 and 17 PCW for tissue histological haematoxylin and eosin 
staining (H & E), ISH and IHC, quantitative rtPCR, dissociated cell cultures and 
Western blot were used. The number of samples used at each age in each study 
conducted in the current project was summarized in Table 2.1. Age was estimated from 
measurements of foot length and heel to knee length. These were compared with a 
standard growth chart (Hern, 1984). 
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Studies Experiments Age (PCW) 
Number of 
Samples (n=) 
Ch.3 
Confirmation of graded 
expression of subsets of genes 
identified by Affymetrix gene 
chip analysis 
rtPCR 
8 
10 
12 
3 
4 
4 
Ch.4 
Verification of laminar-
enriched expression patterns 
of SATB2/SATB2 and 
NURR1 
H & E/ 
ISH/IHC 
8 
9 
10 
12 
15 
2 
2 
2 
2 
2 
Ch.5 
Analyses of spatial and 
temporal expression patterns 
of corticofugal projection 
neurone-associated genes 
and/or proteins 
H & E 
ISH/IHC 
8 
9 
10 
11 
12 
14 
15 
17 
3 
3 
3 
2 
1-2 
2 
2 
2 
Characterization of ROBO1 
and SRGAP1 antibodies 
WB 14 2 
Ch.6 
Characterization of in-vitro 
model of regionalisation 
(primary foetal brain cells 
culture) 
rtPCR 
ICC (DAB) 
ICC (F) 
11 
11 
11 
4 
4 
1 
Preliminary gene expression 
regulation study: FGFs 
stimulation 
rtPCR 
10 
11 
12 
1 
1 
1 
Table 2.1. Number of samples used at each age for each study in the current project. 
DAB, 3, 3‟-Diaminobenzidine; F, fluorescence; H & E, haematoxylin and eosin staining; ICC, 
immunocytochemistry; IHC, immunohistochemistry; ISH, in-situ hybridization; rtPCR, real-
time polymerase chain reaction; WB, Western blot.  
 
61 
 
2.2 Dissociated Cell Cultures 
 
2.2.1 3-Day In-vitro Protocol 
  
Both left and right neocortices were used for culture after removal of subcortical 
structures, temporal lobes and meninges of the brains. The neocortices were divided 
into three equal-sized slices along the anterior-posterior axis and cells were isolated 
from the anterior- and posterior-most slices and cultured separately. Short-term 
dissociated human foetal cell cultures were initiated according to an established rodent 
protocol with minor modifications (Figure 2.1; (Franke et al., 2000)). In brief, the 
anterior- and posterior-most neocortices were dissected under sterile conditions and 
briefly soaked in Ca
2+
- and Mg
2+
-free Dulbecco‟s phosphate buffered saline (DPBS, 
Invitrogen, Paisley, UK). The tissues were cut into small pieces trypsinized for 20 
minutes in Ca
2+
- and Mg
2+
-free Hank‟s balanced salt solution (HBSS) containing 0.05% 
trypsin/ethylene diamine tetra-acetic acid (EDTA, Invitrogen). Trypsin action was 
terminated by transferring tissue pieces to HBSS supplemented with 10% heat-
inactivated foetal calf serum (FCS, Invitrogen). The tissue was gently dissociated by 
trituration through a plastic pipette and passed through a 70 μm pore nitex mesh (Becton 
Dickinson, Oxford, UK). Cells were pelleted at 400 g for 5 minutes and re-suspended in 
minimum essential medium (MEM, Invitrogen) supplemented with 10% FCS. Cells 
were plated at 200,000 cells/cm
2
 into 3.8 cm
2
 12-well culture dishes (Falcon, Franklin 
Lakes, USA) and 1.3 cm
2
 4-well SonicSeal Slides (Thermo Fisher Scientific, Thorn 
Business Park, UK) coated with poly-L-lysine (0.01% solution; molecular weight 70-
150 kDa; Sigma-Aldrich, Poole, UK). After 24 hours (one day in-vitro, 1 DIV), cells 
were switched to serum-free MEM/1:1 F12 supplemented with 1:50 B27 (Invitrogen) 
for a further 48 hours (Figure 2.1). For characterization of this dissociated cell culture 
model, RNA was isolated from cells cultured under the above conditions after a total of 
3 DIV and subjected to reverse transcription and rtPCR (see Section 2.3 and 2.4) or 
cells were fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich)/PBS and subjected 
to immunocytochemistry (Section 2.9). 
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Figure 2.1 A schematic diagram showing method of dissecting brain slices for cell cultures. 
After removal of meninges, temporal lobe (T), and subcortical material, tissue was dissected 
from the anterior (A) and posterior (P) neocortex, and subsequently dissociated and cultured 
separately. This example showed an 11 PCW brain (F3), which measured 30 mm along the 
anterior-posterior axis. FCS, foetal calf serum; MEM, minimum essential medium. 
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2.2.2 Treatment of Cell Cultures: Fibroblast Growth Factors Stimulation 
 
After 1 DIV in 10% FCS/MEM, some cells isolated from the anteriorly- and 
posteriorly-derived tissues as above were treated with the fibroblast growth factors 
FGF2 (PeproTech, London, UK) or FGF8 (PeproTech) both at 20 ng/ml in serum-free 
1:1 F12/1:50 B27/MEM for 24 hours (short-term) or 72 hours (long-term). Some cells 
were also treated with MEK inhibitor U0126 (10 µM; Merck, Feltham, UK) only or in 
addition to FGFs treatment for 24 hours (short-term) or 72 hours (long-term). For the 
72-hour long-term stimulation, medium was changed every other day accordingly. The 
various treatments of anteriorly- and posteriorly-derived cells were summarized in 
Table 2.2. RNA was isolated from cells after completion of the treatments and subjected 
to reverse transcription and rtPCR (see Section 2.3 and 2.4).  
 
Abbreviations Treatments Stimulation Time 
C-24hr 
Control – no treatment 
24 hours 
C-72hr 72 hours 
C+U-24hr 
U0126 alone (10 µM) 
24 hours 
C+U-72hr 72 hours 
FGF2-24hr 
FGF2 alone (20 ng/ml) 
24 hours 
FGF2-72hr 72 hours 
FGF2+U-24hr 
FGF2 (20 ng/ml) + U0126 (10 µM) 
24 hours 
FGF2+U-72hr 72 hours 
FGF8-24hr 
FGF8 alone (20 ng/ml) 
24 hours 
FGF8-72hr 72 hours 
FGF8+U-24hr 
FGF8 (20 ng/ml) + U0126 (10 µM) 
24 hours 
FGF8+U-72hr 72 hours 
Table 2.2. Treatments of anteriorly- and posteriorly-derived cells. 
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2.3 RNA Isolation and Reverse Transcription 
 
2.3.1 RNA Extraction and Reverse Transcription 
 
For the production of digoxigenin (DIG)-labelled RNA probes, total RNA from a 
human foetal whole brain or neocortex aged between 8-12 PCW were isolated with 
Trizol/Chloroform (Invitrogen) according to the instructions of the manufacturer. For 
quantification of mRNA expression levels of target genes between the anterior and 
posterior part of the neocortex using rtPCR, right neocortices were used after removal of 
subcortical structures, temporal lobes and meninges of the brains and divided into 5 mm 
slices along the anterior-posterior axis (Figure 2.2). Total RNA was isolated from the 
anterior- and posterior-most of neocortical tissues and dissociated cell cultures using the 
PeqGOLD RNAPure reagent (Peqlab, Fareham, UK) according to the instructions of the 
manufacturer. Total RNA concentration was determined by spectrophotometric 
absorbance at 260 nm using NanoDrop 8000 (Fisher Scientific, Loughborough, UK). A 
total of 2 μg of RNA was reverse transcribed using 200 U/μl of SuperScript Reverse III 
Transcriptase Kit (Invitrogen) and 2 μg random hexadeoxynucleotides primers 
(Promega, Southampton Science Park, UK) in a final volume of 50 μl following the 
instructions of the manufacturers. The transcribed complementary (c)DNA template was 
used directly for the production of DIG-labelled RNA probes, whereas the concentration 
of the transcribed cDNA template was further diluted 2-fold prior rtPCR.  
 
2.3.2 Genomic DNA Contamination Assessment 
 
Genomic (g)DNA contamination of each cDNA sample used was assessed by standard 
PCR assay using SDHA primer sets (Table 2.3). The thermal cycle condition was 95˚C 
for 15 minutes; 40 cycles of 94˚C for 3 seconds, 60˚C for 40 seconds and 72˚C for 50 
seconds, followed by 72˚C for 5 minutes. Positive control was incorporated by 
replacing cDNA sample with human gDNA sample. The amplified PCR products and 
1kb Plus DNA ladder (10787-018; Invitrogen) were electrophorized on 1.5% agarose 
gel. 
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Figure 2.2. A schematic diagram showing method of dissecting brain slices for RNA 
extraction. 
After removal of meninges, temporal lobe (T), and subcortical material, 5 mm coronal slices 
were cut coronally along the anterior-posterior axis. The most anterior (A) and posterior (P) 
slices were used in this study. This example showed an 11 PCW brain (F3), which measured 30 
mm along the anterior-posterior axis. Adapted from (Ip et al., 2010a). 
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2.4 Quantitative real-time PCR (rtPCR) 
 
The mRNA expression of various target genes in the anterior- and posterior-most of the 
neocortex and dissociated cultured cells were determined by rtPCR. The sequence-
specific primer sets (Eurofins MWG Operon, Raynes Park, UK), designed using 
Primer3 (http://frodo.wi.mit.edu/primer3/) except PAX6 (which was obtained from the 
PrimerBank, PrimerBank ID: 4505615a1, http://pga.mgh.harvard.edu/primerbank/), and 
amplicon sizes for all target genes were listed in Table 2.3. 
 
  
Primer sets 
5' to 3' Sequence Amplicon 
size (bp) Forward Primers Reverse Primers 
*β-ACTIN CTACAATGAGCTGCGTGTGGC CAGGTCCAGACGCAGGATGGC 271 
CNTNAP2 TGTCCTTCAGCCTTCATTCC TGACATTCGCGAAACTTCC 110 
COUPTFI GAGCTGTTCGTGCTCAACG ACCTGCTCCTGGAAGATGC 146 
CTIP2 CAGAGCAGCAAGCTCACG GGTGCTGTAGACGCTGAAGG 102 
EMX2 TCCAAGGGAACGACACTAGC TCTTCTCAAAGGCGTGTTCC 126 
FEZF2 ACACGCATATCCGCATCC AGGCCTTGTTGCAGATGG 147 
FGFR1 CGTCTACAAGATGAAGAGTGG GAGTCAGCAGACACTGTTACC 114 
FGFR2 CTCTTCAACGGCAGACACC CACTTGCCCAAAGCAACC 133 
FGFR3 GTGCACAACCTCGACTACTAC GATCATGTACAGGTCGTGTG 255 
*GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 86 
MAP2 TTCCTCCATTCTCCCTCCTC TCTGCGAATTGGCTCTGAC 121 
PAX6 ATGTGTGAGTAAAATTCTGGGCA GCTTACAACTTCTGGAGTCGCTA 103 
PCDH17 GTTCCCAGAACTGGTCATCC TGTCGTTGGAGTCAATCACC 143 
ROBO1 TTGTGAGGGCAGCTAATGC TCTCTGGACCTGCTTGTGG 116 
ROBO2 AAAGAAGGCAGCCAGAACC TCGGAACGTTGAATGTTGG 110 
*SDHA TGGGAACAAGAGGGCATCTG CCACCACTGCATCAAATTCATG 84 
SOX5 ATGACCATGATGCTGTCACC TTCACAACAGCCACCTTCC 103 
SRGAP1 CCAACATTGATGCCTGTCC TCTCATAAACAGGGCCATCC 139 
S100A10 GGAACACGCCATGGAAAC CCACAGCCAGAGGGTCTTT 143 
Table 2.3. List of Primers for rtPCR. 
Gene-specific primer sequences used for rtPCR. * indicates housekeeping genes. CNTNAP2, 
Contactin-associated protein-like 2; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; 
MAP2, Microtubule-associate protein 2; SDHA, Succinate dehydrogenase complex subunit A; 
S100A10, S100 calcium binding protein A10. Adapted from (Ip et al., 2010a). 
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2.4.1 Restriction Enzyme Digestion 
 
The identities of amplified PCR products (PCR condition as described in Section 2.3.2) 
were confirmed using restriction enzyme digestion. The restriction enzymes used for 
each target gene were listed in Table 2.4. Single or double restriction sites in each 
sequence were identified by NEBcutter v2.0 (http://tools.neb.com/NEBcutter2/). 1 μg of 
amplified PCR product of each gene was used for the restriction digestion according to 
the instruction of the manufacturers and subsequently resolved by running the reaction 
mixture alongside with their undigested PCR products and 1 kb Plus DNA ladder 
(10787-018; Invitrogen) on 2% agarose gel.  Upon failure of the reaction, the original 
amplified PCR products were gel extracted using Qiagen gel extraction kit (Qiagen, 
Crawley, UK) and 2 ng/μl of purified samples were sent off for direct sequencing with 
their forward primers (Eurofins MWG Operon Sequencing Service). 
 
Target Genes Restriction Enzymes 
Cut 
position 
Product size 
(bp) 
CNTNAP2 DpnI (#R0176; New England BioLabs, Ipswich, UK) 50 50+60 
COUPTFI SphI (#R0182S; New England BioLabs) 75 75+71 
CTIP2 DpnI 42 42+60 
EMX2 HaeIII (#R6171; Promega) 50 50+76 
FEZF2 HphI (#R0158S; New England BioLabs) 65 65+82 
FGFR1 HaeIII 67 67+47 
FGFR2 PpuMI (#R0506S; New England Biolabs) 57 57+76 
FGFR3 DdeI (#R6291; Promega) 65 65+190 
MAP2 DdeI 25, 33 25+8+88 
PCDH17 HphI 49, 124 49+75+19 
ROBO1 EcoRI (#R6011; Promega) 66 66+50 
ROBO2 DdeI 60 60+50 
SOX5 HphI 16 16+87 
SRGAP1 HaeIII 124 124+15 
S100A10 DdeI 77 77+66 
Table 2.4. List of restriction enzymes for target genes. 
Restriction enzymes used for confirmation of PCR products identities. Single or double cutting 
positions in each sequence and the size of the resulting fragments were also stated. 
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2.4.2 rtPCR  
 
Three housekeeping genes, β–ACTIN, GAPDH and SDHA were used as internal 
reference to normalize the cDNA template between different samples. Negative control 
was incorporated by replacing the cDNA template with Molecular Biology grade water 
(VWR International, Lutterworth, UK). The SYBR Green-based rtPCR assay was 
performed in 7900HT Fast Real-Time PCR system (Applied Biosystems, Warrington, 
UK). A total volume of 10 μl rtPCR reaction was set up in triplicates, containing 5 μl of 
2x SYBR Green rtPCR Master Mix (Invitrogen), 1 μl of the diluted cDNA template, 0.5 
μl of each primer (10 ρmol/μl), and 3 μl of Molecular Biology grade water. The thermal 
cycle protocol for SYBR Green-based rtPCR assay was 95°C for 15 minutes followed 
by 40 cycles of 95°C for 15 seconds, 60°C for 30 seconds, 72°C for 30 seconds and 
74°C for 10 seconds. Amplification of a single PCR product was confirmed by 
dissociation curve analysis of PCR products (68°C for 10 seconds followed by 99°C for 
10 seconds) after completion of each rtPCR reaction. Baseline was set automatically by 
the machine and threshold was set manually above all the background signals. The data 
obtained were analyzed with the qBase software (Hellemans et al., 2007).  
 
Normalized relative quantities (NRQ) of mRNA expression were calculated in qBase 
and NRQ data was presented with fold changes calculated for each gene comparing the 
two regions of the neocortex or cells ± standard error of mean (S.E.M.). A paired 
Student‟s t-test was performed to determine the significance of differences on 
expression levels from anteriorly- and posteriorly-derived neocortical tissue or cells of 
the same age (p≤ 0.05). Two-way analysis of variance (ANOVA) was performed to 
determine the significance of differences on expression levels from anteriorly- and 
posteriorly-derived neocortical tissues of different ages (p≤ 0.05), taking into account of 
the covariate of various sample ages. Factors causing significant differences on gene 
expression levels were subjected to post-hoc analysis (Least significant difference test, 
LSD test) to determine the effect of the factors on gene expression levels (p≤ 0.05). 
NRQ of mRNA expression for each gene of interest in anteriorly- or posteriorly-derived 
cells after various treatments were also calculated in qBase. Changes of their expression 
level were calculated and presented as fold changes ± S.E.M. between (1) FGFs-treated 
and control groups (FGFs/C) or (2) FGFs-, U0126-treated and U0126 alone-treated 
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groups (FGFs+U/C+U). A paired Student‟s t-test was performed to determine the 
significance of differences in expression levels in FGFs-treated and control groups as 
well as in FGFs-, U0126-treated and U0126 alone-treated groups (p≤ 0.05). 
Comparisons of fold changes between (1) and (2) were also made to examine the effects 
of the MEK inhibitor. A paired Student‟s t-test was performed to determine the 
significance of differences in fold changes between (1) and (2) (p≤ 0.05). The average 
of Ct values ± S.E.M. of the reference genes used from the 3 samples were also 
calculated to show if there was any effects of various treatments to their expression 
levels.  
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2.5 Tissue Processing and Sectioning 
 
Tissue fixation and processing was performed by HDBR staffs after collection of 
samples. Prior to sectioning, brains were fixed for at least 24 hours at 4ºC in 0.1M PBS 
containing 4% PFA (Sigma Aldrich). Whole or half brains (divided sagittally) were 
transferred to 70% ethanol for storage at 4ºC prior to overnight tissue processing (70% 
ethanol for 15 minutes, 100% ethanol for 45 minutes, 100% ethanol for 1 hour twice, 
xylene for 45 minutes, xylene for 1 hour twice, wax for 1.5 hours, wax for 1 hour 45 
minutes twice; Shandon Pathcentre Tissue Processor, Thermo Scientific, Epsom, UK) 
and paraffin embedding. 8 μm-thick paraffin sections were cut sagittally or coronally, 
mounted on slides, and used for tissue ISH and IHC. Brainstems subjected to frozen 
sectioning were cryoprotected in 30% sucrose/PBS after fixation in 4% PFA/PBS for at 
least 24 hours. 70 μm-thick sections were cut on freezing microtome and collected in 
PBS. These tissue sections were used for immunohistochemistry. 
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2.6 Haematoxylin and Eosin (H & E) Histological Staining 
 
Paraffin sections were dewaxed in xylene for 5 minutes and rehydrated in serial dilution 
of ethanol with decreasing concentrations and then water for 3 minutes each. Dewaxed 
sections were initially stained with filtered Harris haematoxylin stain (Raymond A 
Lamb Ltd, Eastbourne, UK) for about 1 minute and rinsed in water. Sections were then 
treated briefly with acid alcohol (95% ethanol/1% concentrated hydrochloric acid 
(Sigma-Aldrich)) for 2 seconds to reduce the haematoxylin stain and rinsed in water. 
Nuclei of cells in sections became blue when treated with the weakly alkaline Scott‟s 
tap water substitute (3.5 grams sodium bicarbonate (Sigma-Aldrich), 20 grams 
magnesium sulphate (Sigma-Aldrich) in 1 litre of distilled water) for 10 seconds and 
then rinsed in water. The cytoplasmic components of cells in sections were stained pink 
when treated with filtered eosin stain (1% aqueous, Raymond A Lamb Ltd) for 30 
seconds, and then rinsed in water. All H & E stained sections were dehydrated in 
increasing concentrations of ethanol, cleared in xylene and mounted in DPX mountant 
(Merck). 
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2.7 Tissue in-situ Hybridization (ISH) 
 
2.7.1 Manufacturing of Probes 
 
Primers (Eurofins MWG Operon) were designed using Primer3. The primers were 
designed with SP6 or T7 consensus sequences upstream to the forward (FP) and reverse 
(RP) gene-specific primer sequences respectively. The FP and RP sequences are listed 
in Table 2.5. DIG-labelled RNA probes were manufactured according to the protocol 
published previously (Bayatti et al., 2008b) with some modifications. In brief, gene-
specific sequences were amplified by two rounds of PCR (95˚C for 15 minutes; 40 
cycles of 94˚C for 3 seconds, 55-65˚C for 40 seconds and 72˚C for 50 seconds, followed 
by 72˚C for 5 minutes) and purified using Qiagen gel extraction kit (Qiagen). 75 ng of 
purified gene-specific cDNA was used for in-vitro transcription using DIG-RNA 
labelling kit (SP6/T7; Roche, Welwyn Garden City, UK). The concentration and quality 
of DIG-labelled RNA probes was assessed by spectrophotometric absorbance at 260 nm 
using NanoDrop 8000 (Fisher Scientific, Loughborough, UK), 1.5% agarose gel 
electrophoresis and dot blot. 
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Genes 
GenBank accession 
numbers 
Probe 
sequences 
Primer sequences* Product size 
CTIP2 
NM_138576.2 1892-2351 SP6 (FP) 5‟-AATACGATTTAGGTGACACTATAGAATACAGGAGCTGCTACTGGAGAACGAA-3‟ 
T7 (RP) 5‟-TAAGTTAATACGACTCACTATAGGGCGATCCAGGTCCTTCTCCACCTTGAT-3‟ 
517 bp 
NM_022898.1 1679-2138 
ER81 
NM_004956.4 1609-2173 
SP6 (FP) 5‟-AATACGATTTAGGTGACACTATAGAATACTGACACCTGTGTTGTCCCAGAAA-3‟ 
T7 (RP) 5‟-TAAGTTAATACGACTCACTATAGGGCGACCATGTCTGTCTTCAGCAGTGGA-3‟ 
464 bp 
NM_001163147.1 1343-1907 
NM_001163148.1 1151-1715 
NM_001163149.1 1022-1586 
NM_001163150.1 1088-1652 
NM_001163151.1 1034-1598 
NM_001163152.1 899-1463 
FEZF2 NM_018008.3 1120-1531 
SP6 (FP) 5‟-AATACGATTTAGGTGACACTATAGAATACAAACTTCACCTGCGAGGTGTGC-3‟ 
T7 (RP) 5‟-TAAGTTAATACGACTCACTATAGGGCGAGTTGTGGGTGTGCATATGGAAGG-3‟ 
469 bp 
ROBO1 
NM_002941.2 4013-4499 SP6 (FP) 5‟-AATACGATTTAGGTGACACTATAGAATACTAGCCAAGATGCAAACCAGAAGG-3‟ 
T7 (RP) 5‟-TAAGTTAATACGACTCACTATAGGGCGATGTGTCTTGGATTGGGCAGTAGG-3‟ 
544 bp 
NM_133631.1 4859-5345 
SATB2 NM_015265.2 711-1262 
SP6 (FP) 5‟-AATACGATTTAGGTGACACTATAGAATACTTAGCCAAAGAATGCCCTCTCTCC-3‟ 
T7 (FP) 5‟-TAAGTTAATACGACTCACTATAGGGCGACCTCTTCAGCTCATCTCTGACTTGC-3‟ 
552 bp 
SOX5 
NM_006940.4 1832-2257 
SP6 (FP) 5-AATACGATTTAGGTGACACTATAGAATACCCTTTCCTGACATGCACAACTCC-3‟ 
T7 (RP) 5‟-TAAGTTAATACGACTCACTATAGGGCGACCTCTCCTTTCACACCGTAAGTGC-3‟ 
483 bp NM_152989.2 2062-2487 
NM_178010.1 594-1019 
Table 2.5. List of primers for manufacturing of probes. 
Gene-specific primer sequences used for the manufacturing of probes. Sequences underlined were gene-specific. FP, forward primer; RP, reverse primer. 
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2.7.2 Tissue ISH 
 
Tissue ISH was performed with modifications from the previously published method 
(Bayatti et al., 2008b). Briefly, paraffin sections were dewaxed 3 times in xylene and in 
1:1 xylene/ethanol, before rehydrated in serial dilutions of ethanol in Molecular Biology 
grade water. Sections were rinsed in diethypyrocarbonate-treated PBS and subsequently 
treated with 20 l/ml proteinase K (Sigma-Aldrich) in PBS for 8 minutes at room 
temperature. Sections were post-fixed in 4% PFA/PBS buffer for 20 minutes at room 
temperature, washed in PBS, and treated with 0.1 M triethanolamine (Sigma-Aldrich, 
pH 8.0)/0.25% acetic anhydride (Sigma-Aldrich)/0.2% concentrated hydrochloric acid 
in PBS for 10 minutes at room temperature. Sections were dehydrated in increasing 
concentrations of ethanol and then air-dried by filtered air stream. DIG-labelled sense 
and antisense probes (300 ng) were used with 100 l of DIG Easy Hyb mixture 
(Roche). Probe/Hyb mix (200 l) was used per slide, covered with glass coverslips. 
Slides were incubated in a hybridization chamber overnight at 68ºC. Afterwards, 
sections were rinsed in 5x sodium citrate (SSC, pH 7.2) at 65ºC and subsequently 
washed twice in 2x SSC, then in 0.2x SSC at 50ºC and in 0.2x SSC at room 
temperature. Sections were rinsed in 0.1 M Tris (pH 7.6)/0.15 M NaCl (Buffer 1) and 
blocked with 10% FCS/Buffer 1 for 1 hour at room temperature. After blocking, 
sections were incubated with alkaline phosphatase-conjugated anti-DIG antibody 
(Roche; diluted 1:1000 in 2% FCS/Buffer 1) overnight at 4ºC. After antibody 
incubation, sections were washed 6 times in Buffer 1 at room temperature for 30 
minutes each. Detection of probes was achieved by addition of NBT/BCIP solution 
(Roche; 20 μl/ml) in 0.1 M Tris (pH 9.5)/0.1 M NaCl (Buffer 2). The colour reaction 
was stopped by rinsing slides in Buffer 2 and distilled water. Sections were mounted in 
Aquamount (Merck). 
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2.8 Immunohistochemistry (IHC) 
 
2.8.1 Immunoperoxidase-histochemistry 
 
Paraffin sections were dewaxed twice in xylene for 10 minutes and rehydrated in 
decreasing concentration of ethanol. Subsequently, sections were treated with 3% 
hydrogen peroxide (Sigma-Aldrich) in methanol for 10 minutes to quench the 
endogenous hydrogen peroxidase activities, and boiled in 10 mM citrate buffer (pH 6.0) 
to unmask the epitopes. Sections were incubated with primary antibodies and 3% 
appropriate blocking serum (Vector Laboratory, Peterborough, UK) in 0.1% Triton X-
100/PBS (PBS-T) in a moist chamber at 4˚C overnight. Frozen sections were incubated 
free floating with primary antibodies and 3% appropriate blocking serum in 0.1% PBS-
T at 4˚C overnight with gentle agitation. Table 2.6 provides details of all the primary 
antibodies used. Negative control involving omission of primary antibodies was carried 
out to ensure the specificity of secondary antibodies and streptavidin-horseradish 
peroxidase (HRP) used. After washing 3 times in 0.1% PBS-T for 5 minutes each, 
sections were incubated with appropriate biotinylated-secondary antibodies (Table 2.7; 
Vector Laboratory, 1:200 in 0.1% PBS-T) at 4˚C for 2 hours. Subsequently, sections 
were washed 3 times in 0.1% PBS-T for 5 minutes each after they were incubated with 
streptavidin-HRP (Vector Laboratory, 1:200 in 0.1% PBS-T) at 4˚C for 1 hour. After 
incubation, sections were washed 3 times in 0.1% PBS-T for 5 minutes each then 
incubated with 3, 3'-Diaminobenzidine Enhanced Liquid Substrate System (DAB, 
Sigma-Aldrich) for up to 10 minutes before washing in PBS. Frozen sections were 
mounted on glass slides and air-dried overnight. All sections were dehydrated in 
increasing concentration of ethanol, cleared in xylene and mounted in DPX mountant 
(Merck). 
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Primary 
Antibodies 
Host Species, 
Company 
Working Concentration 
References  IHC  ICC 
WB 
DAB-P F-P DAB-Fr DAB F 
β-ACTIN 
Goat polyclonal,  
Santa Cruz sc1616 
--- --- --- --- --- 1:500 (Zschocke et al., 2005) 
CTIP2 
Rat monoclonal,  
Abcam ab18465 
1:1000 1:500 --- 1:1000 1:500 --- 
(Kwan et al., 2008; Lai et al., 2008; Arlotta 
et al., 2005) 
EMX2 
Rabbit polyclonal, 
 Sigma E6780 
--- --- --- 1:1000 --- --- (Bayatti et al., 2008b) 
GAP43 
Mouse monoclonal,  
Sigma G9264 
1:1000 --- 1:5000 --- --- --- (Bayatti et al., 2008a) 
GFAP 
Mouse monoclonal, 
Sigma G3893 
--- --- --- 1:400 1:400 --- (Bayatti et al., 2008a) 
MAP2 
Mouse monoclonal, 
Sigma M4403 
--- --- --- 1:1000 1:200 --- (Bayatti et al., 2008a) 
NESTIN 
Mouse monoclonal, 
Chemicon MAB5326 
--- --- --- 1:400 1:400 --- (Gu et al., 2002; Messam et al., 2002) 
NURR1 
Goat polyclonal, 
R & D Systems 
AF2156 
1:200 --- --- --- --- --- 
(Hoerder-Suabedissen et al., 2009; Wang et 
al., 2010) 
PAX6 
Rabbit polyclonal, 
Covance PRB-278P 
--- --- --- 1:300 --- --- (Bayatti et al., 2008a) 
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ROBO1 
Rabbit polyclonal, 
Abcam ab7279 
1:4000 1:100 1:10000 --- 1:100 1:1000 
(Lindenmeyer et al., 2010; Marlow et al., 
2010; Sheldon et al., 2009; Siegel et al., 
2009) 
SATB2 
Mouse monoclonal, 
Abcam ab51502 
1:400 1:100 --- --- --- --- 
(Azim et al., 2009; Alcamo et al., 2008; 
Britanova et al., 2008) 
SOX5 
Rabbit polyclonal, 
Sigma AV33323 
1:200 1:100 --- --- --- --- (Kwan et al., 2008) 
SRGAP1 
Mouse monoclonal, 
Abcam ab57504 
1:900 1:100 1:1000 --- 1:100 1:200 --- 
TBR1 
Rabbit Polyclonal, 
Abcam ab31940 
1:500 1:500 --- --- --- --- (Bayatti et al., 2008a) 
TBR2 
Rabbit Polyclonal, 
Abcam ab23345 
--- 1:200 --- --- --- --- (Bayatti et al., 2008a) 
Table 2.6. Details of primary antibodies used for fluorescence (F-) or chromogen-based (DAB-) immunohistochemistry (IHC) on paraffin (P) or frozen (Fr) 
sections, immunocytochemistry (ICC) and Western blot (WB). 
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Primary Antibody Species Serum 
Secondary Antibodies for IHC/ICC Secondary Antibodies for 
WB DAB F 
Goat Horse Biotinylated-Horse Anti-Goat IgG ---  HRP-Horse Anti-Goat IgG 
Mouse Horse Biotinylated-Horse Anti-Mouse IgG Cy3-Horse Anti Mouse IgG HRP-Horse Anti-Mouse IgG 
Rabbit Goat/Sheep Biotinylated-Goat Anti Rabbit IgG 
Alexa Fluor 488 Goat Anti-Rabbit IgG 
Cy3-Sheep Anti-Rabbit IgG 
HRP-Goat Anti-Rabbit IgG 
Rat Goat Biotinylated-Goat Anti-Rat IgG Alexa Flour 488 Goat Anti-Rat IgG HRP-Goat Anti-Rat IgG 
Table 2.7. Details of serum block and secondary antibodies used for fluorescence (F-) or chromogen-based (DAB-) immunochemistry (IHC), 
immunocytochemistry (ICC) and Western blot (WB).  
HRP, horseradish peroxidase. Ig, Immunoglobulin. 
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2.8.2 Immunofluorescent-histochemistry 
 
Paraffin sections were dewaxed twice in xylene for 10 minutes and rehydrated in 
decreasing concentration of ethanol. Sections were boiled in 10mM citrate buffer (pH 
6.0) to break protein cross-links and unmask the epitopes in PFA-fixed tissue sections. 
Double-labelling was performed by incubating sections with primary antibodies in 3% 
appropriate blocking serum (Vector Laboratory) in 0.1% PBS-T on slide in a moist 
chamber at 4˚C overnight. Table 2.6 and Table 2.7 provide details of all the serum, 
primary and secondary antibodies used. After washing 3 times in 0.1% PBS-T for 5 
minutes each, sections were incubated with appropriate fluorochromes-conjugated 
secondary antibodies (Invitrogen, Sigma-Aldrich, 1:200 in 0.1% PBS-T) at room 
temperature for 30 minutes in the dark. Sections were then incubated with 4',6-
diamidino-2-phenylindole (DAPI) nucleic acid stain (Invitrogen, 1:10000 in 0.1% PBS-
T) for 5 minutes at room temperature in the dark and washed twice in 0.1% PBS-T for 5 
minutes each and rinse once in distilled water. Sections were mounted in Vectashield 
mounting medium (Vector Laboratory) and kept in the dark at 4˚C until examination. 
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2.9 Immunocytochemistry (ICC) 
 
After fixation with 4% PFA/PBS, cells were washed 3 times with PBS and incubated 
with primary antibodies and 3% appropriate blocking serum (Vector Laboratory) in 
0.1% PBS-T in a moist chamber at 4˚C overnight with gentle agitation. Table 2.6 
provides details of all primary antibodies used. After washing 3 times in 0.1% PBS-T, 
cells cultured in 3.8 cm
2
 12-well plates were incubated with appropriate biotinylated 
secondary antibodies (Table 2.7; Vector Laboratory, 1:200 in 0.1% PBS-T) at 4˚C for 2 
hours. Alternatively, cells cultured in 1.3 cm
2
 4-well SonicSeal slides were incubated 
with appropriate fluorochromes-conjugated secondary antibodies (Table 2.7; Invitrogen, 
Sigma-Aldrich, 1:200 in 0.1% PBS-T) at room temperature for 30 minutes in the dark. 
Subsequently, cells were washed 3 times in 0.1% PBS-T. Biotinylated-antibody-treated 
cells were then incubated with streptavidin-HRP (Vector Laboratory, 1:200 in 0.1% 
PBS-T) at 4˚C for 1 hour. After incubation, cells were washed 3 times in 0.1% PBS-T 
then incubated with DAB (Sigma-Aldrich) for up to 10 minutes before washing in PBS. 
All cells were then incubated with DAPI nucleic acid stain (Invitrogen, 1:10000 in 0.1% 
PBST) for 5 minutes at room temperature in the dark and subsequently washed 3 times 
in PBS. Cells in 12-well plates were kept in PBS at 4˚C in the dark until examination by 
light and fluorescent microscopy. The wells of the SonicSeal slides were snapped off 
and mounted in Vectashield mounting medium (Vector Laboratory). The slides were 
kept in the dark at 4˚C until examination by confocal microscopy. 
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2.10 Image Acquisition 
 
2.10.1 Light Microscopy 
 
DIG-RNA labelled, immunoperoxidase-stained sections and cells were examined using 
Axioplan 2 and Axiovert 200 microscope equipped with different objectives (Plan-
NeoFluar, 1.25x /0.035, 2.5x /0.075, 5x /0.15, 10x /0.30, 20x /0.50, 40x /1.3 Oil). Both 
microscopes were coupled with Axiocam microscope digital camera (0.5x). Adobe 
Photoshop CS3 was used to convert images to grayscale with resolution set at 300 
pixels/inches. Figures and labelling were made using CorelDRAW 11. 
 
2.10.2 Fluorescent Microscopy 
 
Epi-fluorescence microscopy was carried out on fluorescent dye-stained sections using a 
Zeiss Axio Imager Z1 microscope using the following objectives, EC Plan NeoFluar 
2.5x /0.075, EC Plan NeoFluar 5x /0.15, EC Plan NeoFluar 10x /0.3, EC Plan NeoFluar 
20x /0.5 and Plan Apochromat 40x /1.3 Oil. Sections were triple stained with DAPI, 
Alexa Fluor 488 and Cy3. The excitation source was a Mercury short arc lamp (HBO 
100 W/2) and images were generated using the following filter sets, Zeiss filter set 
49HE for DAPI, Zeiss filter set 38HE for Alexa Fluor 488 and Zeiss filter set 20HE for 
Cy3. Images were captured using an AxioCam HRm cooled monochrome digital 
camera in combination with the Axiovision 4.7 software package. Adobe Photoshop 
CS3 was used to merge images and impose false colours by assigning images into 
green, red and blue channels accordingly to show co-localization of expression. 
 
2.10.3 Confocal Microscopy 
 
Double-labelled cells were imaged using a Zeiss LSM 510 META confocal scan head 
mounted on a Zeiss Axiovert 200M platform, using a 20x /0.5 Plan NeoFluar objective. 
Sequential excitation at 488 nm and 543 nm was provided by Argon (5% power) and 
Helium-Neon (100% power) gas lasers, respectively. Emission filters BP 500-530 nm 
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and BP 565-615 nm were used for collecting Alexa Fluor 488 and Cy3 signal in 
channels 2 and 3 respectively. Images, with a frame size of 1024x1024 and a 4x line 
average, were captured using the Zeiss LSM 510 v.3.0 software. 
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2.11 Quantification 
 
2.11.1 Densitometry 
 
Quantification of expression levels of ROBO1, SRGAP1 and CTIP2 was performed to 
confirm their tangential expression gradients, using the image processing program 
ImageJ (National Institute of Health, NIH; http://rsbweb.nih.gov/ij/). Photographs were 
taken from the anterior- and posterior-most extents of sagittal sections at 8, 9 and 10 
PCW for comparison (n=2 for each stage and at least 3 sections for each embryo/foetus 
were used for statistical analysis). All photographs were taken with the same exposure 
time and cropped to similar widths. The average optical density of histological staining 
in the CP (expression detected in this layer throughout all investigated stages) and VZ 
(considered background staining throughout all investigated stages) were measured in 
rectangular boxes of equal widths, which spanned the thickness of the CP or the VZ, 
and were placed adjacently. To take into account of background staining, the ratio of 
mean grey values in the CP to the VZ was calculated. A paired Student‟s t-test was 
performed to determine the significance of expression level differences between the 
anterior and posterior regions (p≤ 0.05). 
 
2.11.2 Cell Count 
 
Quantification analysis was carried out with immunoperoxidase-stained cells which 
were counter-stained with DAPI nucleic acid stain. Images of four random fields of 
view were taken for each antibody stained. The same objective (Plan NeoFluar 20x 
/0.50) was used to take all images required for counting cells to ensure the surface area 
examined was constant for all samples (n=4). Adobe Photoshop CS3 was used to assign 
DAB staining to the red channel and DAPI to green. The percentage number of stained 
cells was calculated from counting numbers of specifically-labelled cells (red + yellow) 
and comparing with total number of cells (red + green + yellow). An example of 
PAX6/DAPI stained images together with the false-colour image was demonstrated in 
Figure 2.3. When comparing the expression levels between the anterior- and posterior-
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derived cultures, a Student‟s paired t-test was performed and significance was set at p≤ 
0.05. 
 
Figure 2.3. Immunocytochemistry Cell Counting Method. 
(A) Cells immunoreactive for PAX6 were stained with DAB and counter-stained with DAPI. 
(B) For counting purpose, false-colour image was created by assigning DAB-staining to the red 
channel (filled arrowhead) and DAPI to green (empty arrow head). Scale bars indicate 20 μm.  
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2.12 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
and Transfer 
 
For characterization of some antibodies used in the studies, SDS-PAGE and Western 
blot was carried out. The procedures of SDS-PAGE electrophoresis and transfer were 
adapted from the Invitrogen NuPAGE Technical Manual and summarized below. 
 
10 μg of protein sample was heated in 1x NuPAGE® lithium dodecyl sulfate (LDS) 
sample buffer (Invitrogen), 1x NuPAGE
®
 reducing agent (Invitrogen) and distilled 
water. The boiling of sample at 70°C for 10 minutes accelerated the denaturation and 
unfolding of the proteins in the presence of the above ingredients. A discontinuous 
system for SDS-PAGE was performed using the NuPAGE
®
 Novex Bis-Tris Gels with 
the 10-well, 4% polyacrylamide stacking gel which was placed above 4-12% 
polyacrylamide resolving gel of 1 mm thickness to separate proteins according to their 
molecular weights, which could be determined by running samples alongside with the 
Novex
®
 Sharp unstained protein standards (LC5801; Invitrogen). NuPAGE
®
 MOPS 
SDS Running Buffer with NuPAGE
®
 Antioxidant (Invitrogen) was used. When an 
electric field (200 V, start: 100-115 mA/gel, end: 60-70 mA/gel, 50 minutes) is applied 
to SDS-denatured proteins in an SDS-PAGE gel matrix, the larger the denatured 
proteins, the more frequent the proteins were entangled in the gel matrix and thus the 
slower they moved through the gel. 
 
NuPAGE
®
 Transfer Buffer with NuPAGE
®
 Antioxidant (Invitrogen) was used for 
transferring proteins from the gel onto pre-cut PVDF membrane (Invitrogen). Upon 
application of an electric field (30 V, 1 hour) separated proteins were transferred from 
the gel onto the membrane via hydrophilic and hydrophobic interactions between the 
membrane and proteins. After transfer, the membrane was equilibrated in distilled for 5 
minutes. The efficiency of transfer was assessed by staining the membrane with 1x 
Ponceau (0.02% Ponceau, 0.3% trichloracetic acid, 0.3% sulphosalicylic acid). 
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2.13 Western Blot 
 
1x Ponceau was removed by rinsing several times with distilled water. Blocking of non-
specific binding was achieved by placing the membrane in the blocking buffer (5% non-
fat dried milk, 0.05% Tween 20 (Sigma Aldrich) in 1x Tris-based buffer (TBS), pH 7.6) 
for 15 minutes twice at room temperature. The membrane was probed for the protein of 
interest with respective primary antibodies at 4°C overnight in antibody buffer (0.5% 
non-fat dried milk, 0.05% Tween 20 in 1x TBS buffer pH 7.6). β–ACTIN was used as a 
positive control. Optimal antibodies concentration was listed in Table 2.6.  
 
The membrane was subjected to a 10-minute wash in wash buffer (0.05% Tween
 
20 in 
1x TBS pH7.6) for 3 times before and after the secondary antibodies probing to rinse 
off any unbound antibodies. Appropriate species immunoglobulin HRP-linked 
secondary antibodies (Table 2.7; Vector Laboratory) in the antibody buffer were used at 
a final dilution of 1/1000 for 2 hours at room temperature. Immunoreactivity was 
detected using the SIGMAFAST DAB Tablet set (DAB tablet set in 5 ml distilled 
water) with developing time up to 20 minutes. 
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Chapter 3 Investigating Gradients of Gene Expression involved in Early 
Human Neocortical Development 
 
3.1 Aim of Study 
 
The aim of this chapter is to confirm the differential expression for a subset of genes 
identified by Affymetrix whole genome chip array and listed in Table 3.1 using rtPCR 
in neocortical tissue.  
 
A number of known posterior markers were identified, including FGFR3, COUPTFI 
and EMX2 (O'Leary and Nakagawa, 2002; Zhou et al., 1999; Simeone et al., 1992). 
Anteriorly, a number of potential markers of frontal and motor cortex as well as 
corticofugal neurones were observed including CNTNAP2 (Abrahams et al., 2007), 
PCDH17 (Kim et al., 2007), S100A10, CTIP2 (Arlotta et al., 2005), ROBO1 
(Sundaresan et al., 2004) and its downstream signalling molecule SRGAP1 (Wong et al., 
2001). Some other genes were also included (Table 3.2) as they are expressed highly in 
the developing brains but exhibited no or small fold changes in expression when 
comparing levels in anteriorly- vs. posteriorly-derived tissue such as FGFR family 
members: FGFR1 and FGFR2 (Ford-Perriss et al., 2001), the transient anterior marker: 
PAX6 (Bayatti et al., 2008b), a ROBO family member: ROBO2 (Yue et al., 2006), the 
corticofugal neurone-related transcription factor: FEZF2 (Chen et al., 2008; Chen et al., 
2005a; Molyneaux et al., 2005), as well as the Layer VI/SP/corticothalamic neurone-
associated transcription factor: SOX5 (Kwan et al., 2008; Lai et al., 2008) and the pan-
neuronal marker: MAP2 (Bernhardt and Matus, 1984). 
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383 probe sets >1.75-fold in anterior compared to 
posterior neocortex 
Gene                        Fold                    Function 
154 probe sets >1.75-fold in posterior 
compared to anterior neocortex 
Gene                        Fold            Function  
PCDH17 2.84 Motor Cortex/Areal FGFR3 15.57 Areal 
S100A10 2.48 Layer V/Subcerebral COUPTFI 5.97 Areal 
ROBO1 2.15 
Axon Guidance/Layer 
V/Subcerebral 
EMX2 1.77 Areal 
SRGAP1 2.15 
Axon 
Guidance/ROBO-
associated 
   
CNTNAP2 1.97 Frontal    
CTIP2 1.94 Layer V/Subcerebral    
Table 3.1. Selected genes up-regulated anteriorly or posteriorly in RNA extracted from 
human neocortex, hybridized to Affymetrix gene chip (U133plus2 human genome) and 
fold changes analyzed on GeneSpring GX software. 
Performed by Dr. Nadhim Bayatti. Adapted from (Ip et al., 2010a). 
 
Probe sets <1.75-fold anteriorly or posteriorly 
Gene                                               Fold                                                       Function 
FEZF2 1.67 (A<P) Layer V/Subcerebral 
FGFR1 1.59 (A>P) FGFR Family 
FGFR2 - FGFR Family 
MAP2 - Pan-neuronal Marker 
PAX6 - Transient Anterior Marker 
ROBO2 - Axon Guidance 
SOX5 - Layer VI/SP/Corticothalamic Neurones 
Table 3.2. Selected genes exhibited no or small fold changes of expression anteriorly or 
posteriorly in RNA extracted from human neocortex, hybridized to Affymetrix gene chip 
(U133plus2 human genome) and fold changes analyzed on GeneSpring GX software. 
A, anterior; P, posterior; SP, subplate. Performed by Dr. Nadhim Bayatti. Adapted from (Ip et 
al., 2010a). 
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3.2 Results 
 
3.2.1 Confirmation of gDNA-free cDNA Samples used for rtPCR 
 
To ensure all cDNA samples from anterior and posterior neocortical tissues derived 
from human embryonic and foetal brains used for rtPCR were not contaminated by 
gDNA, standard PCR assay was employed with SDHA primer set.  
 
The FP and RP of SDHA targeted sequences on exon 2 and exon 3 of SDHA 
respectively. Thus samples with gDNA would yield products containing intron 
sequence and of around 940 bp. A positive control was incorporated with a human 
gDNA sample instead of cDNA samples. Three bands between 850-1000 bp were 
amplified products of the gDNA positive control (filled arrows, Figure 3.1). All cDNA 
samples from 8-12 PCW neocortical tissues (white lines, Figure 3.1) gave rise only to 
bands below 100 bp which were equivalent to the size of SDHA cDNA (84 bp, Table 
2.3). Thus these cDNA samples used for rtPCR were confirmed gDNA-free.  
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Figure 3.1. Confirmation of gDNA-free cDNA samples from neocortical tissues used for 
rtPCR. 
Amplified products of SDHA using standard PCR assay. Products of positive control with 
human gDNA were indicated by filled arrows, whereas cDNA samples derived from anterior 
and posterior neocortical tissues used for rtPCR were indicated by white lines (8 PCW, n=3; 10 
PCW, n=4; 12 PCW n=4). 1kb Plus DNA ladder was used to determine the size of bands. 
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3.2.2 Confirmation of Amplified PCR Products by Restriction Reaction and Direct 
Sequencing 
 
To confirm the primer sets designed for rtPCR amplified the target genes of interest, 
restriction digestion was performed. Note that although two or three gene fragments 
should be produced after digestion, sometimes the smallest fragments either were too 
small to be resolved or they were of similar size with the larger fragments and thus 
appeared as single band but migrated further away from their original positions. 
Nevertheless, shift of bands further down the gel indicated reduction in size of the gene.  
 
Identities of COUPTFI, EMX2, FGFR1, FGFR3, ROBO2, SRGAP1 and S100A10 were 
confirmed as digestion of their amplified PCR products was successful, indicated by 
shift of bands (arrows, Figure 3.2).  
 
Absence of band or band-shifting after digestion was regarded as failure and purified 
samples were sent for direct sequencing with their forward primers, including CTIP2, 
CNTNAP2, FEZF2, FGFR2, MAP2, PCDH17, ROBO1 and SOX5. Their identities were 
confirmed too as all sequences showed >96% identity to the respective target genes by 
the Basic Local Alignment Search Tool (BLAST) developed by National Center for 
Biotechnology Information (NCBI) and were listed in Table 3.3. 
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Figure 3.2. Confirmation of target genes identities by restriction digestion. 
Amplified PCR products of CNTNAP2, COUPTFI, CTIP2, EMX2, FGFR1, FGFR2, FGFR3, 
MAP2, PCDH17, ROBO1, SOX5, SRGAP1 and S100A10 were digested by various restriction 
enzymes (Table 2.4). Undigested PCR products were loaded on the left lane of the demarcated 
areas (dotted white lines) and digested products on the right, successful restriction reactions 
were indicated by arrows. 1kb Plus DNA ladder was used to determine the size of bands.  
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Genes 
GenBank accession 
numbers 
Sequences 
of PCR 
products 
Nucleotides of sequenced products 
CTIP2  
NM_138576.2 2809-2872 CAGATCGGCAGGAGGTGTACCGCTGCGACATCTGCCAGATGCCCTTCAGCGTCTACAGCA
CCCATTT NM_022898.1 2596-2659 
CNTNAP2 NM_014141.4 2103-2158 CACTTGTAAATTTATACGAAGTGGCACAAAGGAAGCCGGGAAGTTTCGCGAATGTCAA 
FEZF2 NM_018008.3 1387-1487 
CGATTTTGCGGCAAGGCTTTCACCAAAAAGGGAACTACAAGAACCACAAGCTGACCCACA
GCGGCGAGAAGCAGTACAAATGTACCATCTGCAACAAGGCCTGCAGG 
FGFR2 
NM_000141.4 2039-2132 
CGAGTTGACTTCCAGAGGACCCAAAATGGGAGTTTCCAAGAGATAAGCTGACACTGGGCA
AGCCCCTGGGAGAAGGTTGCTTTGGGCAAGTG 
NM_022970.3 2042-2135 
NM_001144913.1 1545-1638 
NM_001144914.1 1206-1299 
NM_001144915.1 1444-1537 
NM_001144916.1 1488-1581 
NM_001144917.1 1691-1784 
NM_001144918.1 1688-1781 
NM_001144919.1 1775-1868 
MAP2 
NM_002374.3 4924-5000 
ATGAGATTCCTTCTCTCTCAACAGTTCTATCTCTTCTTCAGCACGGCGGACCACCAGGTCA
GAGCCAATTCGCAGAAAGGGGGC 
NM_031845.2 856-932 
NM_031847.2 856-932 
NM_001039538.1 1230-1306 
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PCDH17 NM_001040429.2 1519-1608 
TACGCTCGTGCTGACTGCCCTGGACGGTGGCGAGCCTCCACGTTCCGCCACCGTACAGAT
CAACGTGAAGGTGATTGACTCCAACGACAA 
ROBO1 
NM_002941.2 1953-2013 AGTGAAACACAAGATGTCCTACCAACAAGTCAGGGGGTGGACCACAAGCAGGTCCAGAG
AAAAGCACTTTT NM_133631.1 2799-2859 
SOX5 
NM_006940.4 1502-1556 
TGAGGAGCAACTCCGACGGGAACAACAGGTGCTTGATGGGAAGGTGGCTGTTGTGAAAG
CCGGAGTCG 
NM_152989.2 1732-1789 
NM_178010.1 264-318 
Table 3.3. Sequencing results of PCR products using forward primers for rtPCR. 
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3.2.3 Average Expression Levels between 8-12 PCW 
 
After normalizing against expression levels of three housekeeping genes (β-ACTIN, 
GAPDH and SHDA) and averaged over 8-12 PCW, rtPCR confirmed most of the results 
of Affymetrix gene chip analysis (Figure 3.3). The putative anterior markers CNTNAP2 
(2.33-fold), PCDH17 (4.59-fold) and corticofugal neurone-associated genes CTIP2 
(2.00-fold), ROBO1 (2.14-fold), S100A10 (2.24-fold) were found to be significantly 
higher in anteriorly- rather than posteriorly-dissected tissue. SRGAP1 (1.28-fold), 
FGFR1 (1.21-fold) and MAP2 (1.18-fold) were also found to be expressed more highly 
anteriorly, with the differences being small but statistically significant. The previously 
identified rodent posterior markers FGFR3 (61.36-fold), COUPTFI (18.98-fold) and 
EMX2 (1.59-fold) exhibited significantly higher expression posteriorly than anteriorly. 
FEZF2 (1.30-fold), SOX5 (1.25-fold) and FGFR2 (1.21-fold) were also found to be 
expressed more highly posteriorly, with the differences being small but statistically 
significant. PAX6 and ROBO2 exhibited no statistical significance either anteriorly and 
posteriorly. There were no significant differences in the normalized relative expression 
levels of all genes across all investigated ages except for FGFR3 which was found to be 
significantly higher at 12 PCW than at 8 PCW. 
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Figure 3.3. rtPCR confirmation of a subset of differentially regulated genes during early 
human neocortical development (8-12 PCW). 
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Table indicating fold changes (A) and graphical representation (B) of normalized relative 
quantity of a subset of genes determined by rtPCR from RNA extracted from anterior and 
posterior regions of developing human neocortex aged between 8-12 PCW (8 PCW, n=3; 10 
PCW, n=4; 12 PCW, n=4). Genes exhibiting a high anterior to low posterior gradient include 
CNTNAP2, CTIP2, PCDH17, ROBO1 and S100A10. Genes exhibiting a high posterior, low 
anterior gradient include COUPTFI, EMX2 and FGFR3. No gradients were detected for PAX6 
and ROBO2. (Two-way ANOVA; *, p≤ 0.05 Anterior vs. Posterior). Normalized relative 
quantity of FGFR3 at 8 PCW was found to be significantly lower than at 12 PCW (Two-way 
ANOVA, post-hoc LSD test; #, p≤ 0.05 marks the gene with this age-dependent effect), n.d., not 
detected; A, anterior, P, posterior. Adapted and modified from (Ip et al., 2010a). 
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3.2.4 Expression Levels at 8 PCW 
 
At 8 PCW, after normalizing against expression levels of three housekeeping genes (β-
ACTIN, GAPDH and SHDA), the level of fold changes was relatively smaller compared 
to the overall patterns observed between 8-12 PCW (Figure 3.4A). The putative anterior 
markers CNTNAP2 (1.52-fold), PAX6 (1.51-fold), PCDH17 (1.60-fold) and corticofugal 
neurone-associated genes CTIP2 (1.68-fold), ROBO1 (1.75-fold) were found to be 
significantly higher in anteriorly- rather than posteriorly-dissected tissue. The 
previously identified rodent posterior markers FGFR3 (32.72-fold) and COUPTFI 
(8.37-fold) exhibited significantly higher expression posteriorly than anteriorly.  EMX2 
(1.22-fold) was also found to be expressed more highly posteriorly, with the difference 
being small but statistically significant. FEZF2, FGFR1, FGFR2, MAP2, ROBO2, 
SOX5, SRGAP1 and S100A10 exhibited no statistical significance either anteriorly and 
posteriorly. 
 
Figure 3.4B shows NRQ of each selected gene. NRQ for posterior markers COUPTFI 
and FGFR3 was high (3.14 and 5.72 respectively) in the posteriorly-dissected tissue at 8 
PCW. The remaining selected genes displayed NRQ lower than 1.50 in both anteriorly- 
and posteriorly-dissected tissue. 
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Figure 3.4. rtPCR confirmation of a subset of differentially regulated genes during early 
human neocortical development (8 PCW). 
Table indicating fold changes (A) and graphical representation (B) of normalized relative 
quantity of a subset of genes determined by rtPCR from RNA extracted from anterior and 
posterior regions of developing human neocortex at 8 PCW (n=3). Genes exhibiting a high 
anterior to low posterior gradient include CNTNAP2, CTIP2, PAX6, PCDH17 and ROBO1. 
Genes exhibiting a high posterior, low anterior gradient include COUPTFI and FGFR3. No 
gradients were detected for FEZF2, FGFR1, FGFR2, MAP2, ROBO2, SOX5, SRGAP1 and 
S100A10. Normalized relative quantity >1.50 include FGFR3 and COUPTF1 in posteriorly-
dissected tissue. (Student‟s paired t-test, *, p≤ 0.05), n.d., not detected; A, anterior, P, posterior. 
100 
 
3.2.5 Expression Levels at 10 PCW 
 
At 10 PCW, after normalizing against expression levels of three housekeeping genes (β-
ACTIN, GAPDH and SHDA), the level of fold changes followed most of the overall 
patterns observed between 8-12 PCW (Figure 3.5A). The putative anterior markers 
CNTNAP2 (2.93-fold), PCDH17 (4.05-fold) and corticofugal neurone-associated genes 
CTIP2 (2.50-fold), ROBO1 (2.29-fold), S100A10 (3.47-fold) were found to be 
significantly higher in anteriorly- rather than posteriorly-dissected tissue. FGFR1 (1.37-
fold), MAP2 (1.15-fold) and SRGAP1 (1.22-fold) were found to be expressed more 
highly anteriorly, with the differences being small but statistically significant. The 
previously identified rodent posterior markers EMX2 (1.90-fold), FGFR3 (66.55-fold), 
COUPTFI (19.00-fold) together with FGFR2 (1.50-fold) and SOX5 (1.51-fold) 
exhibited significantly higher expression posteriorly than anteriorly. FEZF2, PAX6 and 
ROBO2 exhibited no statistical significance either anteriorly and posteriorly. 
 
Figure 3.5B shows NRQ of each selected gene. NRQ for posterior markers COUPTFI 
and FGFR3 continued to be high at 10 PCW (4.50 and 8.19 respectively) in the 
posteriorly-dissected tissue as compared to 8 PCW (Figure 3.4B). Anteriorly up-
regulated genes CNTNAP2 (1.74), CTIP2 (1.63), PCDH17 (2.07), ROBO1 (1.52) and 
S100A10 (2.05) exhibited higher NRQ in the anteriorly-dissected tissues when 
comparing to the observation at 8 PCW (Figure 3.4B). The remaining selected genes 
continued to display NRQ lower than 1.50 in both anteriorly- and posteriorly-dissected 
tissue. 
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Figure 3.5. rtPCR confirmation of a subset of differentially regulated genes during early 
human neocortical development (10 PCW). 
Table indicating fold changes (A) and graphical representation (B) of normalized relative 
quantity of a subset of genes determined by rtPCR from RNA extracted from anterior and 
posterior regions of developing human neocortex at 10 PCW (n=4). Genes exhibiting a high 
anterior to low posterior gradient include CNTNAP2, CTIP2, PCDH17, ROBO1 and S100A10. 
Genes exhibiting a high posterior, low anterior gradient include COUPTFI, EMX2, FGFR2, 
FGFR3 and SOX5. No gradients were detected for FEZF2, PAX6 and ROBO2. Normalized 
relative quantity >1.50 include FGFR3 and COUPTF1 in posteriorly-dissected tissue and 
CNTNAP2, CTIP2, PCDH17, ROBO1 and S100A10 in anteriorly-dissected tissue. (Student‟s 
paired t-test, *, p≤ 0.05), n.d., not detected; A, anterior, P, posterior. 
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3.2.6 Expression Levels at 12 PCW 
 
At 12 PCW, after normalizing against expression levels of three housekeeping genes (β-
ACTIN, GAPDH and SHDA), the level of fold changes followed most of the overall 
patterns observed between 8-12 PCW (Figure 3.6A). The putative anterior markers 
CNTNAP2 (3.08-fold), PCDH17 (13.81-fold) and corticofugal neurone-associated 
genes CTIP2 (1.86-fold), ROBO1 (2.52-fold), S100A10 (3.62-fold) were found to be 
significantly higher in anteriorly- rather than posteriorly-dissected tissue. ROBO2 (1.25-
fold) and SRGAP1 (1.44-fold) were also found to be expressed more highly anteriorly, 
with the differences being small but statistically significant. The previously identified 
rodent posterior markers EMX2 (1.82-fold), FGFR3 (97.97-fold), COUPTFI (22.22-
fold) together with FEZF2 (1.68-fold) exhibited significantly higher expression 
posteriorly than anteriorly. SOX5 (1.21-fold) was found to be expressed more highly 
posteriorly, with the difference being small but statistically significant. FGFR1, 
FGFR2, MAP2 and PAX6 exhibited no statistical significance either anteriorly and 
posteriorly. 
 
Figure 3.6B shows NRQ of each selected gene. NRQ for posterior markers COUPTFI 
and FGFR3 continued to be high at 12 PCW (4.73 and 9.99 respectively) in the 
posteriorly-dissected tissue as compared to 8 PCW (Figure 3.4B). Anteriorly up-
regulated genes CNTNAP2 (1.77), PCDH17 (3.88), ROBO1 (1.59) and S100A10 (1.96) 
exhibited higher NRQ in the anteriorly-dissected tissues when comparing to observation 
at 8 PCW (Figure 3.4B). The remaining selected genes continued to display NRQ lower 
than 1.50 in both anteriorly- and posteriorly-dissected tissue. 
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Figure 3.6. rtPCR confirmation of a subset of differentially regulated genes during early 
human neocortical development (12 PCW). 
Table indicating fold changes (A) and graphical representation (B) of normalized relative 
quantity of a subset of genes determined by rtPCR from RNA extracted from anterior and 
posterior regions of developing human neocortex at 12 PCW (n=4). Genes exhibiting a high 
anterior to low posterior gradient include CNTNAP2, CTIP2, PCDH17, ROBO1 and S100A10. 
Genes exhibiting a high posterior, low anterior gradient include COUPTFI, EMX2, FEZF2 and 
FGFR3. No gradients were detected for FGFR1, FGFR2, MAP2 and PAX6. Normalized relative 
quantity >1.50 include FGFR3 and COUPTF1 in posteriorly-dissected tissue and CNTNAP2, 
PCDH17, ROBO1 and S100A10 in anteriorly-dissected tissue. (Student‟s paired t-test, *, p≤ 
0.05), n.d., not detected; A, anterior, P, posterior. 
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3.2.7 Summary of Gene Expression Gradients at 8, 10 and 12 PCW 
 
In summary, anteriorly-upregulated genes CNTNAP2, CTIP2, PCDH17 and ROBO1 
(highlighted in yellow, Table 3.4) and posteriorly-upregulated genes COUPTFI, EMX2 
and FGFR3 (highlighted in green, Table 3.4) identified by Affymetrix gene chip 
analysis (>1.75-fold) were confirmed by rtPCR, displaying consistent and significant 
gradients of expression across the developing neocortex at 8, 10 and 12 PCW. Thus 
significant anterior-posterior expression gradients were also obtained when fold changes 
of expression levels were averaged across samples aged 8-12 PCW. 
 
rtPCR showed some presumably non-regulated genes FGFR1, FGFR2 and MAP2 
(<1.75-fold determined by Affymetrix gene chip analysis) showing no significant 
difference in expression levels between the anterior and posterior region of the 
neocortex at 8 and 12 PCW (highlighted in red, Table 3.4). Small but significant 
differences in expression levels were obtained at 10 PCW (highlighted in red, Table 3.4). 
Overall, these resulted in small but significant anterior-posterior expression gradients 
when fold changes of expression levels were averaged across samples aged 8-12 PCW 
(highlighted in red, Table 3.4). 
 
Other anteriorly-upregulated genes identified by Affymetrix gene chip analysis (>1.75-
fold) S100A10 and SRGAP1, and presumably non-regulated genes FEZF2, PAX6, 
ROBO2 and SOX5 (<1.75-fold determined by Affymetrix gene chip analysis) did not 
illustrate consistent gradients of expression by rtPCR from 8 to 12 PCW (Table 3.4). 
Nevertheless the fold changes of PAX6 expression resembled the patterns observed in 
tissue ISH with significantly high anterior, low posterior gradient at 8 PCW and is lost 
by 9 PCW (Bayatti et al., 2008b). 
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 8 PCW 10 PCW 12 PCW 8-12 PCW 
Gene Fold Change Gradient Fold Change Gradient Fold Change Gradient Fold Change Gradient 
PCDH17 1.60* A>P 4.05* A>P 13.81* A>P 4.59
¥ A>P 
S100A10 1.17 n.d. 3.47* A>P 3.62* A>P 2.24
¥
 A>P 
CNTNAP2 1.52* A>P 2.93* A>P 3.08* A>P 2.33
¥ A>P 
ROBO1 1.75* A>P 2.29* A>P 2.52* A>P 2.14
¥ A>P 
CTIP2 1.68* A>P 2.50* A>P 1.86* A>P 2.00
¥ A>P 
SRGAP1 1.11 n.d. 1.22* A>P 1.44* A>P 1.28
¥ A>P 
ROBO2 1.23 n.d. 1.22 n.d. 1.25* A>P 1.05 n.d. 
FGFR1 1.10 n.d. 1.37* A>P 1.23 n.d. 1.21
¥ A>P 
MAP2 1.17 n.d. 1.15* A>P 1.23 n.d. 1.18
¥ A>P 
FGFR2 1.06 n.d. 1.50* A<P 1.09 n.d. 1.21
¥ A>P 
PAX6 1.51* A>P 1.01 n.d. 1.01 n.d. 1.11 n.d. 
#
FGFR3 32.72* A<P 66.55* A<P 97.97* A<P 61.36
¥ A<P 
COUPTFI 8.37* A<P 19.00* A<P 22.22* A<P 18.98
¥ A<P 
EMX2 1.22* A<P 1.90* A<P 1.82* A<P 1.59
¥ A<P 
FEZF2 1.15 n.d. 1.18 n.d. 1.68* A<P 1.30
¥ A<P 
SOX5 1.00 n.d. 1.51* A<P 1.21 A<P 1.25
¥ A<P 
Table 3.4. Summary of gene expression gradients at 8, 10 and 12 PCW confirmed by rtPCR. 
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Genes highlighted in yellow showed significantly consistent high anterior (A), low posterior (P) gradients at all investigated ages (8 PCW, n=3; 10 PCW, n=4; 12 
PCW, n=4). Genes highlighted in green showed significantly consistent low anterior, high posterior gradients at all investigated ages. Genes highlighted in red 
displayed significant differential expression either anteriorly or posteriorly at 10 PCW only. The fold changes in relative expression levels of other genes showed 
variable trends across all investigated ages. Student‟s paired t-test was performed with relative expression level data sets yielded from samples of the same age 
between the anteriorly- and posteriorly-dissected tissue (*, p≤ 0.05). Two-way ANOVA was performed with relative expression level data set yield from samples of 
all ages between the anteriorly- and posteriorly-dissected tissue (¥, p≤ 0.05 Anterior vs. Posterior), and with post-hoc LSD test age-dependent effect was observed 
with FGFR3 in which its relative expression level was significant lower at 8 PCW than at 12 PCW (#, p≤ 0.05).         
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3.3 Discussion 
 
The current study has utilized rtPCR and confirmed some findings of the Affymetrix 
gene chip analysis by consistently showing a subset of genes regulated anteriorly and 
posteriorly in the neocortex during early stages of corticogenesis (8-12 PCW). These 
included CTIP2, CNTNAP2, PCDH17 and ROBO1 being highly upregulated anteriorly, 
and COUPTFI, EMX2 and FGFR3 and being highly upregulated posteriorly. 
 
3.3.1 The Use of Affymetrix Gene Chip and rtPCR Analyses 
 
Affymetrix gene chip arrays provide pixelated-fluorescent intensities data for each of 
the probe sets that hybridized with the biotin-labelled target in the neocortical tissue 
samples, reflecting a relative level of expression of the target genes after background 
correction, normalization and summarization procedures. Similarly, rtPCR in this study 
used fluorescent double-stranded DNA dye SYBR Green to provide NRQ of each target 
genes against several selected reference genes in neocortical tissue samples. Although 
they do not actually indicate absolute expression levels of target genes, both analyses 
are useful for comparison of expression levels in different tissues (i.e. anteriorly- vs. 
posteriorly-dissected neocortical tissues) processed in the same experiment, making 
rtPCR a suitable confirmatory tool for Affymetrix gene chip analysis. One limitation of 
gene chip arrays is that comparisons between genes for the same microarray are not 
appropriate as different RNA molecules may be amplified, labelled and hybridized 
differently in an experiment. Likewise, primer sets for different genes used in rtPCR do 
not perform equally, and without calculating the reaction efficiency, the actual amount 
of cDNA of each target genes in a sample cannot be determined and comparison should 
not be made between different genes in the same sample. Therefore, analyses in this 
study focused on the expression level differences (fold changes) between anteriorly- and 
posteriorly-dissected tissues and did not compare relative expression levels between 
selected subset of genes. However, comparison of relative expression levels of the same 
gene across all investigated ages is achievable. 
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Genes that control the establishment of the early cortical map in rodents are presumed to 
be expressed in gradients throughout the period when neurogenesis is occurring in the 
developing neocortex (Cecchi and Boncinelli, 2000). Affymetrix gene chip arrays have 
previously revealed robust consistent gradients of gene expression in human neocortical 
tissues aged 8-12.5 PCW (Figure 1.13; (Ip et al., 2010a)), an important time of 
neocorticogenesis. This corresponds to the period of development when the CP is 
forming (at 7.5 PCW) (Meyer et al., 2000) and during the early stages of neurogenesis 
(Bystron et al., 2008; ten Donkelaar, 2000) and regionalisation, well before innervation 
by thalamocortical fibres that may exert extrinsic influences on the differentiating 
progenitors (Kostovic and Rakic, 1990). Additionally, global functional information 
deduced by Gene Ontology (GO) categorizations identified some similar and different 
GO categories enrichment in anteriorly and posteriorly up-regulated probe sets (Ip et al., 
2010a). Nevertheless, these functional classifications sometimes fail to identify specific 
groups of genes that may be inter-linked either due to specificity or due to unknown or 
as yet unassigned gene function (e.g. GO category cerebral cortex regionalisation 
GO:0021796 contains EMX1 and EMX2 but not COUPTFI). Therefore by searching 
manually through the gene list we were able to identify a number of anteriorly-regulated 
genes which are potentially involved in regionalisation at the anterior pole of the 
developing neocortex. These include cell-adhesion molecules (such as protocadherins) 
and transcription factors that are associated with motor cortex or corticofugal neurones, 
either at the site of origin of corticofugal neurones in Layer V or expressed in their 
outgrowing fibres (Molnar and Cheung, 2006).  
 
3.3.2 Identification of Anteriorly Up-regulated Genes 
 
A subset of these genes was chosen and patterns of gene expression were confirmed by 
rtPCR in dissected tissue. Of the anterior markers identified, CNTNAP2 is a frontal 
cortex marker (Abrahams et al., 2007), PCDH17, an areal marker corresponding to the 
motor cortex in rodents (Kim et al., 2007), CTIP2, a gene highly expressed by early 
CSMN in Layer V in rodents (Arlotta et al., 2005), ROBO1, a gene encoding axon 
guidance molecule that is expressed in the corticospinal fibres before, during and after 
crossing the midline in the caudal medulla in rodents (Sundaresan et al., 2004), all 
exhibited robust and consistently higher levels in anteriorly-derived tissue at all 
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investigate ages (8, 10 and 12 PCW; Figure 3.3 - Figure 3.6, Table 3.4). However, 
S100A10, another gene highly expressed by early CSMN in Layer V in rodents (Arlotta 
et al., 2005) only exhibited significant high anterior, low posterior gradient at 10 (Figure 
3.5, Table 3.4) and 12 PCW (Figure 3.6, Table 3.4), but not at 8 PCW (Figure 3.4, 
Table 3.4). Furthermore, SRGAP1, a gene encoding the downstream signalling molecule 
of ROBO1 (Wong et al., 2001) only exhibited a small but significant increase in 
anteriorly-derived tissue when fold changes in expression level were averaged between 
8-12 PCW (Figure 3.3, Table 3.4). Nevertheless fold changes in expression level of 
SRGAP1 correlated nicely with that of ROBO1 from 8 to 12 PCW (Figure 3.4 - Figure 
3.6, Table 3.4) and the small fold change in expression level of ROBO1 observed at 8 
PCW might have led to the small fold change in expression level observed with 
SRGAP1 at the same age accordingly (Figure 3.4, Table 3.4). The BLAST developed by 
NCBI was employed to verify and compare the target sequence of primer set of 
SRGAP1 used for rtPCR and that of Affymetrix probe set (1569269_s_at) that exhibited 
2.15-fold higher expression anteriorly. Both target sequences were found to be within 
the coding sequence of SRGAP1 mRNA (NM_020762.2, nucleotide 57-3314) albeit of 
different exons, i.e. target sequences of primer sets were within exon 17 and of probe set 
were within exon 21 to 22. The slight discrepancy observed between the two analyses is 
unlikely to be due to alternative splicing, as no alternative splicing variant has yet been 
identified for SRGAP1, or alternative polyadenylation at 3‟ untranslated region (UTR) 
of its mRNA, as target sequences were not within those regions. Although the SRGAP1 
primer set was not designed to span the exon-exon boundary, gDNA expression 
affecting the fold change detected by rtPCR was minimal, as acidic phenol (pH<4.0) 
was used during phenol/chloroform RNA extraction, retaining RNA in the aqueous 
phase but shifting DNA into the organic phase, and the gDNA-free condition was also 
proven by standard PCR assay with SDHA primer set (Figure 3.1). Nevertheless both 
analyses revealed the same pattern of regulation anteriorly. 
 
3.3.3 Identification of Posteriorly Up-regulated Genes 
 
EMX2 (Simeone et al., 1992), COUPTFI (Zhou et al., 1999) and FGFR3 (O'Leary and 
Nakagawa, 2002) are reported regionalisation genes and exhibited higher expression in 
posteriorly-derived tissue at all investigated ages (8, 10 and 12 PCW; Figure 3.3 - 
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Figure 3.6, Table 3.4). Additional members of the FGFR family that are highly 
expressed in the brain (Ford-Perriss et al., 2001) exhibited small but significant 
gradients of expression. FGFR1 exhibited higher expression anteriorly, while FGFR2 
was higher posteriorly when the fold changes of expression levels were averaged 
between 8-12 PCW (Figure 3.3, Table 3.4). However, they only exhibited significant 
differences in expression levels between the anteriorly- and posteriorly-derived 
neocortical tissues at 10 PCW only (Figure 3.5, Table 3.4), but not at 8 (Figure 3.4, 
Table 3.4) and 12 PCW (Figure 3.6, Table 3.4). Both the Layer V/corticofugal neurone-
associated gene FEZF2 (Chen et al., 2008; Chen et al., 2005a; Molyneaux et al., 2005) 
and the Layer VI/SP/corticothalamic neurone-related gene SOX5 (Kwan et al., 2008; 
Lai et al., 2008) exhibited small but significant gradients of expression posteriorly on 
average (Figure 3.3, Table 3.4). PAX6 and ROBO family member ROBO2 (Yue et al., 
2006) expression exhibited insignificant differences between anterior and posterior 
tissue on average (Figure 3.3, Table 3.4). The neuronal marker MAP2 (Bernhardt and 
Matus, 1984) exhibited a small but significant increase in anteriorly-derived neocortical 
tissue on average (Figure 3.3, Table 3.4). Non-regulated as well as posteriorly up-
regulated genes are good indications that developmental advancement in the anterior 
neocortex cannot simply account for the up-regulation of gene expression detected in 
the anteriorly-derived neocortical tissue. 
 
3.3.4 Potential Human-specific Mechanisms of Regionalisation 
 
As shown by our group previously, when carrying out hierarchical clustering by 
condition tree analysis including all genes, it was interesting to note that samples 
clustered according to their ages (Figure 1.13; (Ip et al., 2010a)). This was also 
confirmed by principal component analysis as age appears to be one major component 
of variance (Ip et al., 2010a). Samples derived from anterior and posterior neocortex at 
each age range clustered closest to each other, the samples between 9-11 PCW formed a 
closely clustered group, while samples from 8 and 12.5 PCW weeks were least related 
(Figure 1.13; (Ip et al., 2010a)). Results from rtPCR of the selected subset of genes 
revealed similar trends. Expression fold changes of most of the selected anteriorly and 
posteriorly up-regulated genes and their NRQ at 8 PCW (Figure 3.4) were 
comparatively smaller than those observed at 10 (Figure 3.5) and 12 PCW (Figure 3.6). 
111 
 
In particular, the NRQ of FGFR3 was significant smaller at 8 PCW as compared to that 
detected at 12 PCW (Figure 3.3). These findings indicate that at 8 PCW, and probably 
before, different developmental mechanisms may be used, resulting in the differing 
gene expression profiles. This observation is supported by previous studies in humans 
that demonstrate a developmental switch may occur between 8 and 9 PCW that results 
in the deregulation of the PAX6 (high anterolateral, low posteromedial) gradient (Table 
1.1; (Bayatti et al., 2008b)) which is maintained in rodents throughout 
neocorticogenesis (Manuel and Price, 2005). The graded expression of PAX6 observed 
at 8 PCW and loss from 9 PCW was also confirmed by rtPCR in this study (Figure 3.4 - 
Figure 3.6, Table 3.4). On the other hand, from 12 PCW onwards, extrinsic influences 
begin to be conveyed to the developing neocortex via the incoming thalamocortical 
afferents which potentially modify and refine the already established expression patterns 
and may cause larger fold changes we observed with a subset of genes at this age, 
supporting the protocortex theory of regionalisation (originally suggested by (Van der 
Loos and Woolsey, 1973) and subsequently developed by (O'Leary, 1989) as cited by 
(Mallamaci and Stoykova, 2006)). 
 
Pax6/PAX6 is expressed by neocortical progenitor cells within the proliferative zones in 
both rodents (Bishop et al., 2002) and humans (Bayatti et al., 2008b), and known to be 
controlling cell proliferation and differentiation in rodent KO studies (Warren et al., 
1999). More notably, in addition to its role in the development of neocortical projection 
neurones, PAX6 is found to be also involved in neurogenesis of neocortical 
interneurones, a function uniquely identified in human in-vitro neocortical progenitor-
enriched culture (Mo and Zecevic, 2008). Thus the transient anteriorly-upregulated 
PAX6 at 8 PCW might be regulating the mechanisms involved in generation of a 
subpopulation of neocortical interneurones originating from the anterior pole of the 
developing neocortex. The hypothesized anterior origin of a subpopulation of 
neocortical interneurones is currently under investigation by members of our group as a 
subset of genes associated with GABAergic interneurones is found to be highly 
upregulated anteriorly by Affymetrix gene chip arrays (Ip et al., 2010a). Recently, 
evidence has accumulated that the Pax6 gradient in rodents is not directly involved in 
regionalisation processes (Pinon et al., 2008; Manuel et al., 2007), as neocortical 
identities indicated by distribution of area-specific thalamocortical and corticofugal 
projections are maintained in conditional Pax6 KO mutants, while over-expression of 
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Pax6 in mutant mice does not alter the expression of Emx2 or other areal markers. 
Over-expression of Emx2 however causes shifts in the position and increases the size of 
primary areas located posteriorly when compared to anterior structures (Hamasaki et al., 
2004). Therefore there is a clear major regionalisation influence in the developing 
neocortex which comes posteriorly from genes such as EMX2 and COUPTFI. Their 
expression is repressed by soluble factors such as FGF8, -15, -17 released from 
signalling centres located anteriorly (Rakic et al., 2009; O'Leary et al., 2007; O'Leary 
and Nakagawa, 2002). 
 
There may be counter-gradients of, as yet, undiscovered regionalisation genes actively 
responsible for anterior specification, but these are yet to be identified. Numerous genes 
are known to be expressed in counter-gradients (Rakic et al., 2009), however a 
distinction must be made between whether these genes affect regionalisation per se or 
arise by being regulated by regionalisation genes which would induce a region-specific 
or areal expression pattern. Classically, regionalisation genes are expressed in the 
proliferative zones while areal genes are expressed downstream in specific layers of the 
developing CP (O'Leary et al., 2007). However, graded expression of regionalisation 
genes such as EMX2 is translocated from the proliferative zones to the developing CP, 
potentially controlling expression of areal genes directly in this post-mitotic layer 
during early stages of corticogenesis in humans (Bayatti et al., 2008b). Although 
Affymetrix gene chip analysis and rtPCR are useful in identifying genes that are 
expressed differentially along the tangential axis of the developing neocortex, more 
thorough investigation is therefore required to localize their expression on human 
neocortical tissues spatially and temporally via tissue in-situ hybridization and 
immunohistochemistry. Of the identified anteriorly up-regulated genes, we have 
decided to further examine some corticofugal neurone-associated genes such as 
ROBO1, SRGAP1 and CTIP2 (Chapter 5), as their early anterior spatial clustering 
implies that cells may have information imparted to them at an early developmental 
stage, possibly as cortical progenitors. This evidence also suggests that the anterior 
neocortex at this stage may be the site of origin of the later developing motor cortex and 
corticofugal neurones in a similar manner to the anterior location of the motor cortex in 
rodents (O'Leary and Nakagawa, 2002). Prior to the investigation of expression patterns 
of corticofugal neurone-associated genes, verification of expression patterns of some 
other neuronal genes or proteins (NURR1 and SATB2) is carried out on human 
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embryonic and foetal tissue (Chapter 4). This is because they are believed to be highly 
expressed in certain layers of the rodent neocortex and therefore after confirming their 
expression patterns in the human neocortex, different laminae of the human neocortex 
can be marked out. 
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Chapter 4 Verification of SATB2 and NURR1 Expression Patterns in 
Early Human Neocortical Development 
 
4.1 Aim of Study 
 
The aim of this chapter is to test the suitability of using SATB2/SATB2 and NURR1 as 
laminar-enriched markers to help to delineating different laminae of the neocortex 
especially within the developing CP.  
 
Although both Satb2 (Layer V at early stages and eventually Layer II-V; (Alcamo et al., 
2008; Britanova et al., 2008)) and Nurr1 (Layer VI and SP; (Hoerder-Suabedissen et al., 
2009)) are highly expressed in certain layers of the neocortex during development in 
rodents, their expression patterns have not yet been reported in humans at our 
investigated ages (8-15 PCW). Therefore tissue ISH and immunoperoxidase- and 
immunofluorescent-histochemistry was performed to verify SATB2/SATB2 and 
NURR1 expression patterns on human embryonic and foetal tissues between 8-15 
PCW.  
 
As previously reported by our group, the SP begins to become visible underneath the 
TBR1-positive developing CP and is GAP43-positive by 12 PCW, while Layer V of the 
developing CP can be marked by ER81 expression by 16 PCW (Bayatti et al., 2008a), 
Therefore, the objective of the present study was to compare the expression patterns for 
ER81, GAP43 and TBR1 with those of SATB2/SATB2 and NURR1 in human 
embryonic and foetal tissues aged between 8-15 PCW. In addition, expression of 
SATB2 and NURR1 across the tangential dimension of the human neocortex was also 
reported. 
 
 
115 
 
4.2 Results 
 
4.2.1 Negative Controls for Tissue ISH 
 
To confirm the specificity of anti-sense probes of ER81 and SATB2 for tissue ISH, the 
negative sense probes of each gene were used alongside during the experiment. All 
sections hybridized with sense probes showed no signal, and representative sections 
were presented in Figure 4.1. 
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Figure 4.1. Detection of anti-sense and sense probes for ER81 and SATB2. 
Specificity test for the anti-sense probes was carried for ER81 and SATB2. Representative 
images were captured with coronal sections of 12 PCW (n=2). The lateral (L) and medial (M) 
part of the neocortex was labelled for orientation purposes. Scale bars indicated 500 µm. 
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4.2.2 Negative Controls for Immunoperoxidase-histochemistry 
 
To confirm the specificity of biotinylated-secondary antibodies used throughout the 
project, immunoperoxidase staining was performed in the absence of primary antibodies 
and applied biotinylated anti-goat IgG, anti-mouse IgG, anti-rabbit IgG or anti-rat IgG 
on each section. All sections immunostained with secondary antibodies showed no 
staining (Figure 4.2). 
 
 
Figure 4.2. Omission of primary antibodies. 
Specificity test for the biotinylated-secondary antibodies was carried out on sagittal sections of 
brain aged 10 PCW (n=1) for anti-goat IgG, anti-mouse IgG, anti-rabbit IgG and anti-rat IgG. 
Higher magnification photos were taken at the boxed regions. The anterior (At) and posterior 
(Pt) part of the neocortex was labelled for orientation purposes. Scale bars indicated 200 μm.   
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4.2.3 Laminar Expression of SATB2/SATB2 during Early Human Neocortical 
Development 
 
To investigate the laminar expression of SATB2/SATB2, tissue ISH and 
immunoperoxidase- and immunofluorescent-histochemistry was performed. Images 
were taken from the dorsolateral anterior neocortex for comparison between sections 
stained with H & E for anatomical references, ER81 and SATB2 sense and anti-sense 
probes and GAP43 and SATB2 antibodies as well as examination of doubled-labelled 
sections with SATB2/TBR1 and SATB2/SOX5 antibodies (Figure 4.3). Adjacent 
sections were selected for each gene/protein between 8-12 PCW.  
 
From 8-9 PCW, SATB2 mRNA expression was almost absent or of very low level as the 
staining between sense and anti-sense probes of SATB2 was of similar intensities 
(Figure 4.3A, B).  
 
At the protein level, SATB2 expression was strongly observed in a few cells scattering 
in the VZ, SVZ, IZ and CP (black double arrowheads, Figure 4.3A), and weakly in cells 
dispersing within the SVZ and IZ (black empty arrowhead, Figure 4.3A) of the 
dorsolateral anterior neocortex at 8 PCW. Within the IZ, some SATB2-expressing cells 
displayed a horizontal orientation (black filled arrow, Figure 4.3A) and thus may be 
migrating along the tangential dimension of the neocortex.  
 
By 9 PCW, a denser layer of cells strongly expressing SATB2 was detected in the lower 
CP and individual SATB2-positive cells of similar intensity were also found to be 
scattered within the VZ, SVZ and IZ of the dorsolateral anterior neocortex (black 
double arrowheads, Figure 4.3B). Cells expressing a lower level of SATB2 remained 
present predominantly in the SVZ and CP at 9 PCW (black empty arrowhead, Figure 
4.3B). Within the CP, some SATB2-expressing cells exhibit a vertically-elongated 
orientation (black empty arrow, Figure 4.3B), which might potentially be migrating 
radially.  
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At 12 PCW, the CP was delineated by the absence of GAP43 immunoreactivity 
underneath the MZ. Cells in the upper CP, presumably the developing Layer V, were 
ER81-positive (strong ER81 anti-sense signal in comparison to the clear sense probe 
staining) and strongly expressed both SATB2 mRNA (strong SATB2 anti-sense signal in 
comparison to the clear sense probe staining) and SATB2 protein (Figure 4.3C). Notice 
the strong and intense anti-sense signal of SATB2 observed at 12 PCW (Figure 4.3C) 
further confirmed the almost absent or very low level of SATB2 mRNA expressed at 8-9 
PCW (Figure 4.3A, B). Within the developing Layer V towards the upper part, cells 
were discreetly expressing either SATB2 or SOX5 (Figure 4.3C‟‟), however in the 
lower Layer V, some cells were found to be co-expressing SATB2 and SOX5 (white 
filled arrow, Figure 4.3C‟‟). A relatively lower level of SATB2/SATB2 mRNA and 
protein expression was detected throughout the lower CP, presumably Layer VI that is 
strongly immunoreactive for TBR1 (Figure 4.3C‟), the SP and IZ (Figure 4.3C). Very 
few or no SATB2/SATB2-expressing cells were detected within the VZ, ISVZ and 
OSVZ (Figure 4.3C). 
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Figure 4.3. Laminar localization of SATB2/SATB2 during early human neocortical 
development (8-12 PCW). 
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Tissue ISH and IHC was performed to determine the laminar expression pattern of 
SATB2/SATB2 in comparison to histological H & E staining, ER81 anti-sense signal and 
GAP43, SOX5 and TBR1 immunoreactivities. 
At 8-9 PCW, SATB2 mRNA expression was minimal or almost absent as sense and anti-sense 
probes of SATB2 yielded similar intensity of staining (A, B). A few individual cells strongly 
immunoreactive for SATB2 were observed in the ventricular zone (VZ), subventricular zone 
(SVZ), intermediate zone (IZ) and cortical plate (CP) at 8 PCW (n=2) (black double arrowheads, 
A). Cells expressing SATB2 at lower level were predominantly dispersed in the SVZ and IZ at 
8 PCW (black empty arrowhead, A). The number of strongly SATB2-positive cells increased by 
9 PCW (n=2), accumulating in the lower CP and was also observed scattering in the VZ, SVZ 
and IZ (black double arrowheads, B). Cells expressing lower level of SATB2 remained present 
predominantly in the SVZ and CP at 9 PCW (black empty arrowhead, B).   
At 12 PCW (n=2), absence of GAP43 immunoreactivity revealed the developing CP underneath 
the MZ (C). SATB2/SATB2 mRNA and protein expression increased drastically within the 
presumptive ER81-positive Layer V of the CP (C). Predominant expression of SATB2 is in 
Layer V above the TBR1-positive Layer VI of the CP (C‟). No co-localization of SATB2 and 
SOX5 was observed in the upper Layer V, but some cells co-expressed SATB2 and SOX5 in 
the lower Layer V (white filled arrow, C‟‟).  
Black filled arrow indicates tangentially migrating cells (A); black empty arrow indicates 
radially migrating cells (B). Scale bars indicate 100 μm.  
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4.2.4 Tangential Expression Gradient of SATB2 during Early Human Neocortical 
Development 
 
To investigate the expression of SATB2 across the tangential axis of the neocortex, 
immunoperoxidase-histochemistry was performed and images were taken separately 
from the anterior and posterior regions of sagittal sections of the neocortex aged 8 and 9 
PCW for comparison. The sagittal sections were taken from a relatively lateral position 
in which the diencephalic origin of the choroid plexus was visible. H & E stained 
sections from nearby regions were presented alongside for anatomical references 
(Figure 4.4).  
 
From 8 PCW, SATB2-immunoreactive cells were mostly observed within the SVZ and 
CP of the neocortex anteriorly and posteriorly (Figure 4.4A). Within the SVZ, there 
were more cells expressing SATB2 in the anterior neocortex, despite having varying 
levels of expression among cells in the same layer, as compared to the posterior region 
of the neocortex (filled arrows indicates strongly SATB2-expressing cells; empty 
arrows indicates weakly SATB2-expressing cells, Figure 4.4A red boxed region, A‟, 
A‟‟). This pattern of expression became more distinctive at 9 PCW, with more strongly 
and weakly SATB2-positive cells being detected within the SVZ in the anterior as 
compared to the posterior neocortex (filled arrows indicates strongly SATB2-expressing 
cells; empty arrows indicates weaker SATB2-expressing cells, Figure 4.4B red boxed 
region, B‟, B‟‟). A few individual strongly SATB2-immunostained cells were also 
observed scattering within the VZ and IZ of both the anterior and posterior neocortex 
(Figure 4.4A, B, filled arrows). Thus these observations indicated that SATB2 is 
expressed in a high anterior, low posterior fashion in the neocortex from 8-9 PCW, and 
the differences were more noticeable within the SVZ. 
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Figure 4.4. Expression gradient of SATB2 during early human neocortical development 
(8-9 PCW). 
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IHC was performed to determine the tangential expression pattern of SATB2 along the anterior-
posterior axis of the developing human neocortex in conjunction with the histological H & E 
staining. Representative sagittal sections of human brains at 8 (n=2, A) and 9 PCW (n=2, B) 
were selected at a lateral level in which the diencephalic origin of the choroid plexus was visible 
and higher magnification pictures were taken at the indicated black boxed regions (A and B) of 
the anterior (At) and posterior (Pt) neocortex. Higher magnification images were also captured 
at the indicated red boxed regions within the VZ/SVZ (A and B) and presented in A‟, A‟‟, B‟ 
and B‟‟. 
Two populations of SATB2-expressing cells were identified at both ages, i.e. the strongly 
SATB2-immunoreactive cells (filled arrows) and the weaker SATB2-positive cells (empty 
arrows; A, B). At both ages, more SATB2-immunoreactive cells (strongly and weakly 
expressing) were detected anteriorly (A‟, B‟) within the SVZ as compared to the posterior 
region of the neocortex (A‟‟, B‟‟). A few individual strongly SATB2-immunostained cells were 
also sparsely distributed within the VZ and IZ of both the anterior and posterior neocortex (A, 
B). Scale bars indicate 200 μm. 
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4.2.5. Tangential and Laminar Expression of NURR1 during Early Human 
Neocortical Development 
 
Expression patterns of NURR1 between 8-10 PCW 
 
To investigate the expression of NURR1 across the tangential axis of the neocortex, 
immunoperoxidase-histochemistry was performed and images were taken separately 
from the anterior, dorsal and posterior regions of sagittal sections of the neocortex aged 
8-10 PCW for comparison. The sagittal sections were taken from a relatively lateral 
position in which the diencephalic origin of the choroid plexus was visible. H & E 
stained sections from nearby regions were presented alongside for anatomical references 
(Figure 4.5).  
 
At 8 PCW, no NURR1 expression was detected throughout the neocortex along its 
anterior-posterior axis (Figure 4.5A). NURR1-immunoreactive cells were only observed 
at the ventral surface of the pons, the pontine flexure and the upper medulla (Figure 
4.5A).  
 
At 9 PCW, small numbers of NURR1-expressing cells were found to be aggregating at 
the lower layer of the CP of the dorsal part of the neocortex, but not in any layer of the 
anterior or posterior region of the neocortex (Figure 4.5B).  
 
By 10 PCW, cells immunostained for NURR1 were detected throughout the neocortex 
along its anterior-posterior axis, but remained restricted to the lower CP (Figure 4.5C). 
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Figure 4.5. Tangential and laminar expression of NURR1 during early human neocortical 
development (8-10 PCW). 
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IHC was performed to determine the tangential expression pattern of NURR1 along the 
anterior-posterior axis of the developing human neocortex in conjunction with the histological 
H & E staining. Representative sagittal sections of human brains at 8 (n=2, A), 9 (n=2, B) and 
10 PCW (n=10, C) were selected at a lateral level in which the diencephalic origin of the 
choroid plexus was visible and higher magnification pictures were taken at the indicated regions 
of the anterior (At), dorsal (d) and posterior (Pt) neocortex. 
At 8 PCW, NURR1 was not expressed by cells in the neocortex along its tangential dimension, 
but by cells locating in the pons (Ps), pontine flexure (PF) and the upper medulla (UM) (A). At 
9 PCW, NURR1 immunoreactivity was detected in the lower cortical plate (CP) of the dorsal 
part of the neocortex, but not in any layer of the anterior or posterior part of the neocortex (B). 
At 10 PCW, NURR1 was expressed by cells within the lower part of the CP throughout the 
entire neocortex along its anterior-posterior axis (C).  
Higher magnification images were also taken at the pons, pontine flexure and the upper 
medulla. Scale bars indicate 200 μm. 
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Expression patterns of NURR1 at 12 and 15 PCW 
 
To investigate the laminar expression patterns of NURR1 along the tangential axes of 
the neocortex aged 12 and 15 PCW, immunoperoxidase-histochemistry with NURR1 
and GAP43 antibodies was performed on coronal sections selected at three different 
levels based on the presence or absence of some anatomical landmarks: i) the most 
anterior sections indicated by the absence of any basal telencephalic structures, the 
ganglionic eminences (LGE and MGE); followed by ii) sections with the presence of 
the LGE/MGE; and further posteriorly iii) sections with the presence of the CGE 
(Figure 4.6). Within each of these sections, three regions of the neocortex were 
examined: medial (m), dorsal (d) and lateral (l) (black solid lines, Figure 4.6).  
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Figure 4.6. Anatomical orientation of coronal sections selected for the study of NURR1 
laminar expression patters at 12 and 15 PCW.  
Three levels of sections aged 12 (n=2, A) and 15 PCW (n=2, B) were selected along the 
anterior–posterior axis of the neocortex based on the presence or absence of some anatomical 
landmarks: anterior to the lateral ganglionic eminence (LGE)/medial ganglionic eminence 
(MGE) indicated by the absence of these subcortical structures, presence of the LGE/MGE and 
presence of the caudal ganglionic eminence (CGE). Black solid lines indicate regions where 
high magnification images were captured within each of these sections, namely the medial (m), 
dorsal (d) and lateral (l) domains of the neocortex. Scale bars indicate 200 μm. 
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From 12-15 PCW, when comparing the laminar expression patterns of GAP43, which 
predominantly expressed in the fibre-rich layers MZ, SP and IZ in humans, different 
NURR1 laminar immunoreactive patterns were observed along the two tangential axes 
of the neocortex: anterior-posterior and medio-dorso-lateral axes. Sections stained with 
H & E at the corresponding levels were also presented alongside with the NURR1- and 
GAP43-immunostained sections to provide additional histological information (Figure 
4.7 and Figure 4.8). 
 
At 12 PCW, at the anterior level with the presence of LGE/MGE as well as the posterior 
level with the presence of CGE, NURR1-expressing cells were found in the lower CP, 
presumably Layer VI, above the GAP43-immunoreactive SP in the medial and lateral 
part of the neocortex, but in both Layer VI of the CP and SP in the dorsal part of the 
neocortex (Figure 4.7A, B). It was found that that Layer VI was packed with more 
NURR1-expressing cells than the SP in the dorsal region of the neocortex. In the dorsal 
SP, NURR1-positive cells were more sparsely distributed (Figure 4.7A, B).  
 
At 15 PCW, at the level anterior to the LGE/MGE, a dense layer of cells expressing 
NURR1 was observed in Layer VI of the CP, with a subset of them also found in the 
GAP43-positive SP in the medial region of the neocortex (Figure 4.8A). However, 
within the dorsal and lateral region of the neocortex, NURR1 immunoreactivity was 
only detected in Layer VI of the CP (Figure 4.8A).  
 
At the relatively posterior levels with the presence of LGE/MGE and CGE at 15 PCW, 
changes of NURR1 laminar expression patterns were observed. In the medial region of 
the neocortex, NURR1 was densely expressed by cells in the upper part of the SP, with 
a few individual NURR1-positive cells scattering towards the lower part of the SP 
(Figure 4.8B, C). Dorsally, a denser layer of NURR1-expressing cells were found in the 
lower layer of the CP, presumably the Layer VI, and fewer cells immunoreactive for 
NURR1 were also detected in the upper part of the SP (Figure 4.8B, C). Laterally at the 
LGE/MGE level, NURR1-immunoreactive cells were predominantly observed in the 
Layer VI of the CP (Figure 4.8B), whereas at the CGE level, cells expressing NURR1 
were found to be aggregating in the upper part of the SP (Figure 4.8C).  
133 
 
 
 
 
Figure 4.7. Tangential and laminar expression of NURR1 at 12 PCW. 
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IHC on paraffin sections revealed NURR1 expression in comparison to GAP43 expression and 
alongside with histological H & E staining at 12 PCW (n=2). Coronal sections of brains were 
selected at two levels: relatively anterior with the presence of lateral ganglionic eminence 
(LGE)/medial ganglionic eminence (MGE) (A) and relatively posterior with the presence of 
caudal ganglionic eminence (CGE) (B). GAP43 immunostained the marginal zone (MZ), 
subplate (SP) and intermediate zone (IZ) at all levels (A, B). At the levels of LGE/MGE and 
CGE, NURR1-immunoreactive cells were found predominantly in Layer VI of the cortical plate 
(CP) medially (m), dorsally (d) and laterally (l) (A, B). Fewer cells expressing NURR1 were 
also observed in the SP solely in the dorsal part (d) of the neocortex (A, B). Scale bars indicate 
100 μm. 
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Figure 4.8. Tangential and laminar expression of NURR1 at 15 PCW. 
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IHC on paraffin sections revealed NURR1 expression in comparison to GAP43 expression and 
alongside with histological H & E staining at 15 PCW (n=2). Coronal sections of brains were 
selected at: (A) most anteriorly with the absence of lateral ganglionic eminence (LGE)/medial 
ganglionic eminence (MGE), (B) relatively mid-level with the presence of LGE/MGE and (C) 
most posteriorly with the presence of caudal ganglionic eminence (CGE). GAP43 
immunostained the marginal zone (MZ), subplate (SP) and intermediate zone (IZ) at all levels 
(A-C). In (A), NURR1-immunoreactive cells were found predominantly in Layer VI of the 
cortical plate (CP) medially (m), dorsally (d) and laterally (l), with fewer cells expressing 
NURR1 were also detected in the SP of the medial part (m) of the neocortex. In (B), 
pronounced NURR1 expression was observed in the upper part of the SP medially. However, 
within the dorsal and lateral region, NURR1 immunoreactivity was mostly found in the Layer 
VI of the CP, and to a lesser extent also in the upper SP of dorsal neocortex. In (C), prominent 
NURR1 expression was observed in the upper part of the SP medially and laterally. However, 
within the dorsal region, NURR1 immunoreactivity was mostly found in the Layer VI of the 
CP, and to a lesser extent also in the upper SP. Scale bars indicate 200 μm.  
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Overall, NURR1 only started to be expressed by cells in the lower CP of the neocortex 
dorsally from 9 PCW and then the entire lower CP of the neocortex by 10 PCW (Figure 
4.5). By 12 PCW when Layer V was forming, NURR1 appeared to be predominantly 
expressed by cells in Layer VI of the CP in humans (Figure 4.7 and Table 4.1). As 
development progresses, NURR1 expression gradually shifted from the Layer VI of the 
CP towards the upper part of the SP when examining sections from the anterior to 
posterior region of the developing neocortex aged 15 PCW (Figure 4.8 and Table 4.1). 
 
 Anterior to LGE/MGE LGE/MGE CGE 
12 
PCW 
m d l m d l m d l 
CP (VI)    ++ ++ ++ ++ ++ ++ 
SP     +   +  
15 
PCW 
   
CP (VI) ++ ++ ++  ++ ++  ++  
USP +   ++ +  ++ + ++ 
Table 4.1. Summary of NURR1 laminar expression between 12-15 PCW. 
+  and ++ indicate relatively lower and higher expression of NURR1 respectively in the Layer 
VI of the cortical plate (CP) and/or subplate (SP), particularly within its upper compartment 
(USP) at 12 (n=2) and 15 PCW (n=2). Medial (m), dorsal (d) and lateral (l) regions of the 
neocortex were examined at three levels along its anterior-posterior axis: anterior to the lateral 
(LGE)/medial ganglionic eminence (MGE), at the level of LGE/MGE and posteriorly at the 
CGE.  
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4.3 Discussion 
 
4.3.1 Verification of SATB2 and NURR1 Expression Patterns during Early 
Human Neocortical Development 
 
The brains of humans and rodents differ not only in terms of their sizes, the 
cytoarchitecture and connectivity of neuronal networks also appear to be more complex 
in humans after evolutionary development (Hill and Walsh, 2005). On the molecular 
basis, genes that are known to play a vital role in corticogenesis and regionalisation in 
rodents are found to be expressed in different patterns in humans too. Therefore 
although the use of various rodent layer-enriched markers could potentially help to 
distinguish between different laminae in the developing neocortex in humans, one 
should be cautious and verify their patterns of expression in humans prior to 
extrapolating data from rodent studies and applying them directly onto human studies. 
The studies in this chapter sought to validate the use of SATB2/SATB2 and NURR1 as 
laminar-enriched markers in humans by comparing their expression patterns with some 
already established markers in humans such as ER81 (Layer V) and GAP43 (MZ, SP 
and IZ) during early human neocortical development.  
 
Previous molecular neuroanatomical studies by our group have shown that by 16 PCW 
Layer V can be visualized by ER81 immunoreactivity in the human neocortex (Bayatti 
et al., 2008a) which is expressed by a subpopulation of neurones in the neocortical 
Layer V of rodents and non-human primates (Yoneshima et al., 2006). The current 
observation of ER81 expression has provided evidence that Layer V in the human 
neocortex is already formed by 12 PCW (Figure 4.3). In addition, the ER81-positive 
Layer V also strongly expressed SATB2/SATB2 (Figure 4.3). Although other transient 
layers of the neocortex also showed a weaker expression of SATB2/SATB2, its 
predominant expression correlating with that of ER81 and above the TBR1-positive 
Layer VI (Figure 4.3) has proven the suitability of employing SATB2/SATB2 as a Layer 
V marker at 12 PCW. However as neocortical development progress, one should not 
exclude the possibility of detecting SATB2/SATB2 expression in upper layers of the 
human CP, as observed in rodents (Alcamo et al., 2008; Britanova et al., 2008). The 
current study was limited by quality of tissue sections at older ages in which tissue ISH 
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was not suitable for tissue sections aged 15 PCW and above. In addition, the ER81 
antibody (obtained from Dr. Jessell) used in previous study (Bayatti et al., 2008a) could 
not be applied on paraffin-embedded tissues which have been used in the current study. 
Therefore, comparison of expression patterns between SATB2/SATB2 and ER81/ER81 
cannot be carried out beyond 15 PCW. Nevertheless, results obtained in the current 
study have validated SATB2/SATB2 as a Layer V marker in the human developing 
neocortex at least at around 12 PCW. 
 
Previous molecular neuroanatomical studies by our group have shown that by 12 PCW 
the SP can be visualized by GAP43 immunoreactivity in the human neocortex (Bayatti 
et al., 2008a). Here, by comparing with the expression pattern of GAP43 from 12 PCW 
onwards, NURR1 was found to be predominantly expressed by neurones in Layer VI of 
the CP in humans, above the GAP43-positive SP, while in some regions it was also 
expressed in the upper SP, overlapping partially with the GAP43 immunoreactivity, 
depending on the developmental stages (Figure 4.7, Figure 4.8, Table 4.1). This spatial 
difference is also observed in rodents, but with different expression patterns such that 
Nurr1 is predominantly a SP marker in the dorsal region of the neocortex, but more 
widely expressed in Layer V, VI and SP towards the lateral part of the neocortex in 
mice from embryonic stage to adulthood (Hoerder-Suabedissen et al., 2009; Arimatsu et 
al., 2003). Therefore using NURR1 solely as a Layer VI or SP marker is not adequate. 
In any case, one should not rely on one marker but always use a combination to 
demarcate boundaries between different layers of the neocortex. For this reason, when 
examining the laminar expression patterns of the corticofugal neurone-associated genes 
in the next chapter (Chapter 5), a range of markers would be included for confirmation 
and better illustration. 
 
4.3.2 Expression Patterns of SATB2 and its Implications 
 
Satb2 is expressed predominantly by post-mitotic, callosal projecting neurones in Layer 
V as well as upper layers of the CP in rodents during corticogenesis (Alcamo et al., 
2008; Britanova et al., 2008). Unlike absence of Satb2 expression in the rodent VZ/SVZ 
(Britanova et al., 2005), strong and weak SATB2-immunoreactive cells are present in 
the heterogeneous proliferative zones in humans (Figure 4.3, Figure 4.4). Whether these 
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cells are proliferative or post-mitotic would require further analyses such as co-
localization studies of SATB2 with INPs or post-mitotic neuronal markers. It has been 
reported in rodents a subset of projection neurones derived from Emx1-positive 
neocortical progenitors expressing SATB2 would migrate tangentially within the rodent 
developing neocortex (Britanova et al., 2006a). We have also observed some 
horizontally elongated SATB2-immunoreactive cells that are potentially migrating 
along the tangential axis. It would be interesting to test if these neurones also co-express 
EMX1 to confirm their neocortical origin.  
 
By 12 PCW, similar to the observation in rodents (Alcamo et al., 2008), the majority of 
SATB2-expressing neurones occupy the ER81-positive Layer V of the CP, above the 
TBR1-positive neurones dominating Layer VI, though TBR1 expression is also detected 
in the lower Layer V in humans (Figure 4.3). Additionally, our findings are consistent 
with a recent study that has reported the observation in human foetal brains at 29 PCW 
that the small numbers of SATB2-expressing neurones observed in Layer VI do not 
express TBR1 (Saito et al., 2010). In contrast, with the use of retrograde tract tracing of 
callosal axons together with microarray analyses and SOX5 immunostaining, it is 
reported that SOX5 is not expressed by callosally projecting neurones in rodents from 
embryonic to postnatal stages investigated (Lai et al., 2008). Within Layer V, 
corticofugal neurones are also found which project their axons towards subcortical 
structures of the brain. This type of neurones will be described and investigated further 
in Chapter 5. Briefly, they express markers such as Fezf2 in proliferative states (Chen et 
al., 2008; Chen et al., 2005b; Chen et al., 2005a; Molyneaux et al., 2005) and Fezf2 as 
well as Ctip2 when they become post-mitotic in rodent studies (Arlotta et al., 2005). 
SOX5 has been shown to down-regulate Fezf2 and Ctip2 in mice and refine their 
expression within Layer V of the CP (Kwan et al., 2008). Additionally, Fezf2 is known 
to act upstream of Satb2 and Ctip2 to repress the callosal- and promote the subcerebral-
projecting phenotypes respectively (Chen et al., 2008). Thus neurones in the lower 
Layer V co-expressing SATB2 and SOX5 (Figure 4.3) are likely to be undergoing 
transitional state between callosal- and subcerebral-projecting phenotypes at post-
mitotic level in which SOX5 is repressing FEZF2 expression to release the inhibition of 
SATB2 thus inducing the differentiation of callosal projecting neurones. (Chapter 1, 
Figure 1.8) 
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Interestingly, our Affymetrix gene chips analysis have shown that SATB2 probe set 
(235147_at) was highly up-regulated by 3.13-fold in the anterior compared to the 
posterior region of the neocortex between 8-12 PCW (Ip et al., 2010a). The graded 
expression of SATB2 has not been reported in rodent studies, yet we have detected a 
high anterior – low posterior expression gradient (3.13-fold) across the developing 
neocortex between 8-12 PCW in Affymetrix gene chips analysis (probe set 235147_at) 
(Ip et al., 2010a) and observed more strongly and weakly SATB2-positive cells 
primarily in the SVZ of the anterior as compared to the posterior neocortex at early 
stages of neocorticogenesis prior to the innervation of any thalamocortical afferents 
(Figure 4.4). However, quantification of these strongly and weakly SATB2-
immunoreactive cells at in both regions with more samples to carry out statistical 
analyses and rtPCR is required to further confirm this expression gradient at protein and 
RNA level respectively in the developing human neocortex. In rodents, loss- and gain- 
of Pax6 function studies show reduced and increased Satb2 expression in the 
developing neocortex respectively (Holm et al., 2007). Thus like TBR2, this high 
anterior – low posterior expression gradient of SATB2 in the SVZ is probably regulated 
by PAX6 before its expression gradient is lost by 9 PCW in humans (Bayatti et al., 
2008b).  
 
4.3.3 Expression Patterns of NURR1 and its Implications 
 
Nurr1 expression is restricted to the SP in the dorsal region of the neocortex, visible as a 
thin band underneath the Layer VI of CP, but widely expressed in Layer V, VI and SP 
towards the lateral part of the neocortex in mice from embryonic stage to adulthood 
(Hoerder-Suabedissen et al., 2009; Arimatsu et al., 2003). Here we have observed 
NURR1 expression varies from region to region and between different developmental 
stages, predominantly expressed in Layer VI of the CP at 12 PCW (Figure 4.7, Table 
4.1) and gradually shifted from Layer VI of the CP to the SP when examining sections 
from anterior to posterior regions of the neocortex at 15 PCW (Figure 4.8, Table 4.1). 
As reported previously in our group, a GAP43-positive human SP begins to form 
visibly underneath Layer VI of the CP from 12 PCW (Bayatti et al., 2008a). However, 
NURR1 expression starts to be detectable from 9 PCW onwards, emerging from lower 
layer of the developing CP in the dorsal region of the neocortex (Figure 4.5). 
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Nevertheless, this dorsal region of the neocortex might correspond to the future 
somatosensory area where the SP begins to form first as compared to the posteriorly-
locating visual area (Kostovic and Rakic, 1990). Thereafter from 12 PCW NURR1 is 
predominantly expressed in the Layer VI of the CP in most regions of the neocortex 
with some in the upper SP of the dorsal neocortex (Figure 4.7, Table 4.1), which may 
correspond to the condensation of parts of Layer VI with the pre-subplate to form the 
SP proper, as proposed by Kostovic and Rakic (1990) (Kostovic and Rakic, 1990). 
FOXP2, a marker delineating Layer VI of the CP in mice, non-human primates and 
humans (Hisaoka et al., 2010; Wang et al., 2010; Takahashi et al., 2008; Vargha-
Khadem et al., 2005), also confirmed the expression of NURR1 spanning the lower 
Layer VI and upper SP of the dorsal cortex at 15 PCW (Wang et al., 2010). In addition 
to the expression of Nurr1 by glutamatergic, pyramidal neurones (Arimatsu et al., 
2003), a recent report has shown that in the sensorimotor cortex of young mice (P18), 
Nurr1 is also expressed by vGlut1- and cholecystokinin-positive, multipolar neurones 
with spiny dendrites, which can be found in the lower Layer VI adjacent to the white 
matter (Andjelic et al., 2009). It would be interesting to probe the various neuronal 
subtypes expressing NURR1 in human foetal neocortex during development. By 16 
PCW, the SP can be divided into the upper SP with more NPY-expressing neurones and 
the lower SP with more K
+
 Cl
-
 co-transporter 2 (KCC2)-immunoreactive neurones 
(Wang et al., 2010; Bayatti et al., 2008a). Here, we have shown that SP could 
potentially be divided into upper and lower SP by 15 PCW in which NURR1 expression 
was predominantly found in the upper part (Figure 4.8, Table 4.1).  
 
Although the low anterior – high posterior expression gradient (1.87-1.92-fold) of 
NURR1 detected between 8-12 PCW by Affymetrix gene chip analysis in humans 
(probe sets 2.16248_s_at, 204621_s_at and 204622_x_at) (Ip et al., 2010a) was not 
observed at the protein level in this study, NURR1 began to be expressed by neurones 
in the neocortex in a regionalised fashion at 9 PCW (Figure 4.5). In rodents, there seems 
to be more neurones expressing Nurr1 in the lateral region compared to the medial 
region of the neocortex persistently from embryonic to postnatal stages (Arimatsu et al., 
2003) and predominant expression in the occipital cortex is observed from E14.5-18 
((Muhlfriedel et al., 2007); http://www.Genepaint.org). In adult rats, expression 
profiling in the neocortex has revealed cortical maps of Layer IV, V and VI that are 
characterized by the differential expression of RORβ, Er81 and Nurr1 (Hirokawa et al., 
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2008). Nurr1 is found to be highly expressed in Layer V of the entorhinal cortex and 
Layer VI of some somatosensory areas in the parietal cortex (Area 2 and the ventral 
area of parietal cortex) (Hirokawa et al., 2008). It is worth looking further into the 
expression pattern of NURR1/NURR1 in the human developing neocortex to determine 
whether its expression begins in a graded or regionalised pattern. 
 
4.3.4 Potential Interaction between SATB2 and NURR1 
 
Although there is no direct biochemical evidence to show interactions between Satb2 
and Nurr1, Satb2 is probably repressing the expression of Nurr1, directly or indirectly, 
since Nurr1 expression is expanded towards the upper layers of the CP in the absence of 
Satb2 expression in mice (Britanova et al., 2008). In humans, the inhibitory effects of 
SATB2 on NURR1 expression probably also exist in order to control the differentiation 
of some projection neurones in Layer V and above to send axons contralaterally 
between the two hemispheres instead of ipsilaterally. Additionally, this inhibitory effect 
probably occurs across the tangential dimension of the neocortex and contributes to the 
potential complementary graded/regionalised expression of SATB2 and NURR1.  
 
Nevertheless, the data we have obtained to-date for SATB2 and NURR1 is preliminary 
and would require more thorough examination, which includes: 
1) rtPCR confirmation of tangential graded expression of SATB2 and NURR1, using 
neocortical tissues from anterior, posterior and possibly dorsal regions of 8, 10 
and 12 PCW. 
 
2) Repetition of immunoperoxidase-histochemistry for SATB2 with Toluidine Blue 
counter-stain on sagittal brain sections from 8-10 PCW, quantification of SATB2-
positive cells in the different layers of the anterior region compared to the 
posterior region of the neocortex and determination of statistical significant 
differences between different layers in different regions. 
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3) Co-localization studies of SATB2 with TBR2 (INP markers) or TBR1 (early post-
mitotic neuronal markers) to confirm the types of cells expressing SATB2 within 
the heterogeneous SVZ from 8 PCW onwards. 
 
4) Co-localization studies of SATB2 with EMX1 to confirm the neocortical origin of 
SATB2-positive, tangentially migrating neurones within the developing 
neocortex. 
 
5) Repetition of immunoperoxidase-histochemistry for NURR1 with more sagittal 
brain sections at various levels (medial vs. lateral) from 8-10 PCW to precisely 
identify the regions in the neocortex where it starts to be expressed. 
 
6) Investigation of the mechanisms that regulate the expression of SATB2 and 
NURR1 in-vitro in human neocortical cell cultures. 
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Chapter 5 Investigating Expression of Corticofugal Neurone-associated 
Genes ROBO1, SRGAP1 and CTIP2 in Early Human Neocortical 
Development 
 
5.1 Introduction 
 
5.1.1 The Descending Fibre Tracts: Corticofugal Projections 
 
The descending fibre tracts in mammals are collectively known as corticofugal 
projections which originate from diverse neocortical areas and terminate at different 
regions of the central nervous system. These include corticothalamic, corticostriatal, 
corticopontine, corticotectal, corticospinal and corticobulbar projections. During 
development, these fibre tracts exit the neocortex and course through the internal 
capsule to reach the telencephalic-diencephalic boundary. At the transition to the 
mesencephalon, the corticospinal axons advance towards the ventral surface and 
together with the corticopontine and corticobulbar axons forming the cerebral peduncles 
(Kahle and Frotscher, 2002). Within each of the cerebral peduncles, the corticospinal 
axons take up the central part and are topographically arranged according to their 
terminations at different levels of the spinal cord (Kahle and Frotscher, 2002). In the 
medulla oblongata, the corticobulbar axons terminate on the cranial nerve nuclei, while 
most of the corticospinal axons travel further towards the spinal cord after crossing over 
to the opposite side in the pyramidal decussation (70-90%), forming the lateral 
corticospinal tract (CST) (Kahle and Frotscher, 2002). The remaining uncrossed fibres 
that stay projecting ipsilaterally towards the spinal cord are known as the anterior CST 
(Kahle and Frotscher, 2002). There are about 19 million axons present in the human 
cerebral peduncle prior to the entry of the pons, and around one million of axons are 
found in the medullary pyramids (Brodal, 1978; Tomasch, 1969). The long trajectories 
of these corticofugal projections require proper guidance to avoid any deviation and 
ensure correct axonal pathfinding and target selection at each point from its origin to its 
destination, and this is believed to be achieved by the interactions of various cell 
adhesion/axon guidance molecules (Faulkner et al., 2008; Runker et al., 2008). 
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5.1.2 Development and Plasticity of the Origin of the Corticofugal Neurones 
 
The motor cortex is an important site of origin for the corticospinal projection neurones, 
whose tract (CST) is the major descending pathway to control voluntary and skilled 
movements of distal musculature. In addition, the motor cortex also houses the majority 
of corticobulbar neurones projecting to cranial motor nuclei, and corticopontine 
neurones projecting to the ventral surface of the pons, as revealed by horseradish 
peroxidase injections in the pontine nuclei of macaque monkeys (Glickstein et al., 1985). 
In humans, imaging techniques have revealed a comparatively larger contribution of the 
prefrontal areas to the corticopontine tract as compared to macaque monkeys (Ramnani 
et al., 2006). The CST together with the corticobulbar fibres convey commands from 
the neocortical motor centres to refine and modify the mechanical and stereotyped 
motions controlled by the subcortical motor centres thereby producing specific, fine-
tuned movements (Kahle and Frotscher, 2002). 
 
The development of CST is the most studied of the descending corticofugal projections. 
In rodents, the corticospinal projection originates from Layer Vb throughout the whole 
developing neocortex postnatally, and is eventually restricted to its adult location 
including posterior frontal/anterior parietal cortex via pruning of collateral projections 
(Oudega et al., 1994; O'Leary and Koester, 1993; O'Leary, 1992; Stanfield and O'Leary, 
1985; Bates and Killackey, 1984). Macaque monkeys at birth have regional cortical 
projections patterns resembling that of the mature macaque (Galea and Darian-Smith, 
1995; Galea and Darian-Smith, 1994). However, the patterns are further refined during 
maturation that areas of cortical origins and targets of projections are reduced through 
collateral elimination, thus resulting in approximately 60% of CST fibres arising from 
the primary, premotor and supplementary motor cortices in the frontal lobe with a 
further 15% arising from the prefrontal, cingulate and insular cortices and 25% from the 
parietal cortex in the mature macaque monkeys (Galea and Darian-Smith, 1995; Galea 
and Darian-Smith, 1994). Similarly in humans, the fibres of the CST originate in the 
primary motor cortex (area 4), premotor and supplementary motor cortices (area 6) in 
the frontal lobe, primary somatosensory cortex (area 1, 2 and 3) as well as the second 
sensorimotor area (area 40) in the parietal lobe (Kahle and Frotscher, 2002). However, 
the proportion of CST fibres arising from the frontal lobe may be even higher in humans 
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as compared to non-human primates due to the increased importance of direct 
neocortico-moto-neuronal connections from the primary motor cortex for human-
specific sensorimotor behaviour including skilled use of the hand and digits (Lemon, 
2008). The origin of the CST appeared to show some degree of variation between 
different species such as rodents (Oudega et al., 1994; O'Leary and Koester, 1993; 
O'Leary, 1992; Stanfield and O'Leary, 1985; Bates and Killackey, 1984), non-human 
primates (Galea and Darian-Smith, 1995; Galea and Darian-Smith, 1994) and humans 
(Lemon, 2008) whereby the proportion of different neocortical areas giving rise to the 
CST varies. This is probably reflecting some species-specific functions that the tract 
subserves and these ontological differences probably arise through species-specific 
developmental mechanisms of corticogenesis and regionalisation, thus highlighting the 
importance of utilizing human materials to study the corticospinal as well as other 
corticofugal systems as compared to other species.  
 
The motor cortex harbouring the above important corticofugal neurones is a common 
site of developmental brain damage leading to cerebral palsy that occurs in one in four 
hundred live births (Eyre, 2007). The corticospinal system is plastic during development 
and perinatal injuries would alter the final patterns of the origin and termination of the 
CST. In cats, unilateral corticospinal inactivation or prevention of limb use results in 
retention of larger number of ipsilateral corticospinal fibres from the more active 
neocortex and causes abnormal visually-guided movements (Martin et al., 2007). 
Similarly, transcranial magnetic stimulation (TMS) of the affected motor cortex though 
fail to elicit responses in the paretic upper limbs of patients with hemiplegic cerebral 
palsy, abnormal responses were evoked when TMS was applied to the unaffected 
ipsilateral motor cortex (Eyre, 2007). A more recent study suggests that lesions at early 
stages of human development may lead to subsequent substantial re-organization of the 
origins of the corticospinal output such that an electromyographic response of the 
ipsilateral biceps was recorded when TMS was applied to the visual area of the infarcted 
side of the neocortex (Basu et al., 2010). Therefore, the present study set out to explore 
how the cortical map is established and the processes preceding motor cortex 
differentiation in order to understand the mechanisms of re-organization and improve 
outcome after such lesions. 
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5.1.3 Corticofugal Neurone-associated Markers 
 
Chapter 3 has discussed the work using Affymetrix gene chips to probe mRNA 
expression in human foetal neocortical tissues between 8-12.5 PCW identified gene 
probe sets related to motor cortex and corticofugal axon development that were highly 
up-regulated at the anterior pole of the neocortex compared to the posterior pole (Table 
3.2; (Ip et al., 2010a)). These included CTIP2, ROBO1 and SRGAP1, genes whose 
expression is not exclusive to corticospinal neurones but crucial to their development. In 
rodents, the transcription factor Ctip2 is expressed by subcerebral projecting neurones 
in Layer V and is important for post-mitotic differentiation of corticospinal neurones 
including fasciculation, outgrowth and pathfinding of their axons but not early 
specification, since its expression is not observed in the proliferative zones (Arlotta et 
al., 2005). Robo protein expression has been demonstrated throughout the developing 
corticofugal pathways including the CST (Sundaresan et al., 2004) and has been shown 
to be involved in human CST development (Jen et al., 2004). E18.5 Robo1
-/-
Robo2
-/-
 
double mutants showed severe mis-projection and crossing over of corticospinal axons 
from the internal capsule towards the midline at the telencephalic level and a complete 
absence of cerebral peduncles in the mesencephalon (Lopez-Bendito et al., 2007). 
Along with their downstream signalling molecule srGAP1, they play a role in axonal 
growth guidance by regulating actin polymerization (Wong et al., 2001). Other 
important functions of srGAPs have been proposed such as regulating transcription 
factor activity or protein transcription as highly regulated shuttling of srGAPs between 
the nucleus and the cytoplasm has been observed throughout neurogenesis (Yao et al., 
2008). 
 
Another corticofugal-related transcription factor Fezf2 is expressed by progenitors and 
post-mitotic Layer V subcerebral projecting neurones in rodents, but is more important 
in earlier specification and differentiation of corticofugal neurones as it acts upstream of 
Ctip2 during development (Chen et al., 2008; Chen et al., 2005b; Chen et al., 2005a; 
Molyneaux et al., 2005). Sox5, a transcription factor acting further upstream of Fezf2 
and Ctip2, is expressed by post-mitotic corticothalamic projecting neurones in Layer VI 
and SP in rodents and is proposed to be responsible for determining the generation 
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sequence and the molecular/laminar identity of corticofugal projection neurones (Kwan 
et al., 2008; Lai et al., 2008).  
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5.2 Aim of Study 
 
In order to test the hypothesis that the anterior pole of the neocortex may be an early site 
of origin of corticospinal neurones and other corticofugal projections, the present study 
aims to study the localized genes/proteins expression of CTIP2, ROBO1 and SRGAP1 
utilizing human neocortical and brainstem tissue from 8-17 PCW, a period of time when 
the CP first starts to form (7.5 PCW, (Meyer et al., 2000)), to when the thalamocortical 
innervation of the SP occurs (13 PCW, (Kostovic and Rakic, 1990)) and the appearance 
of distinct layers in the CP by 16 PCW (Bayatti et al., 2008a).  
 
Objectives of this chapter were: 
1)  to confirmation of the high anterior to low posterior expression gradients of 
ROBO1 and CTIP2 by ISH and SRGAP1 by IHC, in comparison with FEZF2 and 
SOX5.  
 
2)  to analysis of the laminar and cellular mRNA/protein expression patterns of these 
genes in comparison to other laminar-specific markers, i.e. SATB2 (Layer V at 
early stages) (Alcamo et al., 2008), ER81 (Layer V) (Yoneshima et al., 2006), 
NURR1 (Layer VI, SP) (Wang et al., 2010; Hoerder-Suabedissen et al., 2009), 
TBR1 (Layer VI, SP) (Bayatti et al., 2008a; Hevner et al., 2001), Synaptophysin 
and GAP43 (MZ, SP) (Bayatti et al., 2008a) in order to identify and localize these 
genes/proteins to the emerging Layer V. 
 
3) to demonstration of ROBO1 and SRGAP1 as corticofugal neurone-associated 
markers in humans by showing their expression in Layer V of the CP and along 
the subcerebral projecting fibres in the brainstem. 
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5.3 Results 
 
5.3.1 Negative Controls for Tissue ISH 
 
To confirm the specificity of anti-sense probes of CTIP2, FEZF2, ROBO1 and SOX5 for 
tissue ISH, the negative sense probes of each gene were used alongside during the 
experiment. All sections hybridized with sense probes showed no signal, and 
representative sections were presented in Figure 5.1. 
 
Comparison of sense and anti-sense probes of ER81 and SATB2 was presented in Figure 
4.1. 
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Figure 5.1. Detection of anti-sense and sense probes for CTIP2, FEZF2, ROBO1 and SOX5. 
Specificity test for the anti-sense probes was carried for CTIP2, FEZF2, ROBO1 and SOX5. 
Representative images were captured with sagittal sections of 8 PCW (n=3) for FEZF2, ROBO1 
and SOX5 and of 10 PCW (n=3) for CTIP2. The anterior (At), lateral (L), medial (M) and 
posterior (Pt) part of the neocortex was labelled for orientation purposes. Scale bars indicated 
500 µm. 
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5.3.2 Characterization of Primary Antibodies 
 
Primary antibodies used in this study were obtained commercially and staining patterns 
observed by other research groups were published (Table 2.6) except SRGAP1. Of the 
publication-used antibodies, ROBO1 has not been used on any brain or neocortical 
tissues.  
 
Therefore SDS-PAGE and Western blot was performed to characterize ROBO1 and 
SRGAP1 antibodies, using protein samples obtained from the anterior and posterior 
regions of the human foetal neocortical tissues aged 14 PCW. Positive control was 
included using β–ACTIN antibody, revealing a band slightly above 40 kDa (actual size 
44 kDa) (Figure 5.2). A strong single band between 110-160 kDa was observed with 
SRGAP1 antibody (actual size 124 kDa), proving its specificity (Figure 5.2). 
 
For ROBO1 antibody, multiple bands were observed including the ones of correct size 
(175-181 kDa, arrows, Figure 5.2). The immunogen used to manufacture this antibody 
was a synthetic peptide: -VLGGYERGEDNNE conjugated to KLH, corresponding to 
amino acids 1632-1644 of human ROBO1 (Abcam datasheet; 
http://www.abcam.com/Robo1-antibody-ab7279.html). This sequence was blast with 
Blastp of NCBI against the non-redundant protein sequences (nr) of the Homo sapiens 
database. The blast results showing proteins with size ranging from 10-260 kDa were 
summarized in Table A.1 in Appendix. Briefly, the immunogen was 100% identical to 
all isoforms of human ROBO1 protein with molecular weight ranging from 175-181 
kDa. 61% or less of the immunogen sequence was similar to other protein segments 
including, Ankyrin 2 (ANK2; 63 kDa), Arrestin domain-containing 3 (ARRDC3; 46 
kDa), Chromogranin B/Secretogranin 1 (CHGB; 78 kDa), Exocyst complex component 
4 (EXOC4; 110 kDa), Glutamate receptor, ionotropic, AMPA 3 (GRIA3; 101 kDa), 
Immunoglobulin heavy chain variable region (IGH; 13 kDa), N-acetylated alpha-linked 
acidic dipeptidase-like 2 (NAALADL2; 36-89 kDa), Never in mitosis gene A (NIMA)-
related kinase 9 (NEK9; 107 kDa), Nuclear receptor co-repressor 2 (NCOR2), Ras 
responsive element binding protein 1 (RREB1; 52-188 kDa), Rho GTPase-activating 
protein 4 (ARHGAP4; 28 kDa), Ring finger protein 13 (RNF13; 43 kDa), SLIT-
ROBO1 Rho GTPase-activating protein 2 (SRGAP2; 121 kDa), Secreted protein acidic 
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and rich in cysteine/Osteonectin (SPARC; 35 kDa), WD repeat domain 81 (WDR81; 63 
kDa), Zinc finger FYVE domain-containing protein 1 (ZFYVE1; 40-87 kDa). The 
mRNA transcripts of the above proteins were expressed in the developing human 
neocortex aged 8-12.5 PCW as confirmed by Affymetrix gene chip analysis. This could 
account for the multiple bands observed with Western blot, as the secondary and 
territory structures of proteins were destroyed during denaturation of samples and 
antibody was more likely to recognize the primary sequence with less homology.  
 
Nevertheless, this ROBO1 antibody should not cross react with other members of the 
ROBO family such as ROBO2 and -3 as there is no similarity between the immunogen 
sequence and the sequences of human ROBO2 or -3 proteins. ROBO1 antibody 
adsorption could not be performed as peptide with this particular immunogen sequence 
was not available. Although this commercial ROBO1 antibody did not seem to have the 
best specificity, it nonetheless was able to recognize all isoforms of the human ROBO1 
protein and its immunostaining patterns were comparable to its mRNA expression 
patterns revealed by ISH (Figure 5.5). 
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Figure 5.2. Characterization of ROBO1 and SRGAP1 antibodies. 
SDS-PAGE and Western blot using protein samples obtained from the anterior (At) and 
posterior (Pt) human neocortical tissues at 14 PCW (n=2) revealed a single band with anti-
SRGAP1 antibody of approximately 124 kDa. However, multiple bands were obtained with 
anti-ROBO1 antibody with the correct band of approximately 175-181 kDa (arrows). Anti-β–
ACTIN antibody was used as positive control which revealed a single band of approximately 44 
kDa. Novex
®
 Sharp Unstained Protein Standard was used to determine the size of each band. 
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5.3.3 ISH/IHC Confirmation of ROBO1, SRGAP1 and CTIP2 Tangential 
Gradients 
 
ISH carried out for ROBO1 and CTIP2 and IHC for SRGAP1 at 8, 9 and 10 PCW was 
performed on sagittal sections to determine their tangential expression gradients. 
Expression of all three appeared consistently higher in anterior compared to posterior 
regions of the neocortex at all ages studied (Figure 5.3A, B). The expression levels 
observed were quantified by measuring the relative optical densities of histological 
staining and confirmed significant differences between the anterior and posterior poles 
in expression levels for all three genes at all stages investigated (Figure 5.3C). In 
addition, a statistically significant high posterior to low anterior gradient for FEZF2 was 
detected by ISH at 9 and 10 PCW but not 8 PCW, but SOX5 exhibited no statistical 
significant difference in intensity of expression either anteriorly or posteriorly at all 
investigated stages (Figure 5.3).  
 
Expression patterns of CTIP2, ROBO1, FEZF2 and SOX5 at mRNA level and SRGAP1 
at protein level in coronal sections at 8 and 12 PCW were examined. Laminar staining 
patterns resembled those seen in sagittal sections, but no lateral to medial gradients of 
expression were observed (Figure 5.4). 
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Figure 5.3. ROBO1, SRGAP1 and CTIP2 anterior-posterior expression gradients in 
sections from the developing human neocortex. 
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ISH of sagittal sections for ROBO1, CTIP2, FEZF2 and SOX5 and IHC for SRGAP1 (A, B) 
revealed that ROBO1, SRGAP1 and CTIP2 were expressed at high levels anteriorly within the 
subventricular zone, intermediate zone and cortical plate (CP) between 8-10 PCW. A high 
posterior, low anterior expression of FEZF2 was detected but at 9 and 10 PCW only. No 
gradient was detected for SOX5 at any stage investigated. Higher magnification images, outlined 
with boxes, were taken at the anterior (At) and posterior (Pt) regions of the neocortex. (C) The 
optical density of histological staining for ROBO1, CTIP2, FEZF2, SOX5 mRNA and SRGAP1-
immunoreactivity at the anterior pole of the neocortex (grey bars) was measured in the CP and 
expressed relative to background staining in the ventricular zone (VZ) (see Section 2.11.1) and 
compared to the same ratios measured at the posterior pole (black bars). *, p≤ 0.05 (paired 
Student‟s t-test; 8 PCW, n=3; 9 PCW, n=3; 10 PCW, n=3). Scale bars indicate 200 μm. Adapted 
from (Ip et al., 2010b). 
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Figure 5.4. ROBO1, SRGAP1 and CTIP2 medial-lateral expression gradients in sections 
from the developing human neocortex. 
ISH of coronal sections for ROBO1, CTIP2, FEZF2 and SOX5 and IHC for SRGAP1 revealed 
no difference in expression level between medial (M) and lateral (L) regions of the neocortex at 
8 PCW (A; n=2) and 12 PCW (B; n=2). Areas outlined with boxes are shown at higher 
magnification. CP, cortical plate; VZ, ventricular zone. Scale bars indicate 200 μm. Adapted 
from (Ip et al., 2010b). 
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5.3.4 Laminar and Cellular Expression of ROBO1/ROBO1, SRGAP1 and 
CTIP2/CTIP2 
 
To investigate the laminar expression of ROBO1/ROBO1, SRGAP1 and CTIP2/CTIP2, 
tissue ISH and immunoperoxidase-histochemistry was performed. Images were taken 
from the dorsolateral anterior neocortex for comparison between sections stained with H 
& E for anatomical references, ROBO1 and CTIP2 anti-sense probes as well as ROBO1, 
SRGAP1 and CTIP2 antibodies (Figure 5.5). To investigate the cellular expression of 
ROBO1, SRGAP1 and CTIP2, immunofluorescent-histochemistry was performed and 
sections were doubled-labelled with CTIP2/TBR1, CTIP2/TBR2, CTIP2/ROBO1, 
CTIP2/SRGAP1 and ROBO1/SRGAP1 antibodies (Figure 5.6). Adjacent sections were 
selected for each gene/protein between 8-10 PCW.  
 
From 8-10 PCW, the majority of expression of ROBO1 and CTIP2/CTIP2 was found in 
cell bodies in the CP and the SVZ. To a lesser extent, they were also expressed in the 
migrating neurones passing through the IZ of the dorsolateral anterior neocortex. 
(Figure 5.5A, B). At 10 PCW although the IZ and SP contained few ROBO1-positive 
cell bodies, immunoreactivity for ROBO1 and SRGAP1 protein was high in these 
regions showing that receptor complexes containing these proteins were highly 
expressed on growing axons passing through these regions (Figure 5.5B). 
 
The human SVZ, constituting a heterogeneous population of cells including radial glia-
like cells, intermediate neuronal precursors (INPs) and early post-mitotic, immature 
neurones (Fietz et al., 2010; Hansen et al., 2010; Bayatti et al., 2008a) is profoundly 
different from the thin rodent SVZ, (Martinez-Cerdeno et al., 2006) at comparable 
developmental stages. At 10 PCW, double-labelling of CTIP2 with INPs marker, TBR2 
(Hevner et al., 2006) showed that although CTIP2 expression was detected in the SVZ, 
it was not expressed by INPs (Figure 5.6A), but TBR1-positive immature neurones 
(Figure 5.6B, arrow; (Bayatti et al., 2008a)). Similarly within the CP, a subset of post-
mitotic neurones also co-expressed CTIP2 and TBR1 (Figure 5.6B, arrow). In addition, 
double-labelling of CTIP2/ROBO1, CTIP2/SRGAP1 and ROBO1/SRGAP1 showed 
that a substantial subpopulation of post-mitotic neurones co-expressed CTIP2, ROBO1 
and SRGAP1 (Figure 5.6C-E, arrows). Note that the intracellular location of CTIP2 was 
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distinct from those of ROBO1 and SRGAP1 in which CTIP2 was predominantly 
expressed within the nuclei and ROBO1 and SRGAP1 showed cytoplasmic and/or cell 
surface localization (Figure 5.6C-E). 
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Figure 5.5. Laminar localization of ROBO1, SRGAP1 and CITP2 during early human 
neocortical development (8-10 PCW). 
ISH and IHC on paraffin sections revealed expression of ROBO1 mRNA and protein, SRGAP1 
protein and CTIP2 mRNA and protein in the subventricular zone (SVZ), intermediate 
zone/subplate (IZ/SP) and cortical plate (CP) at 8 (n=3) and 10 PCW (n=3) (A, B). All sections 
were taken from the dorsolateral region of the neocortex and adjacent sections were selected for 
each gene/protein at each stage. Note the higher expression of ROBO1 and SRGAP1 protein in 
the IZ and SP compared to ROBO1 mRNA, which was more highly expressed in the CP. This 
revealed the predominant localization of the proteins to receptor complexes in axons compared 
to the predominant localization of mRNA in the cell body. CTIP2, a transcription factor, was 
predominantly localized to the nucleus of positive cells. Histological H & E stained sections of 
the corresponding level were included for anatomical references. Scale bars indicate 200 μm. 
Adapted and modified from (Ip et al., 2010b). 
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Figure 5.6. Cellular localization of ROBO1, SRGAP1 and CTIP2 at 10 PCW. 
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(A-B) At 10 PCW (n=2), within the subventricular zone (SVZ), most CTIP2-positive cells 
(green) did not express TBR2 (red) a marker for INPs, but co-expressed with post-mitotic 
marker TBR1 (yellow, arrow), indicating that CTIP2 positive cells are predominantly post-
mitotic neurones. (B) Within the CP, CTIP2 and TBR1 were also co-expressed by a 
subpopulation of post-mitotic neurones within the nuclei (yellow, arrow) (C-E) A subset of 
post-mitotic neurones co-expressed CTIP2 (nucleic localization), ROBO1 and SRGAP1 
(cytoplasmic and/or cell surface localization) (arrows). Scale bars indicate 100 μm. Adapted and 
modified from (Ip et al., 2010b). 
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5.3.5 Laminar and Cellular Expression of ROBO1/ROBO1, SRGAP1 and 
CTIP2/CTIP2 during the Emergence of Layer V  
 
The expression patterns of ER81, SATB2, TBR1, NURR1, GAP43 and Synaptophysin 
observed at 12 PCW led us to propose that Layer V of the CP was formed at around this 
time point (Figure 5.7A). The CP was found to be delineated by the absence of GAP43 
and Synaptophysin expression, which were prominently detected in the SP, IZ and MZ 
(Figure 5.7A). The segregation of layers in the CP was revealed by strong ER81 and 
SATB2 expression in the upper CP (Figure 5.7A), presumably Layer V and strong TBR1 
and NURR1 expression in the lower CP (Figure 5.7A), presumably Layer VI. ROBO1, 
SRGAP1 and CTIP2 together with FEZF2 and SOX5 were expressed by neocortical 
neurones in both layers of the CP (Figure 5.7A). In the upper CP, discrete populations 
of CTIP2-positive and SATB2-positive cells were observed with only a small number 
of them co-expressing both markers (arrow, Figure 5.7A‟). However, a larger 
proportion of cells in the upper CP co-expressed both ROBO1 and SATB2 (arrow, 
Figure 5.7A‟‟). Notice the cytoplasmic and/or cell surface localization of ROBO1 
resulted in punctate staining observed in individual cells, in comparison to CTIP2 and 
SATB2 which were localized to the nuclei of cells (Figure 5.7A‟, A‟‟).  
 
At 15 PCW, a similar expression pattern was observed with some refinements (Figure 
5.7B). SATB2 remained strongly expressed by neocortical neurones located in the 
upper CP (Layer V) (Figure 5.7B). Layer VI neurones continued to express TBR1 and 
NURR1, however a subset of NURR1-expressing cells were observed in the GAP43-
positive SP. CTIP2 and SOX5 continued to be expressed by neocortical neurones in 
both Layer V and VI of the CP (Figure 5.7B). ROBO1 and SRGAP1 were expressed 
strongly by neocortical neurones in Layer V of the CP (Figure 5.7B), however, ROBO1 
and SRGAP1 expression in the SP was weaker between 12-15 PCW (Figure 5.7) than at 
earlier stages. This suggested that axon growth cones expressing the ROBO1 receptor 
complex were not present in the SP at this stage. 
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Figure 5.7. Laminar and cellular localization of ROBO1, SRGAP1 and CTIP2 at 12 and 
15 PCW. 
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(A) Comparison of expression of ROBO1, SRGAP1 and CTIP2 with various laminar-specific 
markers (SATB2, ER81, TBR1, NURR1, GAP43 and Synaptophysin) revealed the emergence of 
Layer V by 12 PCW (n=2). The cortical plate (CP) was identified by GAP43- and 
Synaptophysin-negative immunoreactivity, proximal to the marginal zone (MZ). Within the CP, 
strong SATB2 expression was detected in the Layer V above the TBR1- and NURR1-expressing 
Layer VI. ROBO1, SRGAP1 and CTIP2 together with FEZF2 and SOX5 expression were 
observed throughout the CP (Layer V and VI). (A‟) At 12 PCW, within Layer V of the CP, 
post-mitotic neurones predominantly expressed either CTIP2 (green) or SATB2 (red), and very 
few co-expressed both markers (arrow). (A‟‟) However, there were many more ROBO1 and 
SATB2 co-expressing cells (arrow).  
(B) At 15 PCW (n=2), NURR1-expressing cells were observed in Layer VI and also in the 
upper parts of the GAP43-positive subplate (SP). Expression of CTIP2 together with SOX5, 
SATB2 and TBR1 were detected in both Layer V and VI with different intensities, whereas 
intense immunostaining of ROBO1 and SRGAP1 were observed mostly in the Layer V. All 
sections were taken from the dorsolateral region of the neocortex and adjacent sections were 
selected for each gene/protein at each foetal stage.  
IZ, intermediate zone; Scale bars represent 50 μm. Adapted and modified from (Ip et al., 2010b). 
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5.3.6 ROBO1 and SRGAP1 Expression in Corticofugal Axons 
 
At 12 PCW, GAP43 immunoreactivity revealed growing axons of all corticofugal 
projections such as corticothalamic, corticostriatal, corticopontine, corticotectal, 
corticobulbar and corticospinal axons through the internal capsule at the LGE, MGE 
levels of the telencephalon (white arrows, Figure 5.8A). However, ROBO1 and 
SRGAP1 expression in the internal capsule appeared to be complementary to the 
expression pattern of GAP43 (white arrows, Figure 5.8A). Additionally, cells in the 
developing striatum including the caudate nucleus and putamen also expressed ROBO1 
and SRGAP1 (Figure 5.8A). Note that the pattern of ROBO1 mRNA expression was 
similar to its protein expression (small insert, Figure 5.8A). These observations 
indicated that ROBO1/ROBO1 and SRGAP1 were likely to be produced by cells 
locating in the developing striatum and that the ROBO1/SRGAP1 receptor complexes 
were not expressed by fibre segments travelling through the internal capsule at this 
stage.  
 
At the mesencephalic level, fibres such as corticopontine, corticobulbar and 
corticospinal axons projecting through the ventral surface formed the cerebral peduncle 
were strongly immunoreactive for GAP43, but weaker for ROBO1 and SRGAP1 
(Figure 5.8B). Nevertheless, their expression patterns were similar. At the level of pons, 
corticofugal fibres including corticospinal, corticobulbar and corticopontine axons 
travelled longitudinally and were found in large distinct bundles at a relatively 
ventrolateral position of the pontine bulb, which were revealed by GAP43 
immunoreactivity (arrow, Figure 5.8C). These longitudinally projecting corticofugal 
axons were also immunoreactive for both ROBO1 and more strongly SRGAP1 (filled 
arrows, Figure 5.8C). The pontine bulb also housed another type of fibres which were 
projecting transversely from the pons towards the cerebellum (pontocerebellar axons) 
which were locating near the midline and dorsomedial to the corticofugal bundles. 
However, due to the damage of the tissue sections during sectioning, only one half of 
the pontine bulb towards the lateral side was preserved and thus expression of GAP43, 
ROBO1 and SRGAP1 in the pontocerebellar fibres could not be determined. The tissue 
in and around the corticofugal fibres consisted of pontine grey neurones which were 
negative for GAP43, ROBO1 and SRGAP1 immunoreactivity (empty arrows). 
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Figure 5.8. ROBO1 and SRGAP1 expression along the corticofugal projections. 
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(A) Coronal sections of the human brain at telencephalic level revealing the LGE, MGE, 
developing striatum (CN, caudate nucleus; P, putamen) and internal capsule at 12 PCW (n=2). 
GAP43 expression was detected in all growing axons of different pathways through the internal 
capsule (white arrows). However, the patterns of ROBO1/ROBO1 mRNA (small insert) as well 
as protein and SRGAP1 protein expression were found to be complementary to that of GAP43 
within the internal capsule (white arrows). ROBO1/ROBO1 and SRGAP1 expression was also 
observed in the developing striatum. (B) Transverse mesencephalic sections of the human brain 
revealing the cerebral peduncle at 12 PCW (n=1). Strong GAP43 expression was detected in all 
growing axons of different pathways through the cerebral peduncle. Weaker but similar patterns 
of ROBO1 and SRGAP1 immunoreactivity were observed. (C) Transverse human brainstem 
sections revealing the pons at 12 PCW (n=1). GAP43, ROBO1 and SRGAP1 immunoreactivity 
was observed in the longitudinally projecting corticofugal axons which included corticopontine 
and corticospinal projections (filled arrows). The pontine grey neurones found in and around the 
corticofugal fibres did not express all three markers (empty arrows). Scale bars indicate 0.1 cm. 
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At 11 PCW, GAP43 immunoreactivity revealed growing axons in multiple pathways 
through the medulla at the level of olives (Figure 5.9A), whereas both ROBO1 and 
SRGAP1 immunoreactivity were restricted to the two small regions at the ventral 
surface of the medulla (arrow, Figure 5.9B, C). When examining sections at the level of 
decussation of corticospinal axons, small numbers of fibres immunoreactive for GAP43 
were found extending from the ventral surface of the medulla crossing over the 
decussation (Figure 5.9D). However, expression of ROBO1 and SRGAP1 was not 
detected in fibres crossing over the decussation but was present in fibres on the ventral 
surface at this level (arrows, Figure 5.9E, F). 
 
ROBO1- (Figure 5.9G) and SRGAP1- (Figure 5.9H) immunoreactive pyramidal fibres 
were first detected at the decussation at around 14 PCW. By 17 PCW, prominent 
pyramids were present on the ventral surface of the medulla and these were strongly 
immunoreactive for both ROBO1 (Figure 5.9I) and SRGAP1 (Figure 5.9J) as fibres 
have extended to the decussation and beyond. It was noteworthy that expression of 
ROBO1 and SRGAP1 was stronger in pyramidal fibres in the caudal medulla (Figure 
5.9) as compared to the corticofugal axons in the mesencephalon and the pons (Figure 
5.8 B, C).   
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Figure 5.9. ROBO1 and SRGAP1 are corticospinal tract markers in the caudal medulla. 
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(A-C) Caudal medulla sections at the level of olives at 11 PCW (n=2). GAP43 expression was 
detected in all growing axons of different pathways revealed in this section (A). However, 
ROBO1- (B) and SRGAP1- (C) immunoreactive fibres were observed only in the two small 
regions at the ventral surface of the medulla, presumably where the future medullary pyramids 
are formed. (D-F) show caudal medulla sections at the level of decussation at 11 PCW. Small 
numbers of fibres crossing over the midline in the medulla were immunoreactive for GAP43 
(D), but negative for ROBO1 (E) and SRGAP1 (F). (G-J) Caudal medulla sections at the level 
of decussation at 14 (n=2) and 17 PCW (n=2). Both ROBO1 (G, I) and SRGAP1 (H, J) showed 
strong expression in fibres crossing over at the decussation. Scale bars represent 0.5 mm. 
Adapted from (Ip et al., 2010b). 
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5.4 Discussion 
 
In order to understand the origins and formation of the human corticofugal projections, 
we have examined the expression patterns of three corticofugal neurone-related genes 
and/or proteins ROBO1/ROBO1, SRGAP1 and CTIP2/CTIP2 using ISH and IHC 
during the early stages of corticogenesis. Prominent ROBO1 and SRGAP1 
immunoreactivity was seen in corticofugal axons from and beyond mesencephalic level 
at around 12 PCW (Figure 5.8) and pyramidal fibres in the medulla from 11–17 PCW 
(Figure 5.9), confirming their role in the development of corticofugal projections. All 
three genes showed graded expression at the early stages of CP formation being highly 
at the anterior pole of the neocortex (Figure 5.3), providing evidence that this region 
might be an early site of the developing motor cortex where corticofugal projection 
neurones were generated. Furthermore, two transcription factors deemed key to the 
development of Layer V subcortical projection neurones, FEZF2 (Chen et al., 2008; 
Chen et al., 2005b; Chen et al., 2005a; Molyneaux et al., 2005) and SOX5 (Kwan et al., 
2008; Lai et al., 2008), showed no gradients or small posterior to anterior gradients 
depending on age and method of study (Figure 5.3), indicating that anterior to posterior 
expression gradients are not universal to Layer V-related genes at this stage of 
development. ROBO1/ROBO1, SRGAP1 and CTIP2/CTIP2 were all persistently 
expressed in both the SVZ and CP of the neocortex from 8-15 PCW (Figure 5.5, Figure 
5.7). However, expression in the SVZ was in post-mitotic neurones only and not in 
INPs (Figure 5.6). By 15 PCW, expression of ROBO1 and SRGAP1 was concentrated 
in Layer V of the CP (Figure 5.7), the origin of subcerebral projection neurones.   
 
5.4.1 Ontogeny of Corticofugal Projections Development Revealed by Expression 
of ROBO1 and SRGAP1 along the Corticofugal Axons 
 
The corticofugal projections such as corticospinal and corticopontine axons are the 
major descending pathways that predominantly originate from Layer V of the frontal 
motor areas in primates (Lemon, 2008; Glickstein et al., 1985; Porter, 1985). These long 
distance projections require proper guidance for correct axonal pathfinding and target 
selection at each point from its origin to its destination, potentially through cell 
adhesion molecules (Faulkner et al., 2008; Runker et al., 2008). Here, we show that the 
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cell adhesion/axon guidance molecule ROBO1 and its downstream signalling molecule 
SRGAP1 were expressed along the corticofugal axons at various foetal stages during 
their formation (Figure 5.8, Figure 5.9), potentially playing a role in guiding axons 
towards different targets at least from the mesencephalon up to the caudal medulla that 
have been investigated.  
 
Although multiple GAP43-positive axon pathways were present in the medulla at 11 
PCW, ROBO1 and SRGAP1 were solely expressed by fibres located at the future sites 
of the CST pyramids on the ventral surface of the medulla (Figure 5.9). Thus these 
ROBO1- and SRGAP1-positive fibres probably represent the earliest arriving 
corticospinal axons at the level of the olives. In more caudal sections, small numbers of 
GAP43-positive but ROBO1- and SRGAP1-negative fibres crossed the decussation 
(Figure 5.9). Perhaps these decussating fibres are not corticospinal axons but pioneer 
fibres in the CST serving as scaffolds or temporary targets for the developing 
corticospinal axons, in the same way as the establishment of subcortical projections is 
dependent on the guidance of pioneer axons from subplate cells projecting towards the 
internal capsule (McConnell et al., 1994; Kim et al., 1991; McConnell et al., 1989). It is 
noteworthy that these GAP43-immunoreactive fibres crossing over at the decussation at 
11 PCW were of small amount (Figure 5.9) and probably only detectable in a few thick 
sections cut at 70 µm. Thus double immunofluorescent labelling of all the sections with 
GAP43/ROBO1 antibodies would be useful to confirm whether these fibres are truly 
pioneer (GAP43-positive, ROBO1-negative) or corticospinal axons (GAP43-positive, 
ROBO1-positive). However, one should be cautious with the application of ROBO1 
antibodies due to relatively poor specificity based on the results of Western blot and 
NCBI protein BLAST analysis (Figure 5.2). SRGAP1 antibody would probably be a 
better option as it is a monoclonal antibody and has shown better specificity (Figure 5.2). 
However both GAP43 and SRGAP1 antibodies were raised in mice, limiting their uses 
in combination. One way to overcome this limitation is by labelling these antibodies 
directly with fluorescent dyes of different absorbance and emission profiles (labelling 
kits available commercially), thus the use of species-specific, fluorescent dye-
conjugated secondary antibodies could be avoided.  Alternatively, CST growth cones 
may not express the ROBO1 receptor complex as they cross the decussation to avoid 
repulsive interaction with SLIT expressed in the extracellular matrix at the midline 
(Long et al., 2004; Kidd et al., 1998). However in mice, Robo (1 and 2) are strongly 
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expressed in corticospinal fibres before, during and after crossing the midline in the 
caudal medulla from P2 onwards and may be involved in axon fasciculation as well as 
guidance (Sundaresan et al., 2004). 
 
By 12 PCW, corticofugal fibres including corticopontine, corticospinal and 
corticobulbar axons travelling through the cerebral peduncle and pons expressed both 
ROBO1 and SRGAP1 (Figure 5.8), however fewer or no expression was detected along 
the fibre segment projecting through the internal capsule (Figure 5.8) or the fibre-rich IZ 
of the neocortex (Figure 5.7). This observation might suggest that corticofugal fibres 
express ROBO1 and SRGAP1 only in their growing regions, i.e. their growth cones, 
and thus indicating these corticofugal axons might still be actively elongating and 
branching in the cerebral peduncle and pons at this stage of development. It is 
noteworthy that similar ROBO1 and SRGAP1 expression patterns were observed in the 
developing dorsal striatum which forms the future caudate nucleus and putamen (Figure 
5.8). This expression pattern is also observed in the rodents during the course of 
interneurones migration and known to be playing a role in their guidance (Andrews et 
al., 2008; Andrews et al., 2007). Therefore, it is likely that the 35% of interneurones 
originating from the basal telencephalon in humans (Letinic et al., 2002) also require the 
guidance of ROBO1/SRGAP1 complexes to reach the neocortex. Within each of the 
cerebral peduncle, the mature CST and corticobulbar axons occupies the central part 
with corticopontine axons flanking either side of them (Kahle and Frotscher, 2002). 
ROBO1, SRGAP1 and GAP43 expression showed no clear segregation between these 
corticofugal fibre subtypes (Figure 5.8) raises possibilities that these axons might be 
projecting through the entire cerebral peduncle during development. Axonal pruning, a 
mechanism shown in rodents to selectively eliminate collateral axons from 
inappropriate targets (Low et al., 2008; O'Leary and Koester, 1993), might also occur at 
later stages in the cerebral peduncle to further refine the patterns to its mature form. 
However, until now there is no evidence that axonal pruning take place in humans. In 
the ventral pontine bulb, the more strongly and diverse SRGAP1 expression in the 
longitudinally projecting corticofugal axons as compared to the expression of ROBO1 
(Figure 5.8) probably suggests that other members of the ROBO family proteins e.g. 
ROBO2 is also involved in guiding these axonal tracts through associating with 
SRGAP1. 
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By 14-17 PCW, prominent pyramids were present which are strongly immunoreactive 
for both ROBO1 and SRGAP1, as were fibres extending to the decussation and beyond 
(Figure 5.9). The decussation of ROBO1- and SRGAP1-positive fibres was observed 
around the time when a distinct ROBO1- and SRGAP1-positive Layer V emerges in the 
neocortex (Figure 5.7). 
 
5.4.2 Expression of Corticofugal Neurone-associated Genes/Proteins in the SVZ 
and IZ 
 
The expression of CTIP2/CTIP2 in the human SVZ is an intriguing discovery since its 
expression is absent in the mouse VZ or SVZ from E12 to P6 (Arlotta et al., 2005). The 
human SVZ, however, is relatively larger and divided into two layers, the inner and 
outer SVZ, by the IFL from 11 PCW onwards and contains post-mitotic markers such as 
TBR1 (Bayatti et al., 2008a; Bystron et al., 2008). By comparison, the thin rodent SVZ 
constitutes only a few layers of cells at a comparable developmental stage (Martinez-
Cerdeno et al., 2006) and is Tbr1-negative (Hevner et al., 2006; Hevner et al., 2003). In 
the present study, CTIP2-positive cells were not found to express the INPs marker 
TBR2 (Hevner et al., 2006; Hevner et al., 2003) but early post-mitotic marker TBR1 
(Hevner et al., 2006; Hevner et al., 2003) (Figure 5.6). Therefore Arlotta and others‟ 
(2005) proposal that Ctip2 is not involved in early specification of neocortical 
progenitors in mice due to the lack of its expression in the VZ or SVZ (Arlotta et al., 
2005) is likely to hold true in humans also, despite its expression in the SVZ. Instead, 
CTIP2 may control the expression of ROBO1 and SRGAP1 which are related to 
corticofugal neurones and could be required from the earliest stages of development, for 
instance, in guiding the outgrowth of their axons towards the internal capsule whilst the 
immature neurones are still migrating towards the CP. In contrast to the sparsely 
distributed SATB2-positive cells observed in the SVZ at 8 and 9 PCW (Figure 4.3, 
Figure 4.4), CTIP2/CTIP2 expression was already abundant in the SVZ and CP at 8 
PCW (Figure 5.5). This might suggest that despite some SATB2-expressing neurones 
designated to occupy with CTIP2-expressing neurones in Layer V, the callosal 
projecting neurones are probably generated later than the subcerebral projecting 
neurones. Alternatively, it might be due to some differential regulatory machineries 
causing SATB2 expression to be switched on later than CTIP2. 
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 Our observation of ROBO1 and SRGAP1 expression in the human SVZ and IZ (Figure 
5.5-Figure 5.7) was largely in agreement with the expression patterns in mice. Robo1 
protein expression was detected in the axons transversing the lower IZ/SVZ from E15.5 
while srGAP1 mRNA expression was observed in the proliferative zone at E16.5 in 
mice (Bacon et al., 2009; Andrews et al., 2008; Andrews et al., 2007; Andrews et al., 
2006). Our observation of a gradual loss of ROBO1 and CTIP2 mRNA expression 
within SP/IZ from 10 PCW onwards (Figure 5.5, Figure 5.7) suggests the occurrence of 
radial somal translocation of ROBO1+/CTIP2+ subcerebral projecting neurones through 
the SP/IZ towards the CP is potentially guided by ROBO1/SRGAP1 receptor 
complexes. 
 
5.4.3 Emergence of Laminar Specific Expression of Corticofugal Neurone-
associated Genes/Proteins in the CP 
 
Expression of ROBO1 mRNA, SRGAP1 protein and CTIP2/CTIP2 mRNA and protein 
within the human CP (Figure 5.5-Figure 5.7) was largely consistent with the expression 
patterns observed in rodents (Bacon et al., 2009; Lopez-Bendito et al., 2007; Arlotta et 
al., 2005; Bagri et al., 2002; Whitford et al., 2002). An exception is ROBO1 protein 
which is weakly expressed in the CP of mice (Andrews et al., 2007; Andrews et al., 
2006). The expression of these genes and proteins in the human CP (Figure 5.5-Figure 
5.7), which constitutes post-mitotic neurones, suggest that ROBO1/ROBO1, SRGAP1 
and CTIP2/CTIP2 are likely to play a role in mediating processes involved in the 
differentiation of subcerebral projecting neurones such as axonal projection 
fasciculation, outgrowth and pathfinding. Note that SRGAP1 cytoplasmic expression 
was observed at all stages investigated in our study (Figure 5.5-Figure 5.7) which 
differs from the reported nucleus-cytoplasm shuttling phenomenon occurring from P1 to 
adult in mice (Yao et al., 2008). Nuclear expression of SRGAP1 might be observed at 
later stages in human neocortical development not studied here. Alternatively, the lack 
of nucleus-cytoplasmic shuttling observation is probably due to the use of post-mortem 
human tissue instead of experimental mouse tissue in which optimal preservation is 
achievable. 
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In humans, previous work has shown both Layer V and VI can be distinguished within 
the CP by 16 PCW (Bayatti et al., 2008a). Our new observations suggest that Layer V is 
probably formed slightly earlier, from 12-15 PCW. Layer V was easily distinguishable 
by the restricted expression of SATB2/SATB2 and concentrated expression of ER81 in 
this layer and the absence of expression of NURR1 (Figure 4.3, Figure 4.7, Figure 4.8). 
However, ROBO1 and SRGAP1 expression was not restricted to the putative Layer V 
at 12 PCW, but only at 15 PCW (Figure 5.7). Thus, the present study in humans only 
finds ROBO1-, SRGAP1- and CTIP2-positive neurones that are restricted to Layer V 
(Figure 5.7) by the time that presumptive ROBO1- and SRGAP1-positive corticospinal 
fibres are crossing the decussation in large numbers (Figure 5.9).   
 
The expression of ROBO1 and SRGAP1 in Layer V of the CP (Figure 5.7) is consistent 
with the findings in rodents, in which Robo1 was expressed at Layer V in P7 mice 
(Schuurmans et al., 2004; Sundaresan et al., 2004) and Layer II and V in P10 rats 
(Whitford et al., 2002), while srGAP1 was primarily expressed at Layer II to V in P7 
mice (Bacon et al., 2009). Expression of ROBO1 and SRGAP1 in superficial layers of 
the CP might also be observed at later stages in human neocortical development not 
studied here. In addition to guiding subcerebral projection neurones, Robo protein was 
found to be responsible for establishing various forebrain commissures in rodents 
(Andrews et al., 2006; Sundaresan et al., 2004; Jones et al., 2002). That a sub-
population of SATB2+ callosal projecting neurones (Alcamo et al., 2008; Britanova et 
al., 2008) co-expressed ROBO1 (Figure 5.7) might suggest its involvement in directing 
this neuronal subtype in Layer V. 
 
Although CTIP2 expression is seen in both Layer V and VI at 15 PCW (Figure 5.7), it 
has been shown to be predominantly expressed in Layer V at 19 PCW in humans 
(Johnson et al., 2009). The change in laminar expression pattern is likely to be under the 
control of two genes; Fezf2, an upstream gene that promotes Ctip2 expression (Chen et 
al., 2008; Leone et al., 2008; Chen et al., 2005a; Molyneaux et al., 2005) and Sox5, 
which was found to regulate and restrict the expression of Fezf2 and Ctip2 from a 
domain spanning the SP, Layer VI and V at E14.5 to only Layer V by P0 in mice 
(Kwan et al., 2008). Similarly, FEZF2 expression is restricted to Layer V in the human 
neocortex at 22 PCW (Kwan et al., 2008) but was shown to be expressed throughout the 
CP in our study at 12 PCW (Figure 5.7). Despite the lack of CTIP2/CTIP2/FEZF2 
181 
 
enrichment in Layer V at this stage, the molecular identities of neurones within this 
layer were already specified, including SATB2+/ROBO1+/CTIP2- or 
SATB2+/ROBO1-/CTIP2- callosal projecting neurones and CTIP2+/ROBO1+/SATB2- 
subcerebral projecting neurones (Figure 5.7). 
 
5.4.4 Is the Anterior Neocortex the Potential Site of Origin of the Motor Cortex 
during the Early Stages of Human Cortical Plate Development? 
 
This chapter provides further extensive evidence for high anterior to low posterior 
expression gradients for ROBO1, SRGAP1 and CTIP2 (Figure 5.3), in addition to our 
previously published evidence for similar gradients for other genes, including S100A10 
and ER81 (Ip et al., 2010a) associated with the development of corticospinal neurones 
but also with all subcerebral projection neurones (Yoneshima et al., 2006; Arlotta et al., 
2005; Hevner et al., 2003). FEZF2 and SOX5, acting upstream to promote and repress 
expression of transcription factors such as CTIP2 in subcerebral projection neurones 
and SP/Layer VI/corticothalamic neurones respectively (Chen et al., 2008; Kwan et al., 
2008; Leone et al., 2008; Chen et al., 2005a; Molyneaux et al., 2005), were not 
expressed in this gradient (Figure 5.3). Why should it be that, as development unfolds, 
gene expression associated with corticofugal axon projections is relatively higher at the 
anterior pole of the neocortex? 
 
It may be that a much higher number of Layer V neurones from frontal cortex are 
corticofugal neurones compared with Layer V neurones at the occipital pole. Retrograde 
tracing has demonstrated that the various motor areas of the frontal lobe make the 
predominant contribution to both corticospinal (Galea and Darian-Smith, 1995; Galea 
and Darian-Smith, 1994) and corticopontine (Glickstein et al., 1985) pathways in the 
adult macaque monkeys, whereas retrograde labelling from the superior colliculus 
results in a patchy distribution of labelled neurones in the visual cortex sometimes 
present at a relatively low density (Lock et al., 2003). This disparity could be reflected 
in relatively higher expression of some corticofugal neurone-related genes anteriorly 
compared to posteriorly. The motor cortex is not found predominantly towards the 
anterior pole of the neocortex in the adult human brain as it is in the rodent. This may be 
because the prefrontal cortex, a much larger structure in the human compared to rodent 
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brain, starts to expand during later stages of development (Fuster, 2002) such that the 
motor cortex location would then begin to shift posteriorly to its adult position anterior 
to the central sulcus. 
 
In order to ensure that the required larger numbers of corticofugal neurones are initially 
specified at anterior pole of the neocortex, regionalisation mechanisms may interact 
with the specification of corticofugal identity by genes such as SOX5 and FEZF2, 
accounting for the observed anterior to posterior expression gradients of 
ROBO1/SRGAP1 and CTIP2 (Figure 5.3). It is known that the conditional KO of the 
transcription factor Sp8, expressed in a high anteromedial to low posterolateral gradient 
across the VZ in mice (Sahara et al., 2007), results in a reduction of Robo1 expression 
in deep layers of the CP at E18.5 (Zembrzycki et al., 2007). Another transcription factor 
PAX6 is expressed in a high anterolateral to low posteromedial gradient in humans at 8 
PCW (Bayatti et al., 2008b) and in mice throughout neocortical development (Bishop et 
al., 2000). Similar phenotypes, in which thalamocortical and corticofugal fibres were 
ventrally misprojected at the diencephalic level in mice at E18.5, have been observed in 
Pax6
-/-
 mutant mice (Jones et al., 2002) and robo1
-/-
robo2
-/-
 double mutants (Lopez-
Bendito et al., 2007). Recently, a more direct relationship between Pax6 and Robo1 has 
been demonstrated in which the expression of Robo1 and -2 in the thalamus is markedly 
reduced in the Pax6
-/-
 mutant mice, which potentially accounts for the misrouted 
thalamocortical projections observed in their previous study (Clegg et al., 2010). In 
addition, Robo2 expression disappears from the neocortical epithelium in the 
homozygous Pax6 mutant at E13 (Jimenez et al., 2002). In humans the PAX6 gradient 
has disappeared by 9 PCW, so although the ROBO1 expression may also be under the 
regulation of PAX6, this may be indirect or under the control of genes downstream of 
PAX6 which exhibit gradients at later stages (Bayatti et al., 2008b). It is noteworthy that 
an isoform of ROBO1 (DUTT1/ROBO1b) was also found to be highly enriched in the 
prefrontal region of the neocortex during late mid-foetal stages in humans (Johnson et 
al., 2009).  
 
A recent study in KO mice (Tomassy et al., 2010) has revealed that the transcription 
factor CouptfI, expressed in a high posterior to low anterior gradient across the 
neocortex in both mice (Armentano et al., 2007) and humans (Ip et al., 2010a), represses 
the differentiation of Layer VI corticothalamic neurones in sensory areas into Layer V 
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corticofugal neurones by inhibiting expression of Ctip2 and Fezf2, such that, in the 
absence of CouptfI function, presumptive corticothalamic neurones abnormally display 
the molecular features and projection patterns of  corticospinal neurones. At the same 
time, Layer V neurones in the sensorimotor cortex fail to develop into corticospinal 
neurones. Therefore, the observation of a high anterior to low posterior gradient in 
CTIP2 expression between 8-12 PCW (Figure 5.3) may reflect necessary suppression of 
CTIP2 expression by COUPTFI in Layer VI of the posterior, sensory cortex. 
 
Elevated expression of ROBO1, SRGAP1 and CTIP2 by corticospinal neurones 
compared to other corticofugal projection neurones may be required for growth and 
maintenance of the CST beyond the pons and across the medullary decussation (Lopez-
Bendito et al., 2007; Arlotta et al., 2005), whereas the other major neocortical 
subcerebral projections terminate, in maturity, predominantly ipsilaterally in the 
mesencephalon and pons. In the rodent early neocortical development, all of the Layer 
V neurones of the neocortex project to the spinal cord but subsequently selective axon 
pruning reduces the origins of the CST to the sensorimotor cortex (Oudega et al., 1994). 
There is no direct evidence that this is also the case in humans, however a recent study 
found that an early lesion to the frontal and parietal cortex resulted in the formation of 
direct connections from occipital cortex to spinal cord motoneurones from the same 
hemisphere (Basu et al., 2010). This could represent retention of a pathway normally 
removed during development. Regionalised expression of specific cell-cell signalling 
molecules such as ROBO1/SRGAP1 (Figure 5.3) may protect corticospinal axons from 
retraction from the spinal cord and promote their removal from inappropriate target 
areas, in the same way as regionalised expression of Plexin 3A and -4A in the rodent 
visual cortex that promotes pruning of their corticospinal projections and protection of 
appropriate projections to the superior colliculus (Low et al., 2008). However, the 
plasticity of corticospinal development under pathological or experimental conditions 
(Basu et al., 2010; Li et al., 1995; Sharkey et al., 1986) suggests that genetically 
specified regionalisation mechanisms can be overridden by epigenetic influences. 
 
Defining the temporal and spatial expression patterns of genes that specify the 
phenotype of corticofugal neurones especially the corticospinal neurones will be 
invaluable in understanding how lesions and infections can perturb the protomap during 
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neocortical development, and how to produce corticospinal neurones from stem cells for 
the repair of brain following neonatal hypoxia or adult stroke. The chapter provides 
evidence for the localized expression of genes associated with corticofugal neurones in 
the early stages of human neocortical development. The next step will be to probe the 
mechanisms that regulate the expression of these genes in-vitro in human neocortical 
cell cultures. 
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Chapter 6  Characterization of Human in-vitro Regionalisation Model 
and its Application 
 
6.1 Introduction 
 
6.1.1 Fibroblast Growth Factor System 
 
The FGF signalling is intriguing due to the differential molecular and biochemical 
properties, spatiotemporal distribution, affinities/specificities of the ligands (FGFs) and 
their receptors (FGFRs) across the developing neocortex as well as the diverse 
downstream signalling pathways.  
 
There are 22 members of FGFs (FGF1-23; human FGF19 and mouse Fgf15 are 
orthologous genes) in mice and humans which can be grouped on the basis of the 
evolutionary relatedness of their sequences into 7 subfamilies via phylogenetic analysis, 
or 6 subfamilies via analysis of the location of genes on chromosomes, or 4 subfamilies 
based on their mechanisms of release from cells (Itoh, 2007; Stachowiak et al., 2007; 
Itoh and Ornitz, 2004). The genes encode proteins that contain about 150-300 amino 
acids (aa), accounting for their size differences. The proteins have a 120-aa conserved 
domain with 30-70% aa sequence identity (Itoh, 2007; Itoh and Ornitz, 2004). Among 
them, Fgf2 and Fgf8 play a vital role in early stages of corticogenesis such as 
proliferation, differentiation and patterning. Their expression is detected at high level 
early in the developing rodent brains, with Fgf2 expression more widespread throughout 
the developing neural tube by both proliferating and differentiating cells and Fgf8 
expression more confined to specific regions of the developing CNS by proliferating 
cells (Ford-Perriss et al., 2001). In-vitro studies have shown that Fgf2 stimulates the 
proliferation of neural crest cells directly  in the presence of serum (Murphy et al., 1994) 
and controls the proliferative and differentiative division of neocortical neural precursor 
cells in a dose-dependent manner, in which low Fgf2 concentrations result in 
proliferation and high Fgf2 concentrations cause cells to differentiate, expressing 
markers for neurones and astrocytes (Murphy et al., 1990a). In addition, the lineage 
differentiation of neocortical progenitors is also regulated by different dosages of Fgf2: 
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lower Fgf2 concentrations lead to neuronal differentiation predominantly, whereas 
higher, threshold level of Fgf2 stimulates oligodendroglial production (Qian et al., 
1997). In-vivo studies of Fgf2 micro-injection and Fgf2
-/-
 null mice demonstrate that the 
number of rounds, but not the cell cycle length of division, of neocortical progenitors is 
regulated by this factor during early neurogenesis (Raballo et al., 2000; Vaccarino et al., 
1999). However, a later in-vitro study suggested otherwise that Fgf2 also regulates cell 
cycle pro- and anti-mitogenic regulators such as cyclin D1 and p27 to achieve 
proliferation of neocortical precursor cells in rat (Li and DiCicco-Bloom, 2004). Fgf2 is 
thought to also regulate post-mitotic differentiation such as axonal growth (Kawamata 
et al., 1997). More recently, a study has shown in rat that Fgf2 is able to induce 
functional recovery from neonatal motor cortex injury, possibly via restoration of the 
corticospinal connectivity from the refilled but non-stratified lesioned region of the 
motor cortex to the cervical spinal cord with the re-grown fibre projection (Monfils et 
al., 2008). As described in Chapter 1, Fgf8 is an important secreted ligand that is highly 
expressed in the anterior patterning centre (ANR/CoP) and involved in the patterning of 
the brain during early corticogenesis (Crossley et al., 2001; Fukuchi-Shimogori and 
Grove, 2001). A recent study, in another patterning centre situated at the 
mesencephalic-rhombencephalic boundary, has shown that Fgf8 can regulate the 
anteriorly-directed growth of midbrain dopaminergic axons, by inducing expression of 
axon guidance molecules such as sema3F (Yamauchi et al., 2009). 
 
The receptors for FGFs are known as FGFRs and have three immunoglobulin-like (Ig) 
loops flanking an acidic box extracellularly, a single transmembrane domain, and 
intracellular tyrosine kinase domains (Eswarakumar et al., 2005). In contrast to the vast 
amount of ligand subtypes, there are only four subtypes of FGFRs (FGFR1-4) identified 
in mice and humans that are encoded by four genes independently (Itoh and Ornitz, 
2004). Among them, only FGFR1-3 are present in the mammalian forebrain during 
development and each of the FGFR1-3 has an isoform which arises from alternative 
splicing of the exon corresponding to the third of the Ig domain (Ig-III), generating 
receptor isoforms IIIb or IIIc of each FGFR1-3 (Iwata and Hevner, 2009; Itoh and 
Ornitz, 2004). Other proteins have been identified to bind FGFs or FGFRs including: 
heparin sulphate proteoglycans (HSPGs), that act as co-receptors (Allen and Rapraeger, 
2003; Ford-Perriss et al., 2002); Klotho proteins, which are novel transmembrane 
proteins acting as co-receptors for binding of endocrine FGFs to FGFRs (Kuro-o, 2008); 
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and cell adhesion molecules (CAMs)/cadherins, interacting with the acidic box of 
FGFRs (Sanchez-Heras et al., 2006; Cavallaro and Christofori, 2004). Across the 
mammalian developing neocortex, FGFRs (1-3) are expressed by progenitor cells with 
some of them being differentially regulated. In both rodents and humans, Fgfr3/FGFR3 
expression is detected at higher level in the posterolateral region of the developing 
neocortex (Ip et al., 2010a; Iwata and Hevner, 2009; Fukuchi-Shimogori and Grove, 
2003). No graded expression of Fgfr1 and higher expression of Fgfr2 is only detected in 
the lateral region of the rodent developing neocortex (Iwata and Hevner, 2009; Hebert et 
al., 2003; Vaccarino et al., 1999). However in humans, we have reported small but 
significant differences of FGFR1 and -2 expression between the anterior and posterior 
poles of the developing neocortex: FGFR1 expression being higher anteriorly while 
FGFR2 expression being higher posteriorly (Chapter 3; (Ip et al., 2010a)). Fgfr3 was 
originally thought to play a role in regionalisation due to its graded expression pattern 
across the rodent developing neocortex, but rather it is shown to be involved in 
regulating the proliferation of neocortical progenitors during embryonic development in 
rodents as illustrated by a remarkable enlargement of the brain which is due to an 
increased rate of proliferation paralleled by a decreased rate of developmental apoptosis 
in mutants with Ffgr3 kinase domain mutation (Thomson et al., 2007; Inglis-Broadgate 
et al., 2005). Recently, a study using Xenopus laevis has shown the importance of the 
Fgfr in maintenance of axon guidance cues during development since broad inhibition 
of the Fgfr function causes the expression of xsema3A and xslit1 to decrease, which is 
accompanied by a failure of the axons of retinal ganglion cells to project beyond the 
mid-diencephalon (Atkinson-Leadbeater et al., 2010). 
 
Upon binding of FGFs, FGFRs undergo homodimerization and autophosphorylation 
that activates a range of downstream signalling pathways differentially. i) The mitogen-
activated protein kinase (MAPK) cascade is one of the major downstream pathways 
which regulate proliferation/differentiation and expression of a number of genes 
downstream of Fgfs (Iwata and Hevner, 2009; Mason, 2007; Thomson et al., 2007; 
Eswarakumar et al., 2005). Furthermore, some interesting studies have shown the 
inhibition of Fgf2-induced MAPK downstream signalling pathway via MEK inhibitor 
or elevation of intracellular cyclic adenosine monophosphate (cAMP) levels would 
drive the glial cells from proliferation to functional differentiation and up-regulate 
expression of glutamate transporters in neocortical astroglial culture in-vitro, a potential 
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mechanism of neuroprotection in the case of neuroexcitotoxicity (Figiel et al., 2003; 
Bayatti and Engele, 2001). ii) phosphatidylinositol-3 (PI3) kinase-Akt pathway 
promotes the survival and proliferation of cells (Brader and Eccles, 2004); iii) 
Phospholipase Cγ (PLCγ) pathway activates protein kinase C (PKC) and triggers 
calcium signalling (Iwata and Hevner, 2009); and iv) Rac-cdc42-Rho pathway mediates 
cell adhesion and migration via cytoskeletal remodelling (Iwata and Hevner, 2009).  
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6.2 Aim of Study 
 
6.2.1 Characterization of Human in-vitro Regionalisation Model 
 
Previous work using an Affymetrix whole genome chip array (Figure 1.13; (Ip et al., 
2010a) and rtPCR (Figure 3.3; (Ip et al., 2010a)) to analyze the gradients of gene 
expression in developing neocortical tissue between 8 and 12.5 PCW has identified and 
confirmed some potential anterior and posterior markers during human neocortical 
development, supporting the protomap theory (Rakic et al., 2009; Rakic, 1991). The aim 
of the first half of this chapter was to assess whether these intrinsically-regulated 
putative markers would exhibit similar expression profile outside their normal 
physiological environment. 
 
The objectives were:  
1) to establish an in-vitro human cell culture model of regionalisation by dissecting 
tissue from anterior and posterior neocortex aged 11 PCW, dissociating and 
culturing in isolation. 
2)  to characterize this cell culture model by IHC of cells for various characteristic 
proteins: GFAP for astrocytes, Nestin for neural progenitors and MAP2 for 
neurones. 
3) to confirm the maintenance of intrinsic molecular identities of cells isolated from 
the anterior neocortex by double-immunofluorescent labelling for CTIP2, ROBO1 
and SRGAP1 which are known to be associated with corticofugal neurones 
(Chapter 5), together with the above markers used.  
4) to confirm the maintenance of intrinsic regional identities of cells out of their 
environment by rtPCR and IHC for the examination of expression levels of a 
subset of genes/proteins for which graded expression patterns had been previously 
confirmed by rtPCR in neocortical tissue (Chapter 3).  
 
Once the cell culture model was successfully establishes and characterized, it could then 
be utilized for the study of gene regulation, in order to identify potential mechanisms 
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controlling the expression of some putative anterior and posterior markers in the 
developing human neocortex. 
 
6.2.2 Preliminary study: Application of Human in-vitro Regionalisation Model 
 
The specificities/affinities of different FGFs binding to their FGFRs is intriguing as they 
are not identical, for example Fgf2 preferentially binds to Fgfr1, whereas Fgf8 binds 
with stronger affinity to Fgfr3 (Iwata and Hevner, 2009). As FGFR1 and -3 showed 
differential expression across the developing neocortex in humans (Chapter 3; (Ip et al., 
2010a)), cultured cells isolated from the anterior and posterior poles of the developing 
human neocortex, if they had maintained their intrinsic regional identities, would 
express these FGFRs at different levels. Thus, when stimulating these cells with FGF2 
or -8, differential activation of FGFR1 or -3 would result and potentially initiate 
different downstream signalling cascades in the anteriorly- and posteriorly-derived cells 
(Fortin et al., 2005).  
 
Since FGFs system is shown to be important in the guidance of various axonal 
projections during neocortical development, we initiated a preliminary investigation 
into the potential of FGF signalling in regulating the expression of some corticofugal 
neurone-associated genes that were expressed highly in the anterior neocortical tissues 
(CTIP2, ROBO1 and SRGAP1). We hypothesized that FGFs is potentially regulating the 
expression of these corticofugal neurone-associated genes, and tested the involvement 
of MAPK downstream signalling pathway. Furthermore, given the differences in 
biochemical properties and spatiotemporal expression patterns of FGFs/FGFRs within 
the developing neocortex, we sought to test the hypothesis that FGFs regulate these 
corticofugal neurone-associated genes differentially in the anterior and posterior region 
of the neocortex. Finally, the effects of FGFs on the expression of genes encoding their 
cognate receptors, FGFRs were also investigated. 
  
The objectives of the second half of this chapter were to use our established human in-
vitro regionalisation model in order to: 
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1) investigate the changes in expression levels of the corticofugal neurone-associated 
genes and genes encoding receptors of FGFs in the anteriorly- and posteriorly-
derived cells by rtPCR after FGF2 or -8 treatments for 24 hours and 72 hours in 
comparison to the non-treated cells that has been cultured for the same period of 
time.  
2) look into the effect of blocking the MAPK pathway on the expression levels of the 
corticofugal neurone-associated genes and genes encoding receptors of FGFs in 
the anteriorly- and posteriorly-derived cells by rtPCR after administration of the 
MEK inhibitor, U0126, together with FGF2 or -8 treatments for 24 hours and 72 
hours in comparison to cells treated with U0126 only and has been cultured for 
the same period of time. 
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6.3 Results 
 
6.3.1 Characterization of Human Neocortical Dissociated Cultures 
 
Immunoperoxidase-histochemistry 
 
A putative in-vitro model of human regionalization was established by initiating human 
neocortical cultures using dissected and dissociated anterior and posterior slices of 
human neocortex aged 11 PCW (Figure 6.1A). Cell cultures were maintained in 
MEM:10% FCS for 24 h followed by 3 DIV in serum-free MEM:F12 medium 
supplemented with B27. Cell cultures were initially characterized by testing 
immunoreactivity for GFAP, Nestin, and MAP2, markers of astrocytes, neural 
progenitors and neurones, respectively (Figure 6.1A). Cell counts were also carried out 
and indicate that MAP2-positive neurones account for the majority of cells cultured 
(75.1 ± 6.1%), while presumably overlapping populations of Nestin- and GFAP- 
positive cells accounted for 26.6 ± 4.8% and 19.2 ± 2.75%, respectively. There were no 
observable differences in the levels of these genes when comparing anteriorly- and 
posteriorly-derived cultures (Figure 6.1C).  
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Figure 6.1. Characterization of human neocortical cultures. 
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Neuronal cell cultures were initiated from 11 PCW (n=4) human neocortex and maintained for 3 
DIV. Panels in (A) depicts cells under phase contrast, and stained with antibodies for GFAP, 
NESTIN and MAP2. (B) Cell counts from random fields of vision (n=4) indicate that MAP2-
positive neurones account for most of the cells in culture (75.1 ± 6.1%), while GFAP- and 
Nestin-positive cells account for 19.2 ± 2.75% and 26.6 ± 4.8%, respectively. In each case, 
immunopositive cells are indicated by filled arrowheads, and examples of negatively stained 
cells are indicated by empty arrowheads. (C) Cell counts from random fields of vision (n=4) 
indicate that cultures derived from anterior and posterior region of the neocortex contained 
similar number of GFAP-, MAP2- and Nestin-positive cells. Scale bars: 20 µm. Adapted from 
(Ip et al., 2010a). 
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Immunofluorescent-histochemistry 
 
To confirm the maintenance of intrinsic molecular identities of cells in in-vitro 
condition, the dissociated cultures initiated from the anterior neocortex were then 
further characterized by double-labelling of CTIP2, that is associated with corticofugal 
neurones, with neural progenitor marker Nestin and astrocytic marker GFAP (Figure 
6.2A, B). The post-mitotic corticofugal neurone-associated marker CTIP2 was not 
expressed by neural progenitors or astrocytes as cells expressing CTIP2 did not co-
express Nestin (Figure 6.2A) nor GFAP (Figure 6.2B) respectively. Note that double-
labelling was also carried out with CTIP2 and MAP2 antibodies. However, 
immunostaining of MAP2 did not yield a satisfactory fluorescent signal and only one 
sample was available, so there is no data regarding the co-localization of CTIP2 and 
MAP2. 
 
On the other hand, a subpopulation of cells co-expressed some corticofugal neurone-
associated markers: CTIP2 (nucleic localization) with ROBO1 (cytoplasmic localization, 
filled arrow, Figure 6.2C) and CTIP2 (nucleic localization) with SRGAP1 (cytoplasmic 
localization, filled arrow, Figure 6.2D), mimicking the immunoreactivity patterns 
observed in tissue sections (Figure 5.6C and D).  
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Figure 6.2. Confirmation of intrinsic molecular identities of cells derived from human 
neocortical cultures. 
Double immunofluorescence was carried out for corticofugal neurone-associated markers with 
Nestin and GFAP on cultures derived from tissue dissected from the anterior poles of 11 PCW 
aged neocortex (n=1). CTIP2 did not co-localize with Nestin (A) nor with GFAP (B) in these 
cells. On the other hand, some cells were co-expressing the corticofugal neurone-associated 
markers CTIP2 (nucleic localization)/ROBO1 (cytoplasmic localization, arrow, C), as well as 
CTIP2 (nucleic localization)/SRGAP1 (cytoplasmic localization, arrow, D). Scale bars: 20 µm. 
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6.3.2 Confirmation of a Subset of Regulated Markers in Human Neocortical 
Dissociated Culture by Immunocytochemistry 
 
To analyze whether neocortical cells maintain their genetic ⁄ regional identities when 
removed from their natural physiological and anatomical environment, cultures were 
analyzed for immunoreactivity to EMX2 and PAX6, putative regionalization markers, 
as well as CTIP2, the anteriorly up-regulated corticofugal neurone-associated marker 
(Figure 6.3A). Cell counts from random fields of view (n=4 for each) indicated 
differences in levels of EMX2 and CTIP2 but not PAX6 when comparing anteriorly- 
and posteriorly-derived cultures (Figure 6.3B). The percentage of cells immunoreactive 
for EMX2 was significantly higher in cell cultures derived from the posterior neocortex 
(80.7 ± 3.0%) as compared with cultures initiated from the anterior neocortex (37.9 ± 
18.3%) indicating a 2.13-fold increase (posterior vs. anterior) between the two cultures. 
The percentage of cells immunoreactive for CTIP2 was slightly but significantly higher 
in cell cultures derived from the anterior neocortex (71.2 ± 5.1%) as compared with 
cultures initiated from the posterior neocortex (53.4 ± 4.7%) indicating a 1.33-fold 
increase (anterior vs. posterior) between the two cultures. PAX6, however, exhibited no 
significant differences between cultures (anterior, 49.37 ± 3.6%; posterior, 57.4 ± 0.9%, 
0.86-fold, anterior vs. posterior). 
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Figure 6.3. Anteriorly- and posteriorly-derived human neocortical cultures exhibit 
differences in EMX2 and CTIP2 but not in PAX6 expression. 
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Immunohistochemistry was carried out for EMX2, PAX6 and CTIP2 on cultures derived from 
tissue dissected from the anterior and posterior poles of 11 PCW aged neocortex (n=4) (A). (B) 
Cell counts carried from random fields of vision (n=4 per anterior and posterior) show a 
significant increase in numbers of cells expressing EMX2 (filled arrowheads in A) posteriorly 
than anteriorly whereas the numbers of CTIP2-positive cells (filled arrowheads in A) were 
slightly but significantly highly in anteriorly- than posteriorly-derived culture. However, PAX6 
(filled arrowheads in A) showed no differences between cultures. EMX2-, PAX6- or CTIP2-
negative cells are indicated by empty arrowheads in A. Scale bar: 20 µm. Student‟s paired t-test, 
*p ≤ 0.05. Adapted and modified from (Ip et al., 2010a). 
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6.3.3 Confirmation of gDNA-free cDNA Samples used for rtPCR in 
Characterization of Human in-vitro Regionalisation Model 
 
To ensure all cDNA samples from cells derived from anterior and posterior human 
neocortex aged 11 PCW used for rtPCR were not contaminated by gDNA, standard 
PCR assay was employed with SDHA primer set. The FP and RP of SDHA targeted 
sequences on exon 2 and exon 3 of SDHA respectively. Thus samples with gDNA 
would yield products containing intron sequence and of around 940 bp. A positive 
control was incorporated with a human gDNA sample instead of cDNA samples. A 
band between 850-1000 bp indicated the amplified product of the gDNA positive 
control (filled arrow, Figure 6.4). The majority of cDNA samples (white line, Figure 
6.4) gave rise only to bands below 100 bp (except the sample indicated by an empty 
arrow, Figure 6.4) which were equivalent to the size of SDHA cDNA (84 bp, Table 2.3). 
Thus these cDNA samples used for rtPCR were gDNA-free. The sample containing 
gDNA (empty arrow, Figure 6.4) was subjected to re-extraction until complete 
elimination of gDNA prior to rtPCR. 
 
 
Figure 6.4. Confirmation of gDNA-free cDNA samples from characterized cultured cells 
used for rtPCR. 
Amplified products of SDHA using standard PCR assay. Product of positive control with human 
gDNA was indicated by filled arrow, whereas cDNA samples from cells derived from anterior 
and posterior neocortex aged 11 PCW (n=4) used for rtPCR were indicated by white lines. The 
sample derived from cells containing gDNA was indicated by empty arrow. 1kb Plus DNA 
ladder was used to determine the size of bands. 
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6.3.4 Confirmation of a Subset of Regulated Markers in Human Neocortical 
Dissociated Culture by rtPCR  
 
At mRNA level, rtPCR was performed on reverse transcribed RNA extracted from cell 
cultures initiated from 11 PCW aged neocortex and maintained for 3 DIV (Figure 6.5). 
Examining some of the genes as characterized in-vivo, a similar pattern of results to that 
of tissue was obtained when comparing expression levels in anteriorly- and posteriorly-
derived cultures. CNTNAP2 (2.67-fold), CTIP2 (2.78-fold), PCDH17 (3.92-fold), 
ROBO1 (2.01-fold) and S100A10 (2.76-fold) were found to be significantly higher in 
anteriorly- than posteriorly-derived cultures. FGFR1 (1.32-fold) was found to be 
marginally but significantly expressed at higher levels anteriorly (Figure 6.5B). The 
posterior markers COUPTFI (10.18-fold), EMX2 (1.73-fold) and FGFR3 (59.28-fold) 
exhibited significantly higher expression when compared to anteriorly-derived cultures 
(Figure 6.5A, B). Six of the genes, FEZF2, FGFR2, MAP2, PAX6, SOX5 and SRGAP1 
exhibited no statistically significant difference in expression either anteriorly or 
posteriorly.  
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Figure 6.5. rtPCR confirmation for a subset of differentially regulated genes during early 
human neocortical development in cultures derived from 11 PCW human neocortex. 
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Table indicating fold changes (A), and graphical representation (B) of NRQ of a subset of genes 
determined by rtPCR from RNA extracted from anteriorly- and posteriorly-derived cultures of 
human neocortex aged 11 PCW (n=4). CNTNAP2, CTIP2, PCDH17, ROBO1 and S100A10 
exhibited a high anterior to low posterior gradient. COUPTFI, EMX2 and FGFR3 exhibited a 
high posterior, low anterior gradient. No gradients were detected for FEZF2, FGFR2, MAP2, 
PAX6, SOX5 and SRGAP1. Student‟s t-test, *p≤ 0.05, n.d., not detected; A, anterior; P, 
posterior. . Adapted and modified from (Ip et al., 2010a). 
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6.3.5 Confirmation of gDNA-free cDNA Samples used for rtPCR in Gene 
Regulation Study 
 
To ensure all cDNA samples from stimulated cells derived from anterior and posterior 
human foetal neocortex used for rtPCR were not contaminated by gDNA, standard PCR 
assay was employed with SDHA primer set. The FP and RP of SDHA targeted 
sequences on exon 2 and exon 3 of SDHA respectively. Thus samples with gDNA 
would yield products containing intron sequence and of around 940 bp. The majority of 
cDNA samples from stimulated cells derived from anterior and posterior neocortex aged 
10-12 PCW (white lines, Figure 6.6) gave rise only to bands below 100 bp (except the 
sample indicated by empty arrow, Figure 6.6) which were equivalent to the size of 
SDHA cDNA (84 bp, Table 2.3). Thus these cDNA samples used for rtPCR were 
gDNA-free. The sample containing gDNA (empty arrow, Figure 6.6) was subjected to 
re-extraction until complete elimination of gDNA prior to rtPCR. 
 
 
Figure 6.6. Confirmation of gDNA-free cDNA samples from treated cells used for rtPCR. 
Amplified products of SDHA using standard PCR assay. cDNA samples from anteriorly- and 
posteriorly-derived cells treated variously for 24 or 72 hours (hr) were indicated by white lines 
(10 PCW, n=1; 11 PCW, n=1; 12 PCW, n=1). The sample derived from cells containing gDNA 
was indicated by empty arrow. 1kb Plus DNA ladder was used to determine the size of bands. 
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6.3.6 Effects of FGFs and/or MEK Inhibitor on Expression of Reference Genes 
 
To confirm the expression of the three reference genes, β-ACTIN, GAPDH and SDHA, 
in cultured neocortical cells was not influenced by the addition of FGFs and/or the 
MEK inhibitor, U0126, their cycle threshold (Ct) values obtained after rtPCR were 
compared between different treatment groups. Ct value was inversely proportional to 
the expression level of a gene.  
 
After different treatments to cells derived anteriorly (for 24 and 72 hours, Figure 6.7A 
and B) and posteriorly (for 24 and 72 hours, Figure 6.7C and D), the averaged Ct values 
of each reference genes from the 3 samples aged 10, 11 and 12 PCW were consistent, 
indicating there was no change in the expression of reference genes in cells subjected to 
various treatments as compared to the non-treated control groups. 
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Figure 6.7. Ct values of reference genes in different groups of cultured cell. 
Graphical representation of cycle threshold (Ct) values of reference genes β–ACTIN (blue), 
GAPDH (pink) and SDHA (green) determined by rtPCR from RNA extracted from anteriorly- 
(A, B) and posteriorly- (C, D) derived cultures of human neocortex aged 10 (n=1), 11 (n=1) and 
12 (n=1) PCW for 24 and 72 hours. C, non-treated control groups; C+U, U0126-treated alone 
groups; FGF2, FGF2-treated groups; FGF2+U, FGF2 and U0126-treated groups; FGF8, FGF8-
treated groups; FGF8+U, FGF8 and U0126-treated groups. 
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6.3.7 Regulation of Corticofugal Neurone-associated Genes and Fibroblast 
Growth Factor Receptor Genes Expression by FGF Signalling 
 
rtPCR was performed on reverse transcribed RNA extracted from cell cultures initiated 
from the anterior and posterior neocortex aged 10-12 PCW, which were treated with 
FGF2 (20 ng/ml) or FGF8 (20 ng/ml) in the presence or absence of U0126 (10 µM), a 
MEK inhibitor, for 24 or 72 hours and used for the preliminary studies of gene 
expression regulation (Table 2.2).  
 
The effects of FGFs treatment on gene expression were determined by calculating the 
fold changes of expression level of each gene in FGFs-treated groups in comparison to 
the control groups (i.e. FGFs/C). The trend and magnitude of fold changes in gene 
expression were graphically presented in which significant and/or ≤ -1.5-/≥ 1.5-fold 
changes indicated the down- and up-regulation of gene expression after stimulation with 
FGF2 or FGF8. Similarly, the effects of blocking FGFs-induced MAPK signalling 
pathways on gene expression were determined by calculating the fold changes of 
expression level of each gene following stimulation with FGFs in the presence of 
U0126 in comparison to control groups which were treated with U0126 alone (i.e. 
FGFs+U/C+U).  
 
Comparisons of fold changes between FGFs/C and FGFs+U/C+U were carried out to 
determine if the changes in gene expression induced by FGFs were MAPK signalling-
dependent or -independent. Any inhibition of putative FGFs-induced up- or down-
regulation of gene expression by U0126 would indicate a dependence on the MAPK 
intracellular signalling pathway. This was carried out by comparison of fold changes 
between FGFs/C and FGFs+U/C+U groups and indicated by statistical significant 
differences and/or ≥ 0.5 in fold change differences between the two groups.  
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Effects of FGF2 Signalling on Expression of CTIP2, ROBO1 and SRGAP1 
 
After 24 hours of FGF2 stimulation, expression of CTIP2 was down-regulated by 1.63- 
and 1.72-fold in the anteriorly- and posteriorly-derived cells respectively (Figure 6.8A). 
Prolonged FGF2 stimulation (72 hours) down-regulated the expression of CTIP2 by 
2.22- and 4.72-fold in the anteriorly- and posteriorly-derived cells respectively (Figure 
6.8A). The FGF2-induced down-regulation of CTIP2 expression appeared to be 
inhibited by U0126 in the anteriorly-derived cells after 24-hour treatment and was 
significantly inhibited after 72 hours (Figure 6.8A). However, the inhibition by U0126 
was only observed in the posteriorly-derived cells after 72 hours (Figure 6.8A). Thus 
the down-regulation of CTIP2 expression induced by FGF2 occurred at all time points 
anteriorly and posteriorly, and the down-regulation of CTIP2 expression was potentially 
dependent on MAPK signalling. 
 
 Expression of ROBO1 in the anteriorly-derived cells was not influenced by short- and 
long-term FGF2 stimulation (Figure 6.8B). Whereas in the posteriorly-derived cells, 
ROBO1 expression was up-regulated marginally but significantly by 1.39-fold after 24-
hour stimulation of FGF2, and prolonged FGF2 stimulation (72 hours) up-regulated 
ROBO1 expression significantly by 2.02-fold (Figure 6.8B). The FGF2-induced up-
regulation of ROBO1 expression was inhibited by U0126 after 72 hours only in the 
posteriorly-derived cells (Figure 6.8B). Thus the up-regulation of ROBO1 expression 
induced by FGF2 only occurred posteriorly, and the substantial up-regulation of 
ROBO1 expression observed after the long-term FGF2 stimulation was potentially 
dependent on MAPK signalling.  
 
In the anteriorly-derived cells, expression of SRGAP1 was significantly down-regulated 
by 1.56-fold only after a prolonged FGF2 stimulation (72 hours) (Figure 6.8C). 
Whereas in the posteriorly-derived cells, SRGAP1 expression was already down-
regulated by 1.50-fold after stimulation of FGF2 for 24 hours, and by 2.38-fold after an 
extended treatment of FGF2 for 72 hours (Figure 6.8C). The FGF2-induced down-
regulation of SRGAP1 expression was all inhibited by U0126 in the anteriorly- and 
posteriorly-derived cells after 72 hours and significantly in the posteriorly-derived cells 
after 24 hours (Figure 6.8C). Thus the down-regulation of SRGAP1 expression induced 
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by FGF2 occurred anteriorly and primarily in the posteriorly-derived cells, and the 
observed down-regulation of SRGAP1 expression was potentially dependent on MAPK 
signalling. 
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Figure 6.8. Spatiotemporal effects of FGF2 signalling on CTIP2, ROBO1 and SRGAP1 
expression. 
Graphical representation of fold changes of CTIP2 (A), ROBO1 (B) and SRGAP1 (C) 
expression determined by rtPCR from RNA extracted from anteriorly- and posteriorly-derived 
cultures of human neocortex aged 10 (n=1), 11 (n=1) and 12 (n=1) PCW, which have been 
treated with FGF2 in the presence or absence of U0126 for 24 and 72 hours (24hr/72hr). Blue 
bars represented the fold changes in gene expression after FGF2 stimulation in comparison to 
non-treated control groups (FGF2/C). Pink bars represented the fold changes in gene expression 
after FGF2 stimulation in the presence of U0126 in comparison to U0126-treated alone groups 
(FGF2+U/C+U). Red dotted lines indicated 1.5-fold increase or decrease of expression level. # 
indicated significant differences of expression level between FGF2 and control groups or 
FGF2+U and C+U groups (p≤ 0.05). * indicated significant differences of fold changes between 
FGF2/C and FGF2+U/C+U (p≤ 0.05). A, anterior; P, posterior. 
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Effects of FGF8 Signalling on Expression of CTIP2, ROBO1 and SRGAP1 
 
After 24 hours of FGF8 stimulation, expression of CTIP2 was down-regulated by 1.57-
fold in the anteriorly-derived cells and a prolonged FGF8 stimulation (72 hours) down-
regulated expression of CTIP2 by 1.91-fold in these cells (Figure 6.9A). Whereas in the 
posteriorly-derived cells, CTIP2 expression was down-regulated by 2.13-fold only after 
72 hours of FGF8 stimulation (Figure 6.9A). The FGF8-induced down-regulation of 
CTIP2 expression was inhibited by U0126 only in the anteriorly-derived cells after 24 
hours (Figure 6.9A). Note that the expression of CTIP2 was significantly down-
regulated by 1.86-fold when the anteriorly-derived cells were treated with both FGF8 
and U0126 for 72 hours (Figure 6.9A). Thus the down-regulation of CTIP2 expression 
induced by FGF8 occurred both anteriorly and posteriorly, and the down-regulation of 
CTIP2 expression anteriorly after 24 hours was potentially dependent on MAPK 
signalling. 
 
Expression of ROBO1 in the anteriorly- and posteriorly-derived cells was not influenced 
by short- and long-term FGF8 stimulation alone (Figure 6.9B). However ROBO1 
expression was marginally but significantly up-regulated by 1.47-fold when the 
anteriorly-derived cells were treated with both FGF8 and U0126 for 24 hours (Figure 
6.9B). Thus the up-regulation of ROBO1 expression was induced by FGF8, however the 
intracellular signalling pathways involved were potentially under the repression of 
MAPK signalling. 
 
In the anteriorly-derived cells, expression of SRGAP1 was slightly but significantly 
down-regulated by 1.27-fold only after a prolonged FGF8 stimulation (72 hours) 
(Figure 6.9C). Similarly in the posteriorly-derived cells, SRGAP1 expression was down-
regulated by 1.58-fold after an extended stimulation of FGF8 for 72 hours (Figure 6.9C). 
The addition of U0126 did not inhibit the FGF8-induced down-regulation of SRGAP1 
expression anteriorly or posteriorly (Figure 6.9C). Thus the down-regulation of 
SRGAP1 expression induced by the long-term stimulation of FGF8 occurred both 
anteriorly and posteriorly, however the down-regulation was independent of MAPK 
signalling. 
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Figure 6.9. Spatiotemporal effects of FGF8 signalling on CTIP2, ROBO1 and SRGAP1 
expression. 
Graphical representation of fold changes of CTIP2 (A), ROBO1 (B) and SRGAP1 (C) 
expression determined by rtPCR from RNA extracted from anteriorly- and posteriorly-derived 
cultures of human neocortex aged 10 (n=1), 11 (n=1) and 12 (n=1) PCW, which have been 
treated with FGF8 in the presence or absence of U0126 for 24 and 72 hours (24hr/72hr). Blue 
bars represented the fold changes in gene expression after FGF8 stimulation in comparison to 
non-treated control groups (FGF8/C). Pink bars represented the fold changes in gene expression 
after FGF8 stimulation in the presence of U0126 in comparison to U0126-treated alone groups 
(FGF8+U/C+U). Red dotted lines indicated 1.5-fold increase or decrease of expression level. # 
indicated significant differences of expression level between FGF8 and control groups or 
FGF8+U and C+U groups (p≤ 0.05). * indicated significant differences of fold changes between 
FGF8/C and FGF8+U/C+U (p≤ 0.05). A, anterior; P, posterior. 
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Effects of FGF2 Signalling on Expression of FGFR1, FGFR2 and FGFR3 
 
After 24 hours of FGF2 stimulation, expression of FGFR1 was up-regulated by 1.94- 
and 2.29-fold in the anteriorly- and posteriorly-derived cells respectively (Figure 6.10A). 
Prolonged FGF2 stimulation (72 hours) up-regulated the expression of FGFR1 by 5.97- 
and 4.25-fold in the anteriorly- and posteriorly-derived cells respectively (Figure 6.10A). 
The FGF2-induced up-regulation of FGFR1 expression was inhibited by U0126 in the 
anteriorly- and posteriorly-derived cells only after 72 hours (Figure 6.10A). Thus the 
up-regulation of FGFR1 expression induced by FGF2 occurred at all time points 
anteriorly and posteriorly, however only the substantial up-regulation of FGFR1 
expression after the prolonged FGF2 stimulation was potentially dependent on MAPK 
signalling. 
 
 Expression of FGFR2 in the anteriorly-derived cells was down-regulated by 2.80- and 
4.46-fold after 24 and 72 hours of FGF2 stimulation (Figure 6.10B). Whereas in the 
posteriorly-derived cells, FGFR2 expression was down-regulated by 3.36-fold only 
after 72-hour stimulation of FGF2 (Figure 6.10B). The FGF2-induced down-regulation 
of FGFR2 expression was all inhibited by U0126 anteriorly and posteriorly (Figure 
6.10B). Thus the down-regulation of FGFR2 expression induced by FGF2 occurred 
both anteriorly and posteriorly, and was potentially dependent on MAPK signalling.  
 
Expression of FGFR3 was down-regulated by 3.21-fold in the posteriorly-derived cells 
after a prolonged FGF2 stimulation (72 hours) only (Figure 6.10C). This FGF2-induced 
down-regulation of FGFR3 expression was significantly inhibited by U0126 (Figure 
6.10C). Note that the expression of FGFR3 was down-regulated by 1.84-fold when the 
anteriorly-derived cells were treated with both FGF8 and U0126 for 72 hours (Figure 
6.10C). Similarly, the expression of FGFR3 was down-regulated slightly but 
significantly by 1.18-fold when the posteriorly-derived cells were treated with both 
FGF8 and U0126 for 24 hours (Figure 6.10C). Thus the down-regulation of FGFR3 
expression induced by FGF2 occurred in the anteriorly- and posteriorly-derived cells 
after FGF2 stimulation, and the prolonged down-regulation of FGFR3 expression 
posteriorly was potentially dependent on MAPK signalling. However, the intracellular 
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signalling pathways involved anteriorly after 72 hours and posteriorly after 24 hours 
were potentially under the repression of MAPK signalling. 
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Figure 6.10. Spatiotemporal effects of FGF2 signalling on FGFR1-3 expression. 
Graphical representation of fold changes of FGFR1 (A), FGFR2 (B) and FGFR3 (C) expression 
determined by rtPCR from RNA extracted from anteriorly- and posteriorly-derived cultures of 
human neocortex aged 10 (n=1), 11 (n=1) and 12 (n=1) PCW, which have been treated with 
FGF2 in the presence or absence of U0126 for 24 and 72 hours (24hr/72hr). Blue bars 
represented the fold changes in gene expression after FGF2 stimulation in comparison to non-
treated control groups (FGF2/C). Pink bars represented the fold changes in gene expression 
after FGF2 stimulation in the presence of U0126 in comparison to U0126-treated alone groups 
(FGF2+U/C+U). Red dotted lines indicated 1.5-fold increase or decrease of expression level. # 
indicated significant differences of expression level between FGF2 and control groups or 
FGF2+U and C+U groups (p≤ 0.05). * indicated significant differences of fold changes between 
FGF2/C and FGF2+U/C+U (p≤ 0.05). A, anterior; P, posterior. 
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Effects of FGF8 Signalling on Expression of FGFR1, FGFR2 and FGFR3 
 
After 24 hours of FGF8 stimulation, expression of FGFR1 was up-regulated by 1.61-
fold in the anteriorly-derived cells and a prolonged FGF8 stimulation (72 hours) up-
regulated its expression by 2.98-fold in these cells (Figure 6.11A). Whereas in the 
posteriorly-derived cells, FGFR1 expression was up-regulated by 1.75-fold after 72 
hours of FGF8 stimulation only (Figure 6.11A). The FGF8-induced up-regulation of 
FGFR1 expression was inhibited by U0126 only in the anteriorly-derived cells after 72 
hours (Figure 6.11A). Note that the expression of FGFR1 was up-regulated by 1.57-fold 
and significantly by 1.45-fold when the posteriorly-derived cells were treated with both 
FGF8 and U0126 for 24 and 72 hours respectively (Figure 6.11A). Thus the up-
regulation of FGFR1 expression induced by FGF8 occurred predominantly in 
anteriorly-derived cells but also posteriorly, and the substantial up-regulation of FGFR1 
expression anteriorly after 72 hour was potentially dependent on MAPK signalling. 
However, the intracellular signalling pathways involved posteriorly were potentially 
under the repression of MAPK signalling. 
 
Expression of FGFR2 in the anteriorly-derived cells was down-regulated by 1.76-fold 
after 24 hours of FGF8 stimulation, whereas in the posteriorly-derived cells its 
expression was down-regulated by 1.73-fold after 72 hours of FGF8 stimulation (Figure 
6.11B). The down-regulation of FGFR2 expression was inhibited by U0126 in the 
anteriorly-derived cells after 24 hours only (Figure 6.11B). Note that FGFR2 expression 
was slightly but significantly down-regulated by 1.22- and 1.30-fold when the 
posteriorly-derived cells were treated with both FGF8 and U0126 for 24 and 72 hours 
respectively (Figure 6.11B). Thus the down-regulation of FGFR2 expression was 
induced by FGF8 both anteriorly and posteriorly, however only the anterior down-
regulation of FGFR2 expression was potentially dependent on MAPK signalling. The 
intracellular signalling pathways involved posteriorly after 24 hours potentially under 
the repression of MAPK signalling. 
 
Expression of FGFR3 was up-regulated by 1.76-fold after a prolonged FGF8 
stimulation (72 hours) in the anteriorly-derived cells only, and no effect was observed 
posteriorly (Figure 6.11C). This FGF8-induced up-regulation of FGFR3 expression was 
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inhibited by U0126 (Figure 6.11C). Note that FGFR3 expression was down-regulated 
by 1.52-fold when the posteriorly-derived cells were treated with both FGF8 and U0126 
for 72 hours (Figure 6.11C). Thus the up-regulation of FGFR3 expression induced by 
the long-term stimulation of FGF8 occurred only anteriorly, and this up-regulation of 
FGFR3 expression was potentially dependent on MAPK signalling. However, 
prolonged stimulation of FGF8 down-regulated FGFR3 expression and the intracellular 
signalling pathways involved were potentially under the repression of MAPK signalling. 
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Figure 6.11. Spatiotemporal effects of FGF8 signalling on FGFR1-3 expression. 
Graphical representation of fold changes of FGFR1 (A), FGFR2 (B) and FGFR3 (C) expression 
determined by rtPCR from RNA extracted from anteriorly- and posteriorly-derived cultures of 
human neocortex aged 10 (n=1), 11 (n=1) and 12 (n=1) PCW, which have been treated with 
FGF8 in the presence or absence of U0126 for 24 and 72 hours (24hr/72hr). Blue bars 
represented the fold changes in gene expression after FGF8 stimulation in comparison to non-
treated control groups (FGF8/C). Pink bars represented the fold changes in gene expression 
after FGF8 stimulation in the presence of U0126 in comparison to U0126-treated alone groups 
(FGF8+U/C+U). Red dotted lines indicated 1.5-fold increase or decrease of expression level. # 
indicated significant differences of expression level between FGF8 and control groups or 
FGF8+U and C+U groups (p≤ 0.05). * indicated significant differences of fold changes between 
FGF8/C and FGF8+U/C+U (p≤ 0.05). A, anterior; P, posterior. 
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6.4 Discussion 
 
6.4.1 Establishment of Human in-vitro Regionalisation Model 
 
To establish whether the regulation of genes observed within the brain is dependent on 
their physiological environment, or whether such information is held intrinsically, we 
have generated dissociated cultures from neocortical tissue dissected from the anterior 
and posterior poles of 11 PCW neocortices. The protomap hypothesis states that 
progenitors possess regional intrinsic information by the time they undergo their final 
asymmetric division in the VZ and their progenies maintain this information, so that by 
the time they have migrated to the CP, they may phenotypically look like all other 
cortical neurones but are genetically different to their neighbours (Rakic et al., 2009; 
Rakic, 1991). The cell culture model employed here involves maintenance of the cells 
in a differentiation-inducing medium that results in the vast majority of cells reacting 
positively for the neuronal marker, MAP2 (Figure 6.1). The detection of GFAP- and 
Nestin-positive cells suggests that radial glia ⁄ astrocytes and other progenitors are also 
present (Figure 6.1). Cell counts from these markers showed no significant differences 
between anterior or posterior cultures indicating no differences in the differentiation 
processes occurring in the cells after 3 DIV (Figure 6.1). 
 
6.4.2 Maintenance of the Intrinsic Regional Molecular Identity of Cells 
 
Further characterization of these cells indicated their intrinsic molecular identity was 
maintained after 3 DIV. In-situ studies have shown that CTIP2, which is associated with 
corticofugal neurones, is expressed solely by post-mitotic neurones in humans (Figure 
5.6) as well as in mice, involving in post-mitotic differentiation such as axonal 
outgrowth, fasciculation and survival (Arlotta et al., 2005). Here, neocortical cells 
cultured for 3DIV that were immunoreactive for CTIP2 did not co-express Nestin or 
GFAP (Figure 6.2), indicating CTIP2 remained to be expressed by post-mitotic 
neurones but not by neural progenitor or astroglial cells in the culture. Furthermore, it 
was demonstrated previously within the developing CP of the human neocortex, a 
subpopulation of post-mitotic neurones co-expressed all three corticofugal neurone-
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associated markers, CTIP2, ROBO1 and SRGAP1 (Figure 5.6). These cells maintained 
their intrinsic molecular identity in-vitro as indicated by the co-localization of 
CTIP2/ROBO1 and CTIP2/SRGAP1 (Figure 6.2). 
 
To confirm whether cells maintained their intrinsic regional identity, cells stained with 
antibodies for PAX6, EMX2 and CTIP2 were quantified. Whereas PAX6-positive cell 
counts from anteriorly- and posteriorly-derived cultures exhibited no significant 
differences, EMX2-positive cells were significantly more numerous in posteriorly-
derived cell cultures and there were significantly more CTIP2-immunoreactive cells in 
the anteriorly-derived cell cultures (Figure 6.3). This supports our previous evidence 
that a PAX6 gradient is not detectable in the developing neocortex at this time point (11 
PCW, (Bayatti et al., 2008b)). Furthermore, EMX2, which has been reported to be 
expressed in the proliferative zones during rodent development (Cecchi and Boncinelli, 
2000), was observed to be expressed in the majority of cells in culture posteriorly, 
indicating that the protein must be expressed in post-mitotic neurones, again supporting 
recent evidence indicating that EMX2 is expressed within the CP during development in 
humans (Bayatti et al., 2008b). This observation raises the interesting question as to 
whether EMX2 exerts an areal influence in the CP in addition to having a 
regionalization function in the proliferative zones in humans. The relative levels of 
EMX2 in culture after 3 DIV (posterior vs. anterior) (Figure 6.3) mirror the relative 
EMX2 levels measured in tissue (posterior vs. anterior) (Figure 3.3; (Ip et al., 2010a)) 
and this may indicate a degree of intrinsic information contained within expressing 
cells.  
 
rtPCR confirmed that expression levels of EMX2 and the other members of the subset of 
genes tested in cultures (Figure 6.5) showed similar posterior ⁄ anterior differences as 
detected by Affymetrix chip analysis (Ip et al., 2010a) and rtPCR (Figure 3.3) using 
tissue RNAs. Robust and consistent anterior > posterior levels of PCDH17, CTIP2, 
S100A10, CNTNAP2 and ROBO1 were detected, whereas levels of COUPTFI, EMX2 
and FGFR3 were found to be posterior > anterior (Figure 6.5).  
 
6.4.3 The Applications of Human in-vitro Regionalisation Model 
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Differences in expression between human and rodent genes are mirrored in the cell 
culture model presented here. Examples include detection of EMX2 expression in 
differentiated neuronal cells (Figure 6.3), and lack of an observable PAX6/PAX6 
gradient (Figure 6.3, Figure 6.5). These findings highlight the usefulness of this culture 
system as a model of regionalisation in humans. In addition to EMX2, a number of 
known regionalisation genes were confirmed clustering posteriorly in this culture 
system (Figure 6.5). These include FGFR3, a gene postulated to be involved in 
regionalisation but reported to be involved in proliferation of cells and regulation of 
brain size (Thomson et al., 2007; Inglis-Broadgate et al., 2005). This observation is 
intriguing as this implies that progenitors or differentiating neurones isolated from the 
anterior neocortex exhibit a different balance in expression of FGFRs (high FGFR1, 
low FGFR3) than those from the posterior neocortex (high FGFR2⁄ 3), which could lead 
to differential signalling activity (Fortin et al., 2005). Thus FGF8, a signalling molecule 
released from an anterior signalling centre and a high affinity ligand for FGFR3, and 
FGF2, with a more widespread expression patterns throughout the CNS but a high 
affinity ligand for FGFR1, could potentially activate different signalling pathways in 
anterior compared to posterior neocortices. Therefore this in-vitro model initiated from 
anteriorly- and posteriorly-derived neocortical cells has provided two separate systems 
which allow identification of putative differences in cell-signalling between these 
populations of cells as well as downstream effects such as proliferation vs. 
differentiation and differential expression of genes. 
 
The preliminary study of FGFs signalling in regulation of corticofugal neurone- 
associated genes and FGFRs genes yields interesting observations. For instance, 
differential regulation of these genes was observed in which CTIP2 and SRGAP1 
expression was generally down-regulated anteriorly and posteriorly, whereas ROBO1 
expression was only up-regulated regionally after FGF2 and FGF8 stimulation (Figure 
6.8, Figure 6.9). Similarly, expression of FGFR1 was generally up-regulated and 
FGFR2 was down-regulated both anteriorly and posteriorly, while changes of FGFR3 
expression varied after FGF2 and FGF8 stimulation (Figure 6.10, Figure 6.11). 
However due to time constraint, there are caveats regarding this set of experiments. Cell 
cultures subjected to FGFs stimulation in the presence or absence of MEK inhibitor 
were initiated from 3 neocortices aged 10, 11 and 12 PCW, and results obtained from 
each sample were averaged and graphically presented. Large error bars in graphs and 
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the lack of statistical significance indicate an inconsistency within a given data set, 
which is potentially due to the sample used. The clustering study and principal 
component analysis conducted previously have revealed the gestational age is a variable 
factor affecting total gene expression between samples, and that samples aged 8 and 
12.5 PCW exhibited more variability as compared to samples aged 9-11 PCW (Figure 
1.13). As this is potentially reflecting a developmental switch occurring at 8 and 12.5 
PCW, different regulatory machineries may be taking place and results in different 
levels of gene expression as compared to samples aged 9-11 PCW. Thus the data 
obtained in the current studies on the basis of 3 samples of different ages could 
potentially be skewed by the least-related 12 PCW aged sample. Furthermore, the small 
sample size at each age (n=1) also limited the use of two-way ANOVA statistical test to 
allow for the covariate of sample ages. Ideally, at least 3 samples of each age should be 
used in order to acquire data with more consistent patterns, and two-way ANOVA 
should be performed instead of a Student‟s paired t-test. Although the data obtained by 
far might not be showing significant changes of gene expression after different types of 
stimulations, it nevertheless gives a preview of the changing trends and allows initial 
prediction and speculation of the regulatory mechanisms of gene expression involved. 
 
The roles of Fgf2 in controlling proliferation and differentiation of neocortical neural 
progenitors(Li and DiCicco-Bloom, 2004; Raballo et al., 2000; Vaccarino et al., 1999; 
Qian et al., 1997; McFarlane et al., 1995; Murphy et al., 1994; Murphy et al., 1990a; 
Murphy et al., 1990b) and Fgf8 in patterning of the developing brain (Crossley et al., 
2001; Fukuchi-Shimogori and Grove, 2001) have been widely studied. Interestingly, it 
is demonstrated that the Fgf2-induced proliferation of glial cells cultured from rat 
neocortices is activated predominantly via the MAPK signalling pathway and upon 
inhibition of the MAPK signalling cascade or cAMP stimulation, inhibition of the 
cAMP response element-binding (CREB) pathway is released, leading to the functional 
differentiation of cells (Figiel et al., 2003; Bayatti and Engele, 2001). As CTIP2 and 
potentially SRGAP1 are not expressed by GFAP- and/or Nestin-immunoreactive cells 
(Figure 6.2), the down-regulation of CTIP2 and SRGAP1 expression observed after 
FGF2 and FGF8 stimulation (Figure 6.8, Figure 6.9) has initially prompted us to 
speculate an induction of proliferation of GFAP- and/or Nestin-positive progenitor cells, 
which probably out-number the MAP2-positive differentiating cells and reduce the 
proportion of these MAP2-positive differentiating cells expressing CTIP2 and/or 
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SRGAP in the neocortical cultures. However, this might be unlikely as our culture 
system is dominated by MAP2-positive differentiating cells (~80%), the overlapping 
population of GFAP- and Nestin-expressing proliferating cells are of minority (~20%) 
(Figure 6.1). Furthermore, an up-regulation of ROBO1 expression is detected after 
stimulation of FGF2 (Figure 6.8). This observation suggests that the down-regulation of 
CTIP2 or SRGAP1 expression could not be simply due to an increase in the number of 
proliferating cells that do not express these genes, given that ROBO1 remained to be 
solely expressed by post-mitotic cells in-vitro. The treatment of cells with FGFs in the 
presence of the MEK inhibitor U0126 thus serves two purposes: to direct the 
downstream signalling cascade towards the CREB pathway that leads to differentiation 
rather than proliferation of cells and to determine whether the FGFs-induced changes in 
gene expression is dependent on the MAPK signalling. Yet it is necessary to determine 
the ratio of proliferating to differentiating cells in the cultures after various stimulations 
such as counting GFAP- and/or Nestin- vs. MAP2-immunostained cells at protein level, 
performing rtPCR to examine GFAP, Nestin and MAP2 expression at RNA level and 
methylthiazol tetrazolium (MTT) cell proliferation assay. Furthermore, the co-
localization of CTIP2/ROBO1/SRGAP1 with markers such as GFAP, Nestin and MAP2 
via immunocytochemistry requires more thorough investigation to confirm the type of 
cells (e.g. proliferative vs. differentiative; neuronal vs. glial) expressing these 
corticofugal neurone-associated markers. 
 
The preliminary data thus far has revealed a differential down- and up-regulation of 
CTIP2/SRGAP1 and ROBO1 expression (Figure 6.8, Figure 6.9). Although they are all 
implicated in the development of corticofugal projection neurones, by nature they are 
different molecules (transcription factor vs. signalling molecule vs. cell adhesion 
molecule) and so is not surprising that their expression might not be regulated the same 
way. Additionally, our data have shown that cells expressing CTIP2 do not exclusively 
co-express ROBO1 or SRGAP1 both in-situ (Figure 5.6) and in-vitro (Figure 6.2), and 
that the callosal projection neurones expressing SATB2 are found to co-express ROBO1 
within Layer V (Figure 5.7). It is worth looking into the expression of SATB2 in 
relation to ROBO1 and CTIP2 before and after various treatments at RNA and protein 
level. Nevertheless the down-regulation of CTIP2 expression after FGF8 stimulation 
(Figure 6.9) is somewhat unexpected. This is because Fgf8 is known to inhibit the 
expression of the posterior marker CouptfI (Borello et al., 2008; Storm et al., 2006; 
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Garel et al., 2003), which represses the expression of Ctip2 in Layer VI of the sensory 
areas in the mice neocortices (Tomassy et al., 2010). Thus the treatment with FGF8 
should theoretically down-regulate COUPTFI expression as observed in the Fgf8
null/neo
 
hypomorph (Borello et al., 2008) and release the repression of CTIP2 expression in the 
cultured cells. Nevertheless, the FGF8-mediated down-regulation of COUPTFI 
expression is probably only occurring before neocorticogenesis begins as the 
regionalized expression of FGF8 in the ANR is down-regulated while its expression in 
the diencephalon and at the mesencephalic-rhombencephalic boundary remains strong 
at a relative early stage of development in humans (around CS20; 7 PCW; Subrot Sarma, 
unpublished data). It would be useful to probe the expression of COUPTFI after various 
treatments of cells and compared with the expression of CTIP2. 
 
The additional roles of Fgf2 and Fgf8 in regulating the growth and guidance of axons in 
various systems have also been studied more recently. In particular, Fgf2 is able to 
induce functional recovery from neonatal motor cortex injury in rats, probably by re-
establishing the corticospinal tract with the re-growth of neocortical cells in the lesioned 
region of the motor cortex and outgrowth of fibre projection towards the cervical spinal 
cord (Monfils et al., 2008), as Fgf2 signalling has been demonstrated to promote the 
growth and sprouting of axons and sustain the required cues for the guidance of axons 
to reach their targets (Ramirez et al., 1999; Kawamata et al., 1997; Mahler et al., 1997; 
McFarlane et al., 1995). Whereas Fgf8 regulates the anteriorly-directed growth of 
midbrain dopaminergic axons at the midbrain-hindbrain boundary by inducing 
expression of axon guidance molecules such as sema3F (Yamauchi et al., 2009). 
Likewise, a microarray analysis studying the transcriptional targets of FGF signalling 
has revealed EphA2 and A4 receptors, which play a role in axonal guidance, are 
positively regulated via FGF signalling during early development of Xenopus laevis 
(Branney et al., 2009). Thus it is not surprising to observe an up-regulation of ROBO1 
expression after FGF2 and FGF8 stimulations in our neocortical cultures (Figure 6.8, 
Figure 6.9). However what causes the differential up-regulation of ROBO1 expression 
posteriorly after FGF2 stimulation (Figure 6.8) and anteriorly after FGF8 stimulation in 
the presence of U0126 (Figure 6.9) is not known. 
 
The differential regulation of FGFRs expression by their high affinity ligands (Figure 
6.10, Figure 6.11) has also been observed by other research groups within different 
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cellular contexts. In a rat primary cortical culture enriched with cells along the 
oligodendrocyte lineage, exogenous Fgf2 up-regulates the expression of Fgfr1 in early 
oligodendrocyte progenitors, but down-regulates Fgfr2 expression in mature 
oligodendrocytes, whereas the regulation of Fgfr3 expression is independent of the 
exogenous Fgf2 (Bansal et al., 1996). A more recent study that has employed three 
murine cell lines with different lineages shows the expression of Fgfrs are differentially 
regulated by Fgf8 within the same and among different cell types (Mott et al., 2010). 
For instance Fgfr1 expression is up-regulated in fibroblast-derived 3T3 cells and 
neuroendocrine GT1-7 cells, whereas expression of Fgfr3 is down-regulated in 
hippocampal neuronal HT-22 cells and GT1-7 cells following Fgf8 stimulation (Mott et 
al., 2010). Together, the differential regulation of FGFRs expression detected by our 
groups (Figure 6.10, Figure 6.11) and others might suggest that these FGFRs are 
subserving different cell-specific biological functions. The up-regulation of FGFR1 
expression induced by exogenous FGF2 and FGF8 appears to be a consistent 
phenomenon observed by others and in our neocortical culture (Figure 6.10, Figure 
6.11). A positive feedback mechanism is probably in place in which exogenous FGF2 
causes newly-synthesized or internalized FGFR1 to accumulate inside the nuclei of 
developing neurones and glial cells and the nuclei-localized FGFR1 acts as 
transcriptional activator to potentially activate the transcription of other genes as well as 
itself, thereby increasing the synthesis of FGFR1 (Stachowiak et al., 2007; Maher, 
1996). The localization and accumulation of FGFR2 and FGFR3 within the nuclei has 
also been found which associates with the development of other cell types such as 
osteoblasts and Sertoli cells within the gonad (Stachowiak et al., 2007; Marchetti et al., 
2006; Sabbieti et al., 2005; Schmahl et al., 2004; Johnston et al., 1995).  
 
The preliminary data presented here showing differential regulation of corticofugal 
neurone-associated genes expression by FGFs signalling (Figure 6.8, Figure 6.9) 
implicates that FGFs alone might not be sufficient to induce the growth or 
differentiation of corticofugal neurones in our neocortical cultures. Indeed, there are 
other potential regulators including transcription factors such as Sp8 (Zembrzycki et al., 
2007), Pax6 (Clegg et al., 2010; Lopez-Bendito et al., 2007; Jones et al., 2002) and 
CouptfI (Tomassy et al., 2010) in which the expression of Robo1 and Ctip2 is reduced 
in their absence in rodent studies. The knock-down of SP8, PAX6, COUPTFI as well as 
other potential transcription factor genes in our in-vitro regionalisation model could be 
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carried out in order to study their role in regulating the expression of corticofugal 
neurone-related genes. Yet the culture system used in the current study contains a mixed 
population of cells and that changes in gene expression in a particular cell type after 
FGFs stimulation could potentially be masked. Thus combination of other in-vitro 
approaches such as purifying specific sub-populations of developing neocortical cells 
(e.g. radial glia) in culture (Mo and Zecevic, 2008; Mo et al., 2007) and subsequent 
stimulation of cells with FGFs or other factors would allow the tracking of gene 
expression changes in isolated populations of cells. The ultimate aim is to identify 
factors that are required to induce the expression of various corticofugal neurone-related 
genes, and induce the differentiation of pluripotent stem cells (e.g. human umbilical 
cord blood-derived stem cells) into corticofugal projection neurones which could 
potentially be used therapeutically. 
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Chapter 7  General Discussion and Future Work 
 
7.1 Conclusion 
 
In conclusion, the current project has confirmed the graded expression of a subset of 
putative anterior and posterior markers in the developing human neocortex aged 
between 8-12 PCW, including a number of transcription factors, cell adhesion and 
axonal guidance molecules and growth factor receptors.  
 
Importantly, the discovery of some corticofugal projection neurone-associated genes 
and/or proteins (CTIP2, ROBO1 and SRGAP1) being highly up-regulated anteriorly 
might mark the site of the emerging human motor cortex, which is the predominant 
origin of corticofugal projection neurones such as corticospinal and corticopontine 
projection neurones. Since the motor cortex and the corticospinal tract are common sites 
of developmental brain damage leading to cerebral palsy (Eyre, 2007), the identification 
of regulated corticofugal projection neurone-related markers and localization of the 
developmental origin of the above corticofugal projection neurones are crucial in order 
to promote mechanisms that facilitate the replacement or repair of these neurones in the 
affected regions. 
  
This project has also established and characterized the dissociated human cell cultures 
from anteriorly- and posteriorly-derived foetal neocortex to be used as a human in-vitro 
model of regionalisation. The establishment of this model has provided a valuable tool 
to investigate the regulation of various genes. In particular, the identification of 
regulatory mechanisms of corticofugal projection neurone-associated genes would guide 
potential future approaches targeting to stimulate population of endogenous stem cells 
or those from other source to differentiate into a corticofugal neurone phenotype, which 
could potentially be applied therapeutically to improve functional outcomes of patients 
suffering from motor disorders such as cerebral palsy. 
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7.2 Implications of Regionalised Gene Expression during Human 
Neocorticogenesis 
 
7.2.1 Age-Dependent Regulation of Regionalised Gene Expression 
 
During early stages of neurogenesis in rodents, genes that control the establishment of 
the early cortical map are presumed to be expressed in gradients across the tangential 
dimension of the developing neocortex (Cecchi and Boncinelli, 2000). Similarly, 
Affymetrix chip analysis and rtPCR reveals robust consistent gradients of gene 
expression in 8-12.5 PCW aged human neocortical tissues in the current study. The 
selected ages for investigation represent early stages of corticogenesis when the intrinsic 
information carried by the neocortical progenitors are being passed onto their progenies 
(e.g. EMX2/EMX2 expressed by both neocortical progenitors as well as post-mitotic 
neurones; (Bayatti et al., 2008b)) as the CP begins to form (7.5 PCW; (Meyer et al., 
2000)), but their molecular identities are not yet under the influence of extrinsic factors 
that are potentially brought forward via the incoming thalamocortical afferents 
(Kostovic and Rakic, 1990). In humans, the intrinsic information carried in a form of 
graded or regionalised gene expression is probably regulated by different developmental 
mechanisms prior to, or at around 8 PCW, as compared to later ages, evidently 
supported by the age-dependent clustering of samples (Chapter 3), the down-regulation 
of FGF8 expression in the ANR at around CS20/7 PCW (Subrot Sarma, unpublished 
observation) and the deregulation of high anterolateral/low posteromedial gradient of 
PAX6 expression at 9 PCW (Bayatti et al., 2008b), which is otherwise maintained in 
rodents throughout corticogenesis (Manuel and Price, 2005). It would also be interesting 
to compare the gene expression between the current samples (8-12.5 PCW) and older 
samples (>12.5 PCW) to identify expression of genes that are potentially under extrinsic 
influences via microarray analyses and rtPCR.  
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7.2.2 PAX6-Independent Anterior Regionalisation 
 
Despite the persistence of Pax6 gradient in rodents, accumulating evidence argues that 
this gene is not directly involved in regionalisation processes (Pinon et al., 2008; 
Manuel et al., 2007), as neocortical identities indicated by the distribution of area-
specific thalamocortical and corticofugal projections are maintained in conditional Pax6 
knock-out mutants, and the inability of Pax6 over-expression to alter the expression of 
Emx2 or other areal markers. In contrast, over-expression of Emx2 shifts the position 
and increases the size of primary areas located posteriorly when compared to anterior 
structures (Hamasaki et al., 2004). Therefore all neocortical progenitors are proposed to 
carry intrinsic information that impart posterior regional identities by-default such as 
expressing reported regionalisation genes EMX2, COUPTFI and FGFR3, in which their 
expression is repressed by secreted ligands such as FGF8, -15 and -17 released from 
signalling centres located anteriorly (Rakic et al., 2009; O'Leary et al., 2007; O'Leary 
and Nakagawa, 2002), and/or by as yet undiscovered, anteriorly up-regulated 
regionalisation genes that are essential for specification of the anterior neocortex (Rakic 
et al., 2009).  
 
The identified anteriorly up-regulated genes include CNTNAP2, a frontal cortex marker 
(Abrahams et al., 2007), PCDH17, an areal marker corresponding to the motor cortex in 
rodents (Kim et al., 2007), CTIP2 and S100A10, Layer V markers for early corticospinal 
neurones development in rodents (Arlotta et al., 2005), ROBO1, gene encoding axon 
guidance molecule that is expressed in the corticospinal fibres before, during and after 
crossing the midline in the caudal medulla in rodents (Sundaresan et al., 2004), and 
SRGAP1, the downstream signalling molecule of ROBO1 (Wong et al., 2001). However, 
it is important to distinguish whether these genes are regionalisation genes that are 
expressed by progenitor cells or areal genes expressed by post-mitotic neurones in the 
developing CP and regulated by regionalisation genes to induce their graded expression 
patterns (O'Leary et al., 2007). More thorough investigation is therefore required to 
localize their expression on human neocortical tissues spatially and temporally via 
tissue in-situ hybridization and immunohistochemistry to classify them as 
regionalisation or areal genes.  
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7.2.3 Anterior Clustering of Corticofugal Neurone-associated Genes 
 
Among the identified genes up-regulated anteriorly, the laminar and cellular expression 
of CTIP2, ROBO1 and SRGAP1, which are shown to be important in the development 
of corticofugal projection neurones, were examined on human neocortical tissues. 
Although their expression was detected in the proliferative SVZ, an elaborate transient 
layer constituting a heterogeneous population of cells in humans (Bayatti et al., 2008a), 
they were shown to be expressed by post-mitotic neurones. Thus they are not 
regionalisation genes that specify progenitors to become corticofugal projection 
neurones, rather they are areal genes that clustered at the anterior neocortex relatively 
early in cortical development, potentially marking the primitive site of origin of the later 
developing motor cortex and/or corticofugal neurones at a similar location of the motor 
cortex observed in rodents (O'Leary and Nakagawa, 2002). The adult human motor 
cortex is not found to be predominantly located towards the anterior pole of the 
neocortex as it is in rodents. This may be due to the prefrontal cortex, a much larger 
structure in humans compared to the rodent brains, starts to expand during later stages 
of development (Fuster, 2002) resulting in its adult position being in the centre and 
anterior to the central sulcus. Tissue ISH and IHC demonstrating the localization of 
genes and proteins that delineate the motor and prefrontal cortex at later stages would 
potentially reveal the developmental relationship between the two neocortical areas in 
humans. 
 
The anterior up-regulation of these corticofugal neurone-associated genes has further 
implications on the development of various corticofugal projection neurones originating 
from different neocortical areas:  
1)  It may potentially be highlighting a much higher proportion of corticofugal 
neurones generated from the frontal/motor areas as compared to the occipital 
cortex as observed in adult macaque (Lock et al., 2003; Galea and Darian-Smith, 
1994; Glickstein et al., 1985). It would be useful to retrogradely trace these 
different projection neurones from their terminals and identify the proportions of 
various neocortical origins by DiI tracing studies or diffusion tensor imaging 
tractography in human tissues if possible. 
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2) It may also be showing the importance of ROBO1, SRGAP1 and CTIP2 in the 
growth and maintenance of the corticospinal axons beyond the pons and across 
the medullary decussation (Lopez-Bendito et al., 2007; Arlotta et al., 2005), in 
comparison to the other major subcerebral cortical projections that terminate, in 
maturity, ipsilaterally in the midbrain and pons. Additionally, regionalised 
expression of specific cell-cell signalling molecules such as ROBO1/SRGAP1 
may protect corticospinal axons from retraction from the spinal cord and promote 
their removal from inappropriate target areas, in a similar way as arealized 
expression of Plexin 3A and -4A in the rodent visual cortex that promotes pruning 
of their corticospinal projections and protection of appropriate projections to the 
superior colliculus (Low et al., 2008). If achievable, explant cultures initiated 
from sagittally dissected human brain tissue that retain all of the corticofugal 
projection tracts in combination with RNA interference (siRNA) of 
CTIP2/ROBO1/SRGAP1 and DiI tracing would potentially reveal the importance 
of the three genes in maintaining appropriate corticofugal axonal projections 
during development. 
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7.3 Ontogenesis of Layer V Pyramidal Neurones in the Developing Human 
Neocortex 
 
Studies of various gene expression patterns not only provided information regarding the 
development of neocortical areas, their laminar-specific expression patterns also 
revealed the formation of cortical layers in the developing human neocortex. In 
particular, the formation of Layer V is of primary interest as it harbours a heterogeneous 
population of pyramidal neurones projecting subcerebrally and callosally, expressing 
some of the markers used in the current project (Molnar and Cheung, 2006). Previous 
molecular neuroanatomical studies by our group have shown that by 16 PCW, Layer V 
is visualized by ER81 immunoreactivity in the human neocortex (Bayatti et al., 2008a). 
The expression of ER81 observed in this project suggested Layer V is already formed 
by 12 PCW and also strongly expressing SATB2, above the TBR1- and NURR1-
positive Layer VI and GAP43-, Synaptophysin-immunoreactive SP in the developing 
human neocortex. 
 
The spatiotemporal expression of the studied genes and proteins observed in the present 
project not only delineated the formation of various cortical layers, it potentially reflects 
the development of pyramidal projection neurones residing in these layers. Within the 
developing neocortex, a subpopulation of post-mitotic neurones was demonstrated to 
co-express ROBO1, SRGAP1 and CTIP2, which are related to the corticofugal 
projection neurones, when the CP is forming at around 10 PCW. At the caudal medulla 
level, the pyramids containing corticospinal axons were immunoreactive for both 
ROBO1 and SRGAP1 which was observed as early as 11 PCW, however the 
decussation of these fibres only took place at around 14 PCW, visualized by prominent 
ROBO1- and SRGAP1-positive fibres extending to the decussation and beyond. 
Expression of ROBO1 and SRGAP1 was not restricted to the putative Layer V during 
its emergence, but only at 15 PCW. Thus the present study have found at least a subset 
of ROBO1+/SRGAP1+/CTIP2+ corticofugal neurones to be restricted to Layer V by 
the time that presumptive ROBO1- and SRGAP1- positive corticospinal fibres are 
crossing the decussation in large numbers.  
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In addition to the corticofugal projection neurones, Layer V also contains callosal 
projection neurones expressing markers such as SATB2. As corticogenesis begins, 
SATB2-positive cells were sparsely distributed in the SVZ, whereas CTIP2 was already 
abundantly expressed by post-mitotic neurones in both the SVZ and CP. This might be 
suggesting that although some SATB2-expressing neurones are destined to occupy 
Layer V alongside CTIP2-expressing neurones, the callosal projection neurones are 
probably generated later than subcerebral projection neurones. Alternatively, it might be 
due to some differential regulatory machineries causing SATB2 expression to be 
switched on later than CTIP2, for instance the repression and promotion of SATB2 and 
CTIP2 expression respectively by their upstream gene FEZF2, which is under the 
repression of SOX5 further upstream of FEZF2. Further investigation is required to 
study the expression of SATB2 such as rtPCR and cell counting of immunostained cells 
to confirm the high anterior - low posterior expression across the developing neocortex 
at RNA and protein levels. Co-localization studies of SATB2 with TBR2 (INPs markers) 
or TBR1 (early post-mitotic neuronal markers) are necessary to identify the types of 
cells expressing SATB2 within the heterogeneous SVZ. 
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7.4 Characterization and Application of the Human in-vitro Regionalisation 
Model 
 
Important differences between human and rodent gene expression patterns and 
localization have been identified previously (Bayatti et al., 2008b; Bayatti et al., 2008a), 
thus highlighting the insufficiency of animal models for human studies. Human model 
systems are therefore necessary and important to allow the manipulation of human gene 
expression. Dissociated cultures from human neocortical tissue were dissected from the 
anterior and posterior poles of 11 PCW neocortices and cells were maintained in a 
differentiation-inducing medium. After 3DIV, the anteriorly- and posteriorly-derived 
cells showed no difference in differentiation processes and the vast majority of them 
became immunoreactive for the neuronal marker, MAP2, whereas GFAP- and Nestin-
positive cells were also detected suggesting radial glia ⁄ astrocytes and other progenitors 
were also present. Further characterization of these cells indicated their intrinsic 
molecular identities were maintained after 3 DIV, as shown by the co-expression of 
CTIP2, ROBO1 and SRGAP1 as well as the expression of CTIP2 and EMX2 in post-
mitotic neurones. In addition, rtPCR and cell counting of immunoreactive cells 
confirmed these cultured cells also maintained their intrinsic regional identities by 
displaying similar graded expression of genes and proteins after 3 DIV. 
 
The differential expression of FGFRs is intriguing as this implicates that progenitors or 
differentiating neurones isolated from the anterior neocortex exhibit a different balance 
in expression of FGFRs (high FGFR1, low FGFR3) than those from the posterior 
neocortex (high FGFR2⁄ 3), which could lead to differential signalling activity (Fortin et 
al., 2005). Therefore, a preliminary study was carried out to investigate the gene 
expression regulation by FGF signalling. FGF2 and FGF8, high affinity ligands for 
FGFR1 and FGFR3 respectively, were applied to two separate systems initiated from 
the anteriorly- and posteriorly-derived neocortical cells in the presence or absence of 
MEK inhibitor to show a dependence or independence of MAPK signalling cascade to 
regulate gene expression. 
 
Differential regulation of corticofugal neurone-associated genes and FGFRs genes was 
observed in which CTIP2 and SRGAP1 expression was generally down-regulated 
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anteriorly and posteriorly, whereas ROBO1 expression was only up-regulated regionally 
after FGF2 and FGF8 stimulation. Although they are all implicated in the development 
of corticofugal projection neurones, it should not be surprising that genes encoding for 
transcription factor (CTIP2), signalling molecule (SRGAP1) and cell adhesion molecule 
(ROBO1) are regulated differentially. Additionally, ROBO1 has been implicated in 
mediating axon guidance of other neuronal subtypes in addition to corticofugal 
projection neurones, such as the callosal projection neurones expressing SATB2. 
Nevertheless the down-regulation of CTIP2 expression after FGF8 stimulation is 
somewhat unexpected. This is because Fgf8 is known to inhibit the expression of the 
posterior marker CouptfI  (Borello et al., 2008; Storm et al., 2006; Garel et al., 2003), 
which represses the expression of Ctip2 in Layer VI of the sensory areas in the mice 
(Tomassy et al., 2010). Thus the treatment with FGF8 should theoretically down-
regulate COUPTFI expression and release the repression of CTIP2 expression in the 
cultured cells. Yet, the FGF8-mediated down-regulation of COUPTFI expression is 
probably only occurring before neocorticogenesis begins as the regionalised expression 
of FGF8 in the ANR is weakened at a relative early stage of development in humans 
(around CS20; 7 PCW) while its expression in the diencephalon and at the 
mesencephalic-rhombencephalic boundary remains strong (Subrot Sarma, unpublished 
observation). On the other hand, the up-regulation of ROBO1 expression observed after 
FGF2 and FGF8 stimulation in our neocortical cultures might suggest roles for FGF2 
and FGF8 in regulating the growth and guidance of axons as well as sustaining the 
expression of guidance cues as proposed by other researchers (Branney et al., 2009; 
Yamauchi et al., 2009; Monfils et al., 2008; Ramirez et al., 1999; Kawamata et al., 1997; 
Mahler et al., 1997; McFarlane et al., 1995). 
 
Similarly, expression of FGFR1 was generally up-regulated and FGFR2 was down-
regulated both anteriorly and posteriorly, while changes of FGFR3 expression varied 
after FGF2 and FGF8 stimulation. The differential regulation of FGFRs expression by 
their high affinity ligands has also been observed by other research groups in primary 
cortical cultures (Bansal et al., 1996) as well as in various cell lines (Mott et al., 2010), 
potentially suggesting that these FGFRs are subserving different cell-specific biological 
functions. The up-regulation of FGFR1 expression induced by exogenous FGF2 and 
FGF8 appears to be a consistent phenomenon observed by others and in our neocortical 
culture. A positive feedback mechanism is probably in place in which exogenous FGF2 
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causes newly-synthesized or internalized FGFR1 to accumulate inside the nuclei of 
developing neurones and glial cells that potentially activates the transcription of other 
genes as well as itself, thereby increasing the synthesis of FGFR1 (Stachowiak et al., 
2007; Maher, 1996). The localization and accumulation of FGFR2 and FGFR3 within 
the nuclei has also been found associating with the development of other cell types 
(Stachowiak et al., 2007; Marchetti et al., 2006; Sabbieti et al., 2005; Schmahl et al., 
2004; Johnston et al., 1995).  
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7.5 Further Investigation of Gene Expression Regulation  
 
Despite the interesting changes in gene expression observed preliminarily after various 
treatments, there were caveats in the pilot study of FGF signalling in regulation of gene 
expression. Due to the limited time and availability of samples, cell cultures subjected 
to FGFs stimulation in the presence or absence of MEK inhibitor were initiated from 3 
neocortices aged 10, 11 and 12 PCW. However, data obtained from the three samples of 
various ages have shown large deviation and lack of statistical significances. The 
clustering studies conducted previously have revealed that samples aged 8 and 12.5 
PCW exhibited more variability as compared to samples aged 9-11 PCW (Chapter 3). 
Thus the data obtained in the current studies on the basis of 3 samples of different ages 
could potentially be skewed by the least-related 12 PCW aged sample. Further 
experiments should be carried out with at least 3 samples of each selected age in order 
to acquire data with more consistent patterns.  
 
It is demonstrated that the Fgf2-induced proliferation of glial cells cultured from rat 
neocortices is activated predominantly via the MAPK signalling pathway and upon 
inhibition of the MAPK signalling cascade or cAMP stimulation, the inhibition of 
CREB pathway is released, leading to the functional differentiation of cells (Figiel et al., 
2003; Bayatti and Engele, 2001). As genes such as CTIP2, ROBO1 and SRGAP1 are 
potentially expressed by post-mitotic neurones exclusively, it is necessary to determine 
the effects of proliferation and differentiation of cells after various treatments. This is 
because drastic changes in the proportion of proliferating and differentiating cells would 
potentially masked the actual effects of FGFs on expression of genes of interest. This 
could be achieved by counting GFAP and/or Nestin vs. MAP2-immunostained cells at 
protein level, performing rtPCR to examine GFAP, Nestin and MAP2 expression at 
RNA level, or with a MTT cell proliferation assay. Furthermore, the co-localization of 
CTIP2/ROBO1/SRGAP1 with markers such as GFAP, Nestin and MAP2 via 
immunocytochemistry requires more thorough investigation to confirm the type of cells 
(e.g. proliferative vs. differentiative; neuronal vs. glial) expressing the corticofugal 
neurone-associated proteins. 
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The inhibition of MAPK signalling pathway requires further attention and confirmation 
which involves the use of non-phosphorylated and phospho-specific antibodies to 
p42/p44 (ERK1/2), downstream MAPKs of MEK, to reveal the ratio of non-activated 
and MAPK-activated cells after various treatments. Additionally, double-labelling of 
cells with markers such as GFAP, Nestin and β–Tubulin (in replacement of MAP2) with 
non-phospho and phospho-p42/p44 would identify the types of cells that are affected 
after different treatments. It is also necessary to investigate the involvement of 
additional downstream signalling pathways using various phospho-specific antibodies 
such as CREB, AKT and PKC or by FGF signal transduction pathway-focused arrays.   
 
The preliminary data obtained currently showed differential regulation of corticofugal 
neurone-associated genes expression by FGFs signalling. This implicates that FGFs 
alone might not be sufficient to induce the growth or differentiation of corticofugal 
neurones in our neocortical cultures. Transcription factors such as Sp8 (Zembrzycki et 
al., 2007), Pax6 (Clegg et al., 2010; Lopez-Bendito et al., 2007; Jones et al., 2002) and 
CouptfI (Tomassy et al., 2010) have been shown to affect the expression of Robo1 and 
Ctip2 in rodent knock-out studies. Utilizing our in-vitro regionalisation model, the 
regulation of corticofugal neurone-related genes expression by various transcription 
factors would be achievable by knocking-down SP8, PAX6, COUPTFI as well as other 
potential transcription factor genes. Nonetheless the culture system used in the current 
study contains a heterogeneous population of cells and that changes in gene expression 
in a particular cell type after FGFs stimulation could potentially be masked. Thus 
combination of other in-vitro approaches such as purifying specific sub-populations of 
developing neocortical cells (e.g. radial glia) in culture (Mo and Zecevic, 2008; Mo et 
al., 2007) and subsequent stimulation of cells with FGFs or other factors would allow 
the tracking of gene expression changes in isolated populations of cells. The ultimate 
aim is to identify factors that are required to induce the expression of various 
corticofugal neurone-related genes, and induce the differentiation of pluripotent stem 
cells (e.g. human umbilical cord blood-derived stem cells) into corticofugal projection 
neurones which could potentially be used therapeutically. 
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A Appendix 
 
Accession Description 
Max 
Score 
Total 
Score 
Query 
Coverage 
E-Value Sequence Homology 
NP_001139317.1 roundabout 1 isoform d [Homo sapiens] 44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1532  VLGGYERGEDNNE  1544 
 
Query  5    YERG  8 
            Y+RG 
Sbjct  904  YQRG  907 
 
NP_001139316.1 
roundabout 1 isoform c [Homo sapiens] >gb|AAI57862.1| 
ROBO1 protein [Homo sapiens] >gb|AAI71855.1| 
ROBO1 protein [Homo sapiens] 
44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1587  VLGGYERGEDNNE  1599 
 
EAW68887.1 
roundabout, axon guidance receptor, homolog 1 
(Drosophila), isoform CRA_c [Homo sapiens] 
44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1513  VLGGYERGEDNNE  1525 
 
EAW68888.1 
roundabout, axon guidance receptor, homolog 1 
(Drosophila), isoform CRA_d [Homo sapiens] 
44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1512  VLGGYERGEDNNE  1524 
 
AAI15023.1 ROBO1 protein [Homo sapiens] 44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1532  VLGGYERGEDNNE  1544 
 
Query  5    YERG  8 
            Y+RG 
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Sbjct  904  YQRG  907 
 
AAI15021.1 ROBO1 protein [Homo sapiens] 44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1587  VLGGYERGEDNNE  1599 
 
Query  5    YERG  8 
            Y+RG 
Sbjct  904  YQRG  907 
 
XP_941372.3 
PREDICTED: similar to roundabout 1 isoform 2 [Homo 
sapiens] 
44.8 72.8 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1596  VLGGYERGEDNNE  1608 
 
Query  1     VLGG  4 
             VLGG 
Sbjct  1498  VLGG  1501 
 
AAH01969.1 
Similar to roundabout (axon guidance receptor, 
Drosophila) homolog 1 [Homo sapiens] 
44.8 44.8 100% 3e-05 
Query  1    VLGGYERGEDNNE  13 
            VLGGYERGEDNNE 
Sbjct  475  VLGGYERGEDNNE  487 
 
AAI12337.1 ROBO1 protein [Homo sapiens] 44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1588  VLGGYERGEDNNE  1600 
 
Query  5    YERG  8 
            Y+RG 
Sbjct  904  YQRG  907 
 
NP_598334.1 
roundabout 1 isoform b [Homo sapiens] 
>gb|EAW68884.1| roundabout, axon guidance receptor, 
homolog 1 (Drosophila), isoform CRA_a [Homo sapiens] 
>gb|EAW68885.1| roundabout, axon guidance receptor, 
44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1593  VLGGYERGEDNNE  1605 
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homolog 1 (Drosophila), isoform CRA_a [Homo sapiens] Query  5    YERG  8 
            Y+RG 
Sbjct  910  YQRG  913 
 
CAD98093.1 
hypothetical protein [Homo sapiens] 
GENE ID: 6091 ROBO1 | roundabout, axon guidance 
receptor, homolog 1 
(Drosophila) [Homo sapiens] 
44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1271  VLGGYERGEDNNE  1283 
 
Query  5    YERG  8 
            Y+RG 
Sbjct  588  YQRG  591 
 
NP_002932.1 
roundabout 1 isoform a [Homo sapiens] 
>sp|Q9Y6N7.1|ROBO1_HUMAN RecName: 
Full=Roundabout homolog 1; AltName: Full=H-Robo-1; 
AltName: Full=Deleted in U twenty twenty; Flags: 
Precursor >gb|AAC39575.1| roundabout 1 [Homo 
sapiens] 
44.8 58.5 100% 3e-05 
Query  1     VLGGYERGEDNNE  13 
             VLGGYERGEDNNE 
Sbjct  1632  VLGGYERGEDNNE  1644 
 
Query  5    YERGEDNN  12 
            YER EDNN 
Sbjct  114  YERDEDNN  121 
 
2V53-A Chain A, Crystal Structure Of A Sparc-Collagen Complex 26.5 26.5 61% 8.5 
Query  5   YERGEDNN  12 
           YER EDNN 
Sbjct  88  YERDEDNN  95 
 
BAG61416.1 
highly similar to secreted protein, acidic and rich in 
cysteine, SPARC (Osteonectin) [Homo sapiens] 
26.5 26.5 61% 8.5 
Query  5   YERGEDNN  12 
           YER EDNN 
Sbjct  88  YERDEDNN  95 
 
BAG37963.1 
highly similar to secreted protein, acidic and rich in 
cysteine, SPARC (Osteonectin) [Homo sapiens] 
26.5 26.5 61% 8.5 
Query  5    YERGEDNN  12 
            YER EDNN 
Sbjct  179  YERDEDNN  186 
 
EAW61667.1 
secreted protein, acidic, cysteine-rich (Osteonectin), 
isoform CRA_a [Homo sapiens] >gb|EAW61671.1| 
26.5 26.5 61% 8.5 
 
Query  5    YERGEDNN  12 
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secreted protein, acidic, cysteine-rich (Osteonectin), 
isoform CRA_a [Homo sapiens] 
            YER EDNN 
Sbjct  191  YERDEDNN  198 
AAS50152.1 cysteine-rich protein (SPARC) [Homo sapiens] 26.5 26.5 61% 8.5 
Query  5   YERGEDNN  12 
           YER EDNN 
Sbjct  31  YERDEDNN  38 
 
AAA60993.1 osteonectin [Homo sapiens] 26.5 26.5 61% 8.5 
Query  5    YERGEDNN  12 
            YER EDNN 
Sbjct  178  YERDEDNN  185 
 
1BMO-A 
Chain A, Bm-40, FsEC DOMAIN PAIR >pdb|1BMO|B 
Chain B, Bm-40, FsEC DOMAIN PAIR 
26.5 26.5 61% 8.5 
Query  5    YERGEDNN  12 
            YER EDNN 
Sbjct  109  YERDEDNN  116 
 
1NUB-A 
Chain A, Helix C Deletion Mutant Of Bm-40 Fs-Ec 
Domain Pair >pdb|1NUB|B Chain B, Helix C Deletion 
Mutant Of Bm-40 Fs-Ec Domain Pair 
26.5 26.5 61% 8.5 
Query  5    YERGEDNN  12 
            YER EDNN 
Sbjct  113  YERDEDNN  120 
 
1SRA-A 
Chain A, Structure Of A Novel Extracellular Ca2+-
Binding Module In Bm-40(Slash)sparc(Slash)osteonectin 
26.5 26.5 61% 8.5 
Query  5   YERGEDNN  12 
           YER EDNN 
Sbjct  27  YERDEDNN  34 
 
NP_003109.1 
secreted protein, acidic, cysteine-rich precursor [Homo 
sapiens] >sp|P09486.1|SPRC_HUMAN RecName: 
Full=SPARC; AltName: Full=Secreted protein acidic and 
rich in cysteine; AltName: Full=Osteonectin; Short=ON; 
AltName: Full=Basement-membrane protein 40; 
Short=BM-40; Flags: Precursor >emb|CAA68724.1| 
unnamed protein product [Homo sapiens] 
>gb|AAA60570.1| osteonectin [Homo sapiens] 
>gb|AAH04974.1| Secreted protein, acidic, cysteine-rich 
(osteonectin) [Homo sapiens] >gb|AAH08011.1| Secreted 
protein, acidic, cysteine-rich (osteonectin) [Homo sapiens] 
>gb|AAH72457.1| Secreted protein, acidic, cysteine-rich 
26.5 26.5 61% 8.5 
Query  5    YERGEDNN  12 
            YER EDNN 
Sbjct  179  YERDEDNN  186 
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(osteonectin) [Homo sapiens] >emb|CAG33080.1| 
SPARC [Homo sapiens] >gb|EAW61668.1| secreted 
protein, acidic, cysteine-rich (osteonectin), isoform 
CRA_b [Homo sapiens] >gb|EAW61669.1| secreted 
protein, acidic, cysteine-rich (osteonectin), isoform 
CRA_b [Homo sapiens] >gb|EAW61670.1| secreted 
protein, acidic, cysteine-rich (osteonectin), isoform 
CRA_b [Homo sapiens] >gb|EAW61672.1| secreted 
protein, acidic, cysteine-rich (osteonectin), isoform 
CRA_b [Homo sapiens] 
BAG35170.1 
highly similar to Chromogranin B, CHGB (Secretogranin 
1) [Homo sapiens] 
22.7 38.6 61% 120 
Query  6    ERGEDNNE  13 
            ERGED++E 
Sbjct  177  ERGEDSSE  184 
 
Query  8    GEDNNE  13 
            GE+ NE 
Sbjct  549  GEEENE  554 
 
NP_001810.2 
chromogranin B precursor [Homo sapiens] 
>emb|CAB55272.1| chromogranin B (secretogranin 1) 
[Homo sapiens] 
22.7 38.6 61% 120 
Query  6    ERGEDNNE  13 
            ERGED++E 
Sbjct  177  ERGEDSSE  184 
 
Query  8    GEDNNE  13 
            GE+ NE 
Sbjct  549  GEEENE  554 
 
CAC34360.1 chromogranin B (secretogranin 1) [Homo sapiens] 22.7 22.7 61% 120 
Query  6    ERGEDNNE  13 
            ERGED++E 
Sbjct  157  ERGEDSSE  164 
 
P05060.1 
RecName: Full=Secretogranin-1; AltName: 
Full=Secretogranin I; Short=SgI; AltName: 
Full=Chromogranin-B; Short=CgB; Contains: RecName: 
Full=GAWK peptide; Contains: RecName: Full=CCB 
22.7 38.6 61% 120 
Query  6    ERGEDNNE  13 
            ERGED++E 
Sbjct  177  ERGEDSSE  184 
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peptide; Flags: Precursor >emb|CAA68271.1| unnamed 
protein product [Homo sapiens] >gb|AAH00375.1| 
Chromogranin B (Secretogranin 1) [Homo sapiens] 
>emb|CAG33007.1| CHGB [Homo sapiens] 
>gb|EAX10410.1| Chromogranin B (Secretogranin 1) 
[Homo sapiens] 
Query  8    GEDNNE  13 
            GE+ NE 
Sbjct  549  GEEENE  554 
 
NP_001157281.1 WD repeat domain 81 isoform 1 [Homo sapiens] 22.3 22.3 92% 161 
Query  2    LGGYER-GEDNNE  13 
            L  YER  ED NE 
Sbjct  303  LSAYERPEEDENE  315 
 
BAH13164.1 Ankyrin 2, neuronal, ANK2 [Homo sapiens] 21.8 21.8 61% 216 
Query  6    ERGEDNNE  13 
            E+ EDNNE 
Sbjct  816  EQSEDNNE  823 
 
BAH11860.1 Ankyrin 2, neuronal, ANK2 [Homo sapiens] 21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  1041  EQSEDNNE  1048 
 
Q01484.3 
RecName: Full=Ankyrin-2; Short=ANK-2; AltName: 
Full=Brain ankyrin; AltName: Full=Ankyrin-B; AltName: 
Full=Non-erythroid ankyrin 
21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  3917  EQSEDNNE  3924 
 
NP_001120965.1 Ankyrin 2 isoform 3 [Homo sapiens] 21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  1856  EQSEDNNE  1863 
 
EAX06288.1 
Ankyrin 2, neuronal, isoform CRA_b [Homo sapiens] 
>gb|EAX06291.1| ankyrin 2, neuronal, isoform CRA_b 
[Homo sapiens] 
21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  3929  EQSEDNNE  3936 
 
EAX06287.1 
Ankyrin 2, neuronal, isoform CRA_a [Homo sapiens] 
>gb|EAX06292.1| ankyrin 2, neuronal, isoform CRA_a 
[Homo sapiens] 
21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  1844  EQSEDNNE  1851 
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AAI25236.1 ANK2 protein [Homo sapiens] 21.8 21.8 61% 216 
Query  6    ERGEDNNE  13 
            E+ EDNNE 
Sbjct  548  EQSEDNNE  555 
 
AAI25237.1 ANK2 protein [Homo sapiens] 21.8 21.8 61% 216 
Query  6    ERGEDNNE  13 
            E+ EDNNE 
Sbjct  466  EQSEDNNE  473 
 
NP_001139.3 
Ankyrin 2 isoform 1 [Homo sapiens] >gb|EAX06290.1| 
Ankyrin 2, neuronal, isoform CRA_d [Homo sapiens] 
21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  3950  EQSEDNNE  3957 
 
NP_066187.2 
Ankyrin 2 isoform 2 [Homo sapiens] >gb|EAX06289.1| 
ankyrin 2, neuronal, isoform CRA_c [Homo sapiens] 
21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  1865  EQSEDNNE  1872 
 
CAD97827.1 ANK2 [Homo sapiens] 21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  1856  EQSEDNNE  1863 
 
CAA40279.2 Ankyrin (brank-2) [Homo sapiens] 21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  1865  EQSEDNNE  1872 
 
2003319A Ankyrin B:ISOTYPE=440kD 21.8 21.8 61% 216 
Query  6     ERGEDNNE  13 
             E+ EDNNE 
Sbjct  3917  EQSEDNNE  3924 
 
NP_001003700.1 
Ras responsive element binding protein 1, RREB1, 
isoform 3 [Homo sapiens] 
21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1368  ERGEEDSE  1375 
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Query  7    RGED  10 
            RGED 
Sbjct  844  RGED  847 
 
BAG54712.1 
NIMA (never in mitosis gene a)- related kinase 9, NEK9 
[Homo sapiens] 
21.0 21.0 53% 388 
Query  1  VLGGYER  7 
          VLG YER 
Sbjct  3  VLGEYER  9 
 
Q58DX5.2 
RecName: Full=Inactive N-acetylated-alpha-linked acidic 
dipeptidase-like protein 2; Short=NAALADase L2, 
NAALADL2 
21.0 21.0 61% 388 
Query  3    GGYERGED  10 
            G YE GED 
Sbjct  505  GSYEWGED  512 
 
BAF84442.1 
Arrestin domain-containing protein 3, ARRDC3 [Homo 
sapiens] 
21.0 21.0 76% 388 
Query  4   GYERGEDNNE  13 
           G+ER +DN+E 
Sbjct  90  GHERDDDNSE  99 
 
NP_996898.2 
N-acetylated alpha-linked acidic dipeptidase 2, 
NAALADL2 [Homo sapiens] 
21.0 21.0 61% 388 
Query  3    GGYERGED  10 
            G YE GED 
Sbjct  505  GSYEWGED  512 
 
AAI31600.1 RREB1 protein [Homo sapiens] 21.0 21.0 61% 388 
Query  6    ERGEDNNE  13 
            ERGE+++E 
Sbjct  370  ERGEEDSE  377 
 
EAW81084.1 
zinc finger, FYVE domain containing 1, ZFYVE1, 
isoform CRA_a [Homo sapiens] 
21.0 21.0 46% 388 
Query  5    YERGED  10 
            YERGE+ 
Sbjct  476  YERGEE  481 
 
EAW81221.1 
NIMA (never in mitosis gene a)- related kinase 9, NEK9, 
isoform CRA_b [Homo sapiens] 
21.0 21.0 53% 388 
Query  1  VLGGYER  7 
          VLG YER 
Sbjct  3  VLGEYER  9 
 
CAH73521.1 Ras responsive element binding protein 1 [Homo sapiens] 21.0 36.9 61% 388 Query  6     ERGEDNNE  13 
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>emb|CAI16450.1| ras responsive element binding protein 
1 [Homo sapiens] >emb|CAI14574.1| ras responsive 
element binding protein 1, RREB1 [Homo sapiens] 
             ERGE+++E 
Sbjct  1615  ERGEEDSE  1622 
 
Query  7    RGED  10 
            RGED 
Sbjct  825  RGED  828 
 
CAE75743.1 
TPA: putative N-acetylated alpha-linked acidic 
dipeptidase-like protein 2, NAALADL2 [Homo sapiens] 
21.0 21.0 61% 388 
Query  3    GGYERGED  10 
            G YE GED 
Sbjct  505  GSYEWGED  512 
 
NP_001003698.1 
ras responsive element binding protein 1 isoform 2 [Homo 
sapiens] >ref|NP_001161816.1| ras responsive element 
binding protein 1 isoform 2 [Homo sapiens] 
>sp|Q92766.3|RREB1_HUMAN RecName: Full=Ras-
responsive element-binding protein 1; Short=RREB-1; 
AltName: Full=Raf-responsive zinc finger protein LZ321; 
AltName: Full=Zinc finger motif-enhancer binding-
protein 1; Short=Zep-1; AltName: Full=Finger protein in 
nuclear bodies >gb|EAW55198.1| ras responsive element 
binding protein 1, isoform CRA_a [Homo sapiens] 
>gb|EAW55199.1| ras responsive element binding protein 
1, isoform CRA_a [Homo sapiens] >gb|EAW55200.1| ras 
responsive element binding protein 1, isoform CRA_a 
[Homo sapiens] 
21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1579  ERGEEDSE  1586 
 
Query  7    RGED  10 
            RGED 
Sbjct  844  RGED  847 
 
AAB19094.1 
Ras-responsive element binding protein, RREB1 [Homo 
sapiens] 
21.0 21.0 61% 388 
Query  6    ERGEDNNE  13 
            ERGE+++E 
Sbjct  647  ERGEEDSE  654 
 
AAC25598.1 
Raf responsive zinc finger protein, RREB1 [Homo 
sapiens] 
21.0 21.0 61% 388 
Query  6    ERGEDNNE  13 
            ERGE+++E 
Sbjct  418  ERGEEDSE  425 
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NP_149107.4 
NIMA-related kinase 9 [Homo sapiens] 
>sp|Q8TD19.2|NEK9_HUMAN RecName: 
Full=Serine/threonine-protein kinase Nek9; AltName: 
Full=Never in mitosis A-related kinase 9; Short=NimA-
related protein kinase 9; AltName: Full=Nercc1 kinase; 
AltName: Full=NimA-related kinase 8; Short=Nek8 
>gb|AAH93881.1| NIMA (never in mitosis gene a)- 
related kinase 9 [Homo sapiens] >gb|AAI12102.1| NIMA 
related kinase 9 [Homo sapiens] 
21.0 21.0 53% 388 
Query  1  VLGGYER  7 
          VLG YER 
Sbjct  3  VLGEYER  9 
 
NP_001003699.1 
Ras responsive element binding protein 1, RREB1, 
isoform 1 [Homo sapiens] 
21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1634  ERGEEDSE  1641 
 
Query  7    RGED  10 
            RGED 
Sbjct  844  RGED  847 
 
NP_065852.1 
Arrestin domain containing 3 [Homo sapiens] 
>sp|Q96B67.1|ARRD3_HUMAN RecName: 
Full=Arrestin domain-containing protein 3; AltName: 
Full=TBP-2-like inducible membrane protein; 
Short=TLIMP >gb|AAH15928.1| Arrestin domain 
containing 3 [Homo sapiens] >gb|AAH53619.1| Arrestin 
domain containing 3 [Homo sapiens] >gb|EAW95997.1| 
arrestin domain containing 3 [Homo sapiens] 
21.0 21.0 76% 388 
Query  4   GYERGEDNNE  13 
           G+ER +DN+E 
Sbjct  90  GHERDDDNSE  99 
 
NP_848535.1 
zinc finger, FYVE domain containing 1 isoform 2 [Homo 
sapiens] >gb|AAK27339.1| tandem FYVE fingers-1 
protein [Homo sapiens] 
21.0 21.0 46% 388 
Query  5   YERGED  10 
           YERGE+ 
Sbjct  61  YERGEE  66 
 
AAL87410.1 NIMA-family kinase NERCC1, NEK9 [Homo sapiens] 21.0 21.0 53% 388 
 
Query  1  VLGGYER  7 
          VLG YER 
Sbjct  3  VLGEYER  9 
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AAD31940.1 NEK9 [Homo sapiens] 21.0 21.0 53% 388 
Query  1  VLGGYER  7 
          VLG YER 
Sbjct  3  VLGEYER  9 
 
BAD32776.1 
zinc-finger motif-enhancer binding-protein-1, RREB1 
[Homo sapiens] 
21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1634  ERGEEDSE  1641 
 
Query  7    RGED  10 
            RGED 
Sbjct  844  RGED  847 
 
BAD32779.1 
Zinc-finger motif-Enhancer binding-Protein-1, RREB1, 
gamma [Homo sapiens] 
21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1368  ERGEEDSE  1375 
 
Query  7    RGED  10 
            RGED 
Sbjct  844  RGED  847 
 
BAD32778.1 
zinc-finger motif-enhancer binding-protein-1, RREB1, 
beta [Homo sapiens] 
21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1579  ERGEEDSE  1586 
 
Query  7    RGED  10 
            RGED 
Sbjct  844  RGED  847 
 
BAB13415.1 ZFYV1 [Homo sapiens] 21.0 21.0 46% 388 
Query  5    YERGED  10 
            YERGE+ 
Sbjct  515  YERGEE  520 
 
AAL05428.1 
NIMA-related kinase Nek8 [Homo sapiens] 
>gb|EAW81220.1| NIMA (never in mitosis gene a)- 
21.0 21.0 53% 388 
Query  1  VLGGYER  7 
          VLG YER 
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related kinase 9, isoform CRA_a [Homo sapiens] 
>gb|EAW81222.1| NIMA (never in mitosis gene a)- 
related kinase 9, NEK9, isoform CRA_a [Homo sapiens] 
Sbjct  3  VLGEYER  9 
 
BAB55085.1 ZFYV1 [Homo sapiens] 21.0 21.0 46% 388 
Query  5    YERGED  10 
            YERGE+ 
Sbjct  476  YERGEE  481 
 
 
NP_067083.1 
zinc finger, FYVE domain containing 1 isoform 1 [Homo 
sapiens] >sp|Q9HBF4.1|ZFYV1_HUMAN RecName: 
Full=Zinc finger FYVE domain-containing protein 1; 
AltName: Full=Double FYVE-containing protein 1; 
AltName: Full=Tandem FYVE fingers-1; AltName: 
Full=SR3 >gb|AAG23748.1|AF251025_1 double FYVE-
containing protein 1 [Homo sapiens] >emb|CAC83950.1| 
phosphoinositide-binding protein [Homo sapiens] 
>gb|AAH53520.1| Zinc finger, FYVE domain containing 
1 [Homo sapiens] >gb|EAW81085.1| zinc finger, FYVE 
domain containing 1, isoform CRA_b [Homo sapiens] 
21.0 21.0 46% 388 
Query  5    YERGED  10 
            YERGE+ 
Sbjct  476  YERGEE  481 
 
BAA23165.1 DNA-binding protein, RREB1 [Homo sapiens] 21.0 36.9 61% 388 
Query  6     ERGEDNNE  13 
             ERGE+++E 
Sbjct  1559  ERGEEDSE  1566 
 
Query  7    RGED  10 
            RGED 
Sbjct  825  RGED  828 
 
BAA92614.1 KIAA1376 protein, ARRD3[Homo sapiens] 21.0 21.0 76% 388 
Query  4    GYERGEDNNE  13 
            G+ER +DN+E 
Sbjct  113  GHERDDDNSE  122 
 
BAC02704.1 KIAA1995 protein, NEK9 [Homo sapiens] 21.0 21.0 53% 388 
Query  1   VLGGYER  7 
           VLG YER 
Sbjct  35  VLGEYER  41 
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BAI51368.1 
immunoglobulin heavy chain variable region, IGH [Homo 
sapiens] 
20.6 20.6 53% 521 
Query  5   YERGEDN  11 
           +ERG+DN 
Sbjct  65  FERGQDN  71 
 
BAH12057.1 Exocyst complex component 4, EXOC4 [Homo sapiens] 20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  221  GYQRGEN  227 
 
EAW83806.1 
Exocyst complex component 4, isoform CRA_c [Homo 
sapiens] 
20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  322  GYQRGEN  328 
 
EAW78858.1 
ring finger protein 13, isoform CRA_a [Homo sapiens] 
>gb|EAW78860.1| ring finger protein 13, isoform CRA_a 
[Homo sapiens] >gb|EAW78862.1| ring finger protein 13, 
isoform CRA_a [Homo sapiens] >dbj|BAG52224.1| 
unnamed protein product [Homo sapiens], RNF13 
20.6 20.6 69% 521 
Query  5    YERGEDNNE  13 
            YE  ED+NE 
Sbjct  222  YE--EDDNE  228 
 
NP_001032203.1 Exocyst complex component 4 isoform b [Homo sapiens] 20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  322  GYQRGEN  328 
 
AAH67263.1 Exocyst complex component 4 [Homo sapiens] 20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  322  GYQRGEN  328 
 
 
AAH26174.1 EXOC4 protein [Homo sapiens] 20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  322  GYQRGEN  328 
 
BAB21790.1 KIAA1699 protein, EXOC4 [Homo sapiens] 20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
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Sbjct  314  GYQRGEN  320 
 
NP_009213.1 
ring finger protein 13 [Homo sapiens] >ref|NP_899237.1| 
ring finger protein 13 [Homo sapiens] 
>sp|O43567.1|RNF13_HUMAN RecName: Full=RING 
finger protein 13 >gb|AAC03769.1| RING zinc finger 
protein [Homo sapiens] >gb|AAC28641.1| RING zinc 
finger protein RZF [Homo sapiens] >gb|AAH09781.1| 
Ring finger protein 13 [Homo sapiens] >gb|AAH09803.1| 
Ring finger protein 13 [Homo sapiens] 
>emb|CAG33085.1| RNF13 [Homo sapiens] 
>gb|EAW78859.1| ring finger protein 13, isoform CRA_b 
[Homo sapiens] >gb|EAW78861.1| ring finger protein 13, 
isoform CRA_b [Homo sapiens] >gb|EAW78863.1| ring 
finger protein 13, isoform CRA_b [Homo sapiens] 
>dbj|BAG36109.1| unnamed protein product [Homo 
sapiens] >dbj|BAG52202.1| unnamed protein product 
[Homo sapiens] 
20.6 20.6 69% 521 
Query  5    YERGEDNNE  13 
            YE  ED+NE 
Sbjct  341  YE--EDDNE  347 
 
CAD39134.1 hypothetical protein, EXOC4 [Homo sapiens] 20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  109  GYQRGEN  115 
 
NP_068579.3 
SEC8 protein isoform a [Homo sapiens] 
>sp|Q96A65.1|EXOC4_HUMAN RecName: 
Full=Exocyst complex component 4; AltName: 
Full=Exocyst complex component Sec8 
>gb|AAK57456.1|AF380839_1 secretory protein SEC8 
[Homo sapiens] >dbj|BAB55298.1| unnamed protein 
product [Homo sapiens] >emb|CAD89977.1| hypothetical 
protein [Homo sapiens] >gb|EAL24073.1| SEC8-like 1 (S. 
cerevisiae) [Homo sapiens] >gb|EAW83804.1| exocyst 
complex component 4, isoform CRA_a [Homo sapiens] 
20.6 20.6 53% 521 
Query  4    GYERGED  10 
            GY+RGE+ 
Sbjct  322  GYQRGEN  328 
 
Q9Y618.2 
RecName: Full=Nuclear receptor corepressor 2; Short=N-
CoR2; AltName: Full=Silencing mediator of retinoic acid 
20.2 38.6 100% 699 
Query  8    GEDNNE  13 
            GEDN+E 
253 
 
and thyroid hormone receptor; Short=SMRT; AltName: 
Full=Thyroid-, retinoic-acid-receptor-associated 
corepressor; AltName: Full=T3 receptor-associating 
factor; Short=TRAC; AltName: Full=CTG repeat protein 
26; AltName: Full=SMAP270; NCOR2 
Sbjct  555  GEDNDE  560 
 
Query  1     VLGGYERGED  10 
             VLGG   GED 
Sbjct  2222  VLGG---GED  2228 
BAH12506.1 
Highly similar to Glutamate receptor, ionotrophic, AMPA 
3, GRIA3 [Homo sapiens] 
20.2 20.2 38% 699 
Query  9    EDNNE  13 
            EDNNE 
Sbjct  568  EDNNE  572 
 
BAH12200.1 
 Highly similar to SLIT-ROBO Rho GTPase-activating 
protein 2, SRGAP2 [Homo sapiens] 
20.2 20.2 46% 699 
Query  5    YERGED  10 
            +ERGED 
Sbjct  541  FERGED  546 
 
BAH11812.1 
Highly similar to Rho GTPase-activating protein 4, 
ARHGAP4 [Homo sapiens] 
20.2 20.2 46% 699 
Query  5    YERGED  10 
            +ERGED 
Sbjct  535  FERGED  540 
Table A.1. Blastp results of ROBO1 antibody immunogen sequence. 
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